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2ABSTRACT
Globally malaria still remains the most important parasitic disease of public health interest.
In the recent past, most endemic countries have deployed and scaled up both preventive
and curative interventions to reduce malaria transmission and, ideally, eliminate it. This has
lead to global reductions in both mortality and incidence of malaria. These declines have
been attributed to the reinvigoration of the global malaria control agenda by the explicit
ambition of achieving elimination, which has lead to an increase in funding for national
control programmes to increase coverage of preventive interventions, field compatible
diagnostic tools for confirming parasite infection, and increased access to effective
treatment.  As a result of declines in malaria transmission, the focal nature of malaria
transmission has become much more evident and has lead to consideration of surveillance
as a key intervention for malaria control/elimination in its own right.
Surveillance systems have been well established in most formal health facilities but the
incorporation of these systems at community level and operationalised by community
health workers (CHWs) still remains limited. Additionally, these few examples of CHW-
implemented surveillance systems have been typically only reporting indicators of malaria
infection burden, without capturing indicators of intervention availability, deployment,
coverage and utilisation, thus representing a missed opportunity for routine monitoring and
evaluation of impact of interventions in “real time” to inform program planning and
implementation.
The study was established as part of a multi-country study under the Malaria Transmission
Consortium Project whose primary objective was to develop and evaluate new or improved
methods for measuring malaria transmission.  Thus the overall goal of this study was to
3demonstrate how malaria transmission, and impact of interventions, could be routinely
measured through a novel longitudinal community based surveillance system (CBSS)
operationalised by modestly paid CHWs.
The CBSS included both passive and active surveillance activities using field – compatible
test kits for in situ parasitological detection of malaria infections, based on which confirmed
cases were treated with anti-malarial drugs, coupled with a detailed questionnaire on access
and use of malaria control interventions and population characteristics. Passive surveillance
was achieved conventionally whenever community members self-reported to the CHWs and
active surveillance was achieved through monthly active visits to all households in their
catchment populations to offer testing and treatment. In addition to recording detailed
details of each patient contact in a paper patient register, weekly summaries of selected
data elements were submitted by the CHWs using a mobile phone platform via short
messaging system (SMS). The detailed reference data recorded in the patient register was
then used to monitor malaria infection dynamics in the study population, evaluate the
impact of preventative measures, such as indoor residual spraying (IRS) and long-lasting
insecticidal nets (LLINs) and validate the electronic summaries submitted via SMS.
Overall, the CBSS did not routinely capture all malaria infections in the study population and
was insufficient to eliminate the human parasite reservoir. This was primarily due to limited
study participant participation with the monthly active testing and treatment offered by the
CHWs. However, the CBSS clearly demonstrated the incremental and residual impact to
supplementation of pyrethroid-treated LLINs with non - pyrethroid insecticides applied by
IRS in areas where the dominant malaria vector is highly resistant to pyrethroids. The
adequacy of the SMS reports submitted by the CHWs confirms the great potential of mobile
4phone technology for facilitating and improving the effectiveness of community based
reporting. Despite its limitations, the CBSS successfully provided programmatically relevant
information regarding malaria infection dynamics across the large study area at a very
affordable cost. The CHWs demonstrated their ability to not only provide treatment services
but also adequately report their findings both electronically and on paper. CHWs are
primarily tasked with providing routine health services at community level but clearly also
have a valuable auxiliary role to play in “real time” surveillance of malaria, and most
probably a range of other diseases. If the full potential of CHWs as agents of health
surveillance can be realized, control programme progress can be measured through spatial
and temporal mapping of transmission with greater sensitivity and at finer scales than is
possible with health facilities alone, to enable improved, better-informed program planning,
resource allocation and implementation.
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CHAPTER ONE
GENERAL INTRODUCTION AND LITERATURE REVIEW
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1.1 Introduction
Globally, there have been significant strides made in efforts to control malaria over the last
decade (WHO 2013; WHO 2014). These positive developments have lead to the adoption of
even more ambitious goals of malaria elimination from most endemic countries and,
eventually, its global eradication (WHO 2013; WHO 2014). These positive gains have been
attributed to the integrated approach of malaria control through cost-effective preventive
and curative interventions, facilitated by a renewed global financial, technical and
infrastructural support platform (Eisele, Larsen et al. 2012). The key vector control
interventions are presently protection of sleeping spaces with long-lasting insecticidal nets
(LLINs) and indoor residual spraying (IRS) of houses, and these are coupled with field
compatible confirmatory diagnostic tools and artemisinin-based combination therapies for
treatment (Eisele, Larsen et al. 2012; WHO 2014).
The use of curative drugs has been primarily focussed on addressing clinical manifestations
of infection (McCombie 1996; Tanner and Vlassoff 1998; Najera 2001). However the
majority of malaria parasite infections in the human populations exist as chronic infections
that are often classified as “asymptomatic” because the infected human hosts do not feel ill
enough to seek care, thus sustaining malaria transmission.  Thus, chemotherapy for
reduction of malaria transmission by such chronic carriers is being revisited as a
complementary intervention with which to supplement the main-stream vector control and
passive curative interventions (Okell, Drakeley et al. 2008; Okell, Ghani et al. 2009; Gosling,
Okell et al. 2011) particularly in areas of low and seasonal transmission (Molineaux and
Gramiccia 1980; von Seidlein, Walraven et al. 2003; WHO 2010). Historically, these
approaches have been evaluated in the past in terms of their ability to interrupt malaria
transmission. However, the impact of chemotherapy interventions has been mediocre and
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short-lived at best, particularly when used without population wide vector control
interventions (Molineaux and Gramiccia 1980; Jeffery 1984). Additionally, there have been
concerns about the development of parasite resistance to the treatments due to wide scale
and prolonged use (Greenwood 2010; Kaneko 2010).  Malaria chemotherapy beyond
routine passive curative service provision is broadly described as either mass drug
administration (MDA) or mass screening and treatment (MSAT)(WHO 1963; Gosling, Okell et
al. 2011). The former encompasses administration of anti-malarial drugs to entire targeted
populations irrespective of confirmation of parasite infection, while the latter is provision of
treatment to populations that have been subjected to a confirmatory diagnostic test and
yield a positive test result. A major limitation of MSAT lies in the inability of currently
available rapid diagnostic tests to detect low density infections, which can still contribute to
the infection reservoir (Crowell, Briet et al. 2013). Currently, artemisinin-based combination
therapies (ACTs) is the only available drug class that can potentially be used for MDA and
MSAT.  In addition to clearing asexual stage parasites, ACTs are also known to kill sexual
gametocyte stages when they are immature so they may also reduce malaria transmission
(von Seidlein and Greenwood 2003; Okell, Drakeley et al. 2008; Bousema, Okell et al. 2010).
Chemotherapy interventions are thought to be most effective for transmission control when
applied in low to moderate transmission areas, especially in the low transmission season
when vector populations are at their lowest densities so the risk of re-infection is reduced
(Griffin, Hollingsworth et al. 2010; Okell, Griffin et al. 2011).
Detecting temporal and spatial variations in malaria infection risk, to guide implementation
of preventative and curative interventions, including chemotherapy, requires a viable
surveillance system. These systems are usually weak in resource-limited malaria-endemic
countries, thus limiting accurate assessment of disease trends and guide program planning
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and implementation (WHO 2013). Additionally, they are mostly facility based and thus
biased to reporting only acute symptomatic cases that seek care, which will therefore not be
adequate to eliminate reservoirs of chronic, sub-acute, non-reporting infections. Thus in
endemic countries the “reach” of the health facility, with regard to both service provision
and derived reporting and surveillance functions may be increased with the use of
community health workers (CHWs). These secondary reporting functions, integrated into an
extended Health Management Information System (HMIS), should not distract in any way
from the primary function of CHWs for providing diagnostic and curative services but should
rather be viewed as an additional “spin-off” benefit that delivers enhanced surveillance to
describe spatial and temporal disease trends at a fine scale. The use of community based
surveillance systems (CBSS) have been underutilized globally with regard to malaria disease
burden and service delivery indicators (WHO 2013), despite the availability of well-
documented evidence of the ability of CHWs to both diagnose and treat malaria
(Delacollette, Van der Stuyft et al. 1996; Yeboah-Antwi, Pilingana et al. 2010; Counihan,
Harvey et al. 2012; Kalyango, Rutebemberwa et al. 2012), as well as report their findings
(Hopkins, Talisuna et al. 2007; Alba, Hetzel et al. 2011; Kalyango, Rutebemberwa et al.
2012). In principle, these CBSS have potential to directly evaluate progress of program
implementation with regard to intervention coverage, utilization and associated
epidemiological outcomes in the catchment areas they cover.  Such fine scale information
would be invaluable to local health authorities for guiding resource prioritization and
planning. Furthermore, recent advances in the availability of mobile phone technology in
rural Africa suggest that it should be possible for such data to be reported electronically in
real time so that they can be compiled, assessed and acted upon in a far timelier manner
than existing paper-based HMIS platforms(Kamanga, Moono et al. 2010; Brieger 2012;
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Zurovac, Talisuna et al. 2012).These innovations should be scalable and functional in low
resource settings, easy to use and inexpensive.
However, the full benefits of such CBSS in a routine and sustainable program framework
need to be rigorously evaluated and optimized before they can adopted at national scale up.
1.1.1 Goals and Objectives
1.1.2 Goal
The overall goal of the study was to demonstrate how paid CHWs offering malaria diagnosis
and treatment services both passively and actively can be utilised to routinely monitor,
characterize and control malaria infection burden and to assess the impact of
supplementary vector control measures upon it.
1.1.3 Objectives
1.1.3.1 To evaluate the effectiveness of passively and actively provided malaria diagnosis
and treatment services by CHWs for monitoring, characterizing and controlling infection
burden.
1.1.3.2 To compare and contrast a mobile phone-based malaria reporting system with
source participant register data for capturing spatial and temporal trends in epidemiological
indicators of malaria transmission collected by community health workers in rural Zambia.
1.1.3.3 To demonstrate how community-based surveillance can be used to estimate the
incremental protective efficacy provided by alternative IRS regimes in an area of high ITN
coverage, upon diagnostic positivity and vector density.
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1.2 Literature Review
1.2.1 Introduction to malaria
Malaria still remains the world’s most important parasitic disease (WHO 2013; WHO 2014).
Malaria is caused by a blood infection of protozoan parasites from the genus Plasmodium,
which is transmitted from one human to another by female Anopheles mosquitoes. The
species that infect humans are Plasmodium falciparum, P. malariae, P.ovale and P.vivax
(McKenzie and Bossert 1997; Carter and Mendis 2002; Zimmerman, Mehlotra et al. 2004;
Nadjm and Behrens 2012). A fifth species, P. knowlesi, has also been identified as a clinically
significant pathogen in humans. This species, found in southeast Asia is typically a malaria
parasite of the long and pig tailed monkeys (macaques) (Garnham, Lainson et al. 1957; Chin,
Contacos et al. 1965; Singh, Sung et al. 2004; Cox-Singh, Davis et al. 2008; White 2008; Singh
and Daneshvar 2010; Antinori, Galimberti et al. 2012).  Globally, by far the most common of
these are P. falciparum and P.vivax, with the former being the most lethal of the malaria
parasites infecting humans and the latter being the most common and widespread across
the Middle East, Asia, Central and South America (Table 1), where it is responsible for 70–
90% of the global malaria burden (Carter and Mendis 2002; Hay, Guerra et al. 2004; Galinski
and Barnwell 2008; Guerra, Howes et al. 2010; Prajapati, Joshi et al. 2011; Nadjm and
Behrens 2012).
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Table 1. Human malaria species distribution and clinical /pathologic features (Adapted
from Nadjm & Behrens, 2012)
Species Distribution Clinical/Pathologic Details
P. falciparum Widespread throughout the
tropics
Causes the most fatalities
Pronounced rosetting and sequestration
P. vivax Widespread in tropics and
subtropics, however quite
rare in most parts of Africa
Relapses caused by hepatic hypnozoites
Requires Red Blood Cell Duffy antigen for entry into cells
P. ovale Patchy in West Africa and
southwest Pacific
Relapses caused by hepatic hypnozoites
P. malariae Patchy, worldwide Late recrudescence and chronic infections
Nephrotic syndrome (urinary protein, edema & increased
cholesterol) (rarely)
P. knowlesi Malaysia, Indonesia and
other southeast Asia
Zoonosis (macaque monkeys are common hosts)
Severe disease
Malaria is an acute febrile illness with symptoms that may appear from seven to fifteen days
post exposure to an infective mosquito bite, depending on the causative parasitic species
(Miller, Good et al. 1994; Miller, Baruch et al. 2002; Nadjm and Behrens 2012).  The
multiplication of the parasites in the red blood cells results in several symptoms which may
include fever, chills and vomiting among others, with the possibility of progression to coma
or even death in severe cases (WHO 1963; Bruce Chwatt 1985; Nadjm and Behrens 2012).
The severity of these symptoms is dependent on the patient predisposition with regard to
immunity to malaria (Smith and Schapira 2012) and the causative infective strain of the
parasite (Jeffery and Eyles 1954; Muller, Genton et al. 2009).
A key feature of malaria parasite infections is the periodicity of the fevers they cause, which
occur in multiples of 24 hour intervals (Table 2) (Cunha and Cunha 2008; Antinori,
Galimberti et al. 2012). P. falciparum infection is characterized by acute cerebral, renal, or
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gastrointestinal manifestations and severe paroxysms that reoccur every 2 days (48 hour
interval) (malignant tertian) (Cunha and Cunha 2008; Antinori, Galimberti et al. 2012). If P.
falciparum infection is not urgently treated, it may rapidly progress to severe disease and
even death. Tertian fever or fever that occurs on a 3 day cycle (48 hour interval) is caused by
P.ovale and P. vivax (Collins and Jeffery 2005; Antinori, Galimberti et al. 2012). Infection
with these two parasites is characterised by relapses due to presence of the dormant liver
stage hypnozoites, which are known to have long latent periods that may range from weeks,
months to years (Lysenko and Beljaev 1969; Adak, Sharma et al. 1998; Collins and Jeffery
2005; Garcia 2010; Antinori, Galimberti et al. 2012). P. malariae is the causative agent for
quartan fever, which is an acute febrile episode that returns every fourth day (72 hours
interval) (Collins and Jeffery 2007; Cunha and Cunha 2008; Garcia 2010; Antinori, Galimberti
et al. 2012). This infection has been known to be  benign for up to 50 years in a few
exceptional cases and is usually associated with low levels of parasitaemia infection (Collins
and Jeffery 2007). P.knowlesi infection exhibits a unique daily or quotidian fever cycle, thus
patients may not exhibit typical paroxysms patterns but rather have stable low-grade fever
or an irregular lessening and then re- intensifying fever pattern (Chin, Contacos et al. 1965;
White 2008; Ta, Salas et al. 2010).
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Table 2. Characteristics of infection with the five human infection species (Adapted from
Cunha & Cunha, Antinori et al., 2012, and White & Imwong 2012)
Characteristics P. falciparum P. knowlesi P. malariae P.ovale P.vivax
Pre-erythrocytic
stage (days )
5-7 8-9 14-16 9 6-8
Hypnozoite stage
duration (months)
0 0 0 ½ – 9 months
(exceptional cases
of up to 4 years
have been
reported )
¾ -9 months
Types of malaria Malignant tertian /
Pernicious tertian/
semi tertian
Quotidian Quartan Ovale tertian Benign tertian
Pre-patent period
(days)
9-10 9-12 15-16 10-14 11-13
Erythrocytic cycle
(days)
48 24 72 50 48
Red cells affected All All Mature
erythrocytes
Reticulocytes Reticulocytes
Parasitaemia per µL
Average
Maximum
20,000-500,000
2,000,000
600 -10,000
236,000
6,000
20,000
9,000
30,000
20,000
100,000
Febrile paroxysm
(hours)
16-36 or longer 8-12 8-10 8-12 8-12
Severe malaria Yes Yes No No Yes
Relapses from liver
forms
No No No Yes Yes
Recurrences Yes (treatment
failure)
Yes Yes (as long as
30-50 years
after primary
attack)
No Yes (treatment
failure )
1.2.2 Dynamics of Malaria transmission
Malaria has a complex epidemiology which is determined by four main factors which
include; the environment, vector, parasite and host (Draper and Smith 1957; Hay, Guerra et
al. 2009; Guerra, Howes et al. 2010). The interplay of these ecological and biological factors
for both the human and vector hosts influences malaria transmission (Figure 1) (Drakeley
2013). For the malaria vector to transmit malaria, several key elements of the vector
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population have to be in place and these include; parasite incubation period in the vector,
number of blood meals taken per vector per day, density of vectors in relation to humans
and the  daily survival of the vector (Shililu, Ghebremeskel et al. 2003; Hay, Guerra et al.
2004; Drakeley 2013). The time required for the sporogonic cycle in the mosquito varies and
is dependent on the Plasmodium species and external temperature. The later also affects
mosquito longevity (Onori and Grab 1980; Molineaux, Muir et al. 1988; Beier 1998; Sinka,
Bangs et al. 2012).
Figure 1.Factors that influence infectivity (Adapted from Drakeley 2013)
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Optimal parasite development in the vector occurs between the temperatures 20°C to 30°C,
however sporogony has been known to take place even at lower temperatures that range
from 16°C to 40°C (Vanderberg and Yoeli 1966; LaPointe, Goff et al. 2010). Rainfall plays a
part in providing habitat for breeding of the vector. In Africa Anopheles gambiae and An.
arabiensis can utilise a wide variety of permanent and temporal water bodies that are
exposed to strong sunlight, while A. funestus strongly prefer more permanently shaded
water bodies (Gillies and Meillon 1968).  Thus, higher temperatures in combination with
high relative humidity, favour shortened parasite development, increased vector longevity
and subsequent number of blood meals taken by the Anopheles vector (Onori and Grab
1980; Molineaux, Muir et al. 1988; Shililu, Ghebremeskel et al. 2003; Zhou, Minakawa et al.
2004; Reyburn, Mbatia et al. 2005; Hay, Guerra et al. 2009).
Only Anopheline mosquitoes that survive longer than the sporogonic phase  are able to
transmit malaria (Zucker 1996). However, only a small proportion of the vectors actually live
long enough in nature to be able to transmit the infection. This is alluded to in the basic
reproductive number (R0),which is the  expected number  of secondary cases  produced,  in
a  completely  susceptible  population,  by  a  typical  infected individual  during  its  entire
period  of  infectiousness of vector borne infections (Diekmann, Heesterbeek et al. 1990;
Dietz 1993; Smith, McKenzie et al. 2007). These infections are highly dependent on the
longevity of the vector, specifically its infective life expectancy (Garrett-Jones 1964; Dye
1992; Zucker 1996). Thus, the number of parasite infected person’s increases when R0 is
greater than 1 and decreases if R0 is less than 1. In essence, the goal of infectious disease
eradication is vested in the deployment of interventions aimed at keeping R0 below 1 (Smith
and Schapira 2012).  The  estimates of R0 are based on the entomological inoculation rate
(EIR), which is the mean number of infectious bites received by a person annually and the
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parasite ratio (PR), which is the prevalence of malaria infection in humans (Smith, McKenzie
et al. 2007). The relationship between EIR and PR varies as a result of the human
population’s heterogeneity due to the fact that some populations are bitten more than
others and differ in levels of susceptibility to infection per bite due to among others
mosquito feeding preferences and their proximity to larval habitats (20 % of the population
receive 80 % of the infections) (Smith and Ellis McKenzie 2004; Smith, Dushoff et al. 2005).
Mathematical epidemiologic models provide insight into infectious disease transmission and
their concepts have been utilized in design of various control programmes including the
Global Malaria Eradication Programme in the 1950s and 60s (Farrington, Kanaan et al. 2001;
Smith and Schapira 2012).  One such model pioneered by Ross and later modified with
contributions from Macdonald and others lead to an understanding of the linked
phenomena for mosquito borne pathogen transmission (Ross 1911; Macdonald 1957; Smith,
Battle et al. 2012). The model demonstrated the dependence of R0 on the density of vectors,
their preferred feeding behaviour, vector survival and the infectiousness of the host (Smith
and Schapira 2012). The Ross-Macdonald model was defined as follows (Ross 1911;
Macdonald 1957):
= ∝ (1 − ) −
=∝ (1 − ) −
Where:
is the proportion of the human population infected?
is the proportion of the female mosquito population infected;
is the size of the human population;
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is the size of the female mosquito population;= is the number of female mosquitoes per human host;
is the rate of biting on man by a single mosquito (number of bites per unit time);
is the proportion of infected bites on man that produce an infection;
is the per capita rate of recovery for humans (1/ is the average duration of infection in
the human host);
µ is the per capita mortality rate for mosquitoes (1/µ is the average life time of a mosquito).
Despite its simplistic structure the model (Figure 2) allows for a comparison and subsequent
interpretation of broad epidemiological patterns. A few assumptions were made which
included ; the human host has no acquired immunity, humans are bitten by mosquitoes
randomly, and mosquito and human populations are homogenous in nature (Koella 1991).
Figure 2.Structures of Ross-Macdonald model of malaria transmission (Adapted from
Koella 1991)
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R0 best describes the basic results of the model. According to Aron and May, R0 is derived
using the formula (Aron and May 1982):
=
From the equation above it is clear that, malaria transmission is aided by a high number of
contacts with mosquitoes that a single human has per unit time (high / ); a subsequent
high number of mosquitoes that a single human infects over the entire infectious period
(high ( )); a high number of contacts with humans that one mosquito has per unit time
(high ); a high probability of transmission from an infectious mosquito to a susceptible
human (high ) ; a long mean infectious period of the mosquito (long 1/ ) and; high
number of humans that a mosquito infects through its infectious lifetime (high / ). The
model assumes the probability from an infectious human to a susceptible mosquito is equal
to 1 and 1/ is mean duration of the latent period of the human (Aron and May 1982; Koella
1991).
The model has some key elements missing such as the assumption that the population of
humans and mosquitoes is constant and does not take into consideration the period of time
a mosquito requires to develop into an adult for it to be able to transmit malaria (Smith,
Battle et al. 2012) and that biting rate of the vectors per host is dependent on the biomass
of the person, thus overestimating the challenge faced by small children (Smith, Killeen et
al. 2004). However over the years, others have continued to work on this model to fully
develop the key elements (Smith, Battle et al. 2012).  Some of this work has been based on
various assumptions which include ; there is a host population that is susceptible to
infection, some members of the population are exposed to infection but are not able to pass
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the infection on during the latent period, infected individuals can lead to more infected
populations through interaction with susceptible groups, there is a part of the population
that recovers from the infection, some infected population die due to infection and that the
number of mosquitoes and humans is not constant (Smith, McKenzie et al. 2007; Mandal,
Sarkar et al. 2011).
In the same vain as the Ross –Macdonald model, Smith and colleagues proposed a model
based on the life cycle of P. falciparum, which forms the basis for the formula used to
calculate R0 as illustrated in Figure 3 (parameters described in table 3).
Figure 3.The cycle model and reproductive number (Adapted from Smith et al., 2007)
ma (# bites , per
person per year )
c (% bites on infected
humans that infect a
mosquito)
e –gn (% that survive
sporogony)
S = a/g (# human bites
per mosquito)
b (% bites by
infectious mosquitoes
that infect a human )
1/r (duration of a
human infection)
INFECTIVITY
HUMAN BITING
RATE
INFECTIVITY
STABILITY
INDEX
Ro
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This model is based on the assumption that all humans are bitten at the same rate and that
the population is infinite. Thus, in such populations, humans that are bitten most absorb
more parasites and infect more mosquitoes which results in an increase in R0 (Smith and
Ellis McKenzie 2004; Smith, McKenzie et al. 2007).  The model assumes a stable relationship
between the EIR, PR and vector capacity, which is the number of infectious bites that arise
from all mosquitoes infected by one person on a single day, the human infectivity to
mosquitoes (c), and the stability index (S), the number of bites a vector makes on a human
in its lifetime (Smith, McKenzie et al. 2007).
Table 3. Parameters of life cycle model and reproductive number (Adapted from Smith et
al., 2007)
Parameter Description
a Human feeding rate: the number of bites on a human, per mosquito, per day. Let f
denote the feeding rate, i.e., the number of bites, per mosquito, per day, and Q the
proportion of bites on humans. The human feeding rate is the product a= fQ.
b Infectivity of mosquitoes to humans: the probability that a human becomes
infected from a bite by an infectious mosquito.
With pre-erythrocytic immunity, the infectivity of mosquitoes may depend on EIR,
bE
c Infectivity of humans to mosquitoes: the probability that a mosquito becomes
infected from a bite on an infected human. Infected humans are not infectious all
the time and infectious bites transmit less than perfectly. With transmission
blocking immunity, infectivity of humans may depend on EIR, cE
g Death rate of mosquitoes. The probability a mosquito survives one day is p = e-g, so
g =-ln p. The expected lifespan of a mosquito is 1/g.
m Number of mosquitoes per human. Assuming adult mosquitoes emerge at a
constant rate λ, per human, then m = λ/g.
n Number of days required for a mosquito to complete sporogony.
1/r Expected waiting time to naturally clear a simple infection.
It is however important to note that malaria transmission, particularly P. falciparum malaria,
does not reach its full potential primarily due to host naturally acquired immunity (Smith
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and Schapira 2012). A key effect of acquired immunity is the reduction of asexual parasite
stages, which consequently reduces the number of potential sexual stage parasites thus
affecting the infectivity of humans to mosquitoes particularly in endemic areas (Alavi, Arai
et al. 2003; Smith and Schapira 2012).This however does not prevent transmission from
taking place, as it has been shown that even at low sexual stage densities transmission does
occur, thus bottlenecking the parasite from reaching its full transmission potential (Alavi,
Arai et al. 2003; Bousema and Drakeley 2011; Smith and Schapira 2012).
1.2.3 Global Burden of Malaria
Malaria still remains a major public health problem both globally and regionally. According
to the World Health Organisation (WHO), there were 216 million cases of malaria globally in
2010, of which 81% were in the African region and an estimated 655,000 people (91% of
these in the African region) died from the disease, many of whom were children under the
age of five (WHO 2012). In the last decade there has been great progress made towards the
prevention of malaria. According to the WHO,  global malaria mortality and incidence rates
have reduced by 26% and 17% respectively, since 2000 (WHO 2012). The declines in malaria
deaths has been attributed to an increase in funding which has lead to increased population
wide coverage of malaria control interventions coupled with effective confirmatory
diagnosis and treatment (Eisele, Larsen et al. 2012). The accurate estimation of malaria
attributable mortality still remains a challenge as most deaths occur at home and thus
difficult to authenticate (Korenromp, Williams et al. 2003; de Savigny and Binka 2004).
According to Murray and colleagues, 433,000 more deaths occurred worldwide in the
population under the age of 5 years or older in 2010 than was suggested by the WHO
estimates. Of these malaria deaths, 104,000 were estimated to have occurred outside Africa
(Murray, Rosenfeld et al. 2012).
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In addition to morbidity and mortality, malaria also exerts an economic burden where it
occurs both at a national and household level (Sachs and Malaney 2002; Chima, Goodman
et al. 2003; Laxminarayan 2004). These economic impacts at a national level may include,
decreased productivity due to brain damage from cerebral malaria, working days lost due to
sickness, cost of health care, days lost in education due to reduced cognitive development
particularly in children and a loss of investments and tourism (Greenwood, Bojang et al.
2005; Fink, Olgiati et al. 2013). At the household level, these impacts may include, work time
lost by the unwell household member, time spent giving care to sick family members, loss of
productivity, costs associated with seeking care such as transportation and treatment and
premature mortality among others (Sachs and Malaney 2002; Chima, Goodman et al. 2003;
Laxminarayan 2004).
While Malaria transmission is geographically confined to the tropics and sub-tropics, it was
formerly common in many parts of temperate northern Europe, America and Asia (Sachs
and Malaney 2002; Kiszewski, Mellinger et al. 2004). The favourable climatic conditions
(appropriate temperature and rainfall patterns ) in the tropics and subtropics coupled with
the human biting habits of the mosquito vectors and the presence of complementing
malaria vectors (An. gambiae (wet season) and the An. funestus (dry season)) make these
areas favourable for malaria transmission particularly in west and central parts of Africa
(Bruce-Chwatt, Garrett-Jones et al. 1966; Gillies and Coetzee 1987; Killeen, McKenzie et al.
2001; Keiser, Utzinger et al. 2004; Kiszewski, Mellinger et al. 2004). Approximately 39% of
the global malaria burden occurs in central and south-eastern Asia (Hay, Okiro et al. 2010).
The Asian–Pacific region accounts for 88% of all malaria outside Africa (second to Africa).
This has been attributed to the presence of a wide diversity of physiologically competent
38
vector species that exhibit varied behavioural patterns and preferences (Foley, Rueda et al.
2007; Hay, Okiro et al. 2010).
1.2.4 History of Discovery and Identification of Malaria Parasites
In 500 BC, Greek physician Hippocrates was first to describe the clinical symptoms of
malaria and hypothesized on its linkage to stagnant water, which at the time was thought to
be the causative agent (Cunha and Cunha 2008; Pappas, Kiriaze et al. 2008; George 2009;
Wiser 2011). In 1879, Patrick Manson, a Scottish physician demonstrated that Bancroft’s
filarial (Wuchereria bancrofti) vector was a mosquito of the genus Culex. He, as Hippocrates,
proposed that drinking water had something to do with the transmission of malaria (Dobson
1999; Capanna 2006). A year later in 1880, when Charles Laveran, a French army surgeon
described malarial parasites in the blood of patients during malarial fever episodes, which
he initially named as Oscillaria malariae (Bruce Chwatt 1985; Smith and Sanford 1985;
Dobson 1999; Guillemin 2002; Schlagenhauf 2004). Ettore Marchiafava and Augusto Celli
followed up on the work done by Laveran and proposed the name Plasmodium for this
protozoan (Majori 1999). Between 1883 and 1885, the duo confirmed Laveran’s work, and
added further detail by differentiating tertian and benign fevers on the basis of their sexual
stages of parasite development (Ascenzi 1999; Majori 1999; Cox 2010). They also studied
the morphological differences of Plasmodium parasites in collaboration with a colleague
named Bignami, which later on in 1892, lead to the identification of P. falciparum as a
distinct parasite taxon (Majori 1999; Cox 2010; Ferroni, Jefferson et al. 2012).  Prior to this
in 1890, Giovanni Grassi and Raimondo Filetti introduced the names P. vivax and P.
malariae for two other human malaria parasites (Collins and Jeffery 2007).  Laveran’s
observations were further confirmed in 1886 by other scientists that included Camillo Golgi,
George Sternberg, William Councilman, and William Osler (Smith and Sanford 1985; Cox
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2010). Golgi related the clinical symptoms and fever episodes with the schizogonic phase of
Plasmodium and showed that tertian and quartan intermittent fevers where due to two
different Plasmodium species, namely P. malariae and P. vivax (Ascenzi 1999; Capanna
2006; Tognotti 2007). William Welch, continued to review and build on Laveran’s work and,
in 1897, formally named the malignant tertian malaria parasite P. falciparum. By the early
1890s, Laveran's germ was widely considered the true cause of malarial fever as a result of
this painstaking investigation of the blood stages (Smith and Sanford 1985), however the
mode of transmission between infected humans remained a mystery.
In 1897 Ronald Ross discovered that culicine mosquitoes transmitted P. relictum, an avian
malaria parasite, and proposed that human malaria parasites may also be transmitted by
mosquitoes. By 1899, Ross demonstrated that human malaria parasites were in fact
transmitted by anopheline mosquitoes (Ross 1897; Bruce Chwatt 1985; Dobson 1999;
Guillemin 2002; Schlagenhauf 2004; Cox 2010). John Stephens in 1922, described P. ovale as
an additional human malaria parasite (Majori 1999) while P. knowlesi was first described in
1931 by Robert Knowles and Biraj Mohan Das Gupta (Garnham, Lainson et al. 1957; Singh,
Sung et al. 2004; Singh and Daneshvar 2010).
1.2.5 Life Cycle of Human Malaria Parasites
The malaria parasite has an extraordinary complex, multistage life cycle occurring within
two distinct hosts, the vector mosquito and the vertebrate (Bruce-Chwatt 1985).  The life
cycle of Plasmodium species comprises of three comprehensive stages, the exoerythrocitic
and erythrocytic stages in the vertebrate host and the sporogonic cycle in the mosquito
(Figure 4).  The humans and other vertebrates act as the intermediate host for the parasite,
while the mosquito, in which the sexual reproduction takes place, is considered to be the
definitive host (Bruce Chwatt 1985).
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The life cycle of malaria infection begins in the skin with an infected Anopheles female
mosquito bite.  When the mosquito takes a blood meal, its proboscis probes into the host’s
skin and deposits saliva to avoid blood coagulating (Beier 1998; Krettli and Miller 2001;
Vaughan, Aly et al. 2008).  A single mosquito ejects a few hundred skin infecting sporozoites
which glide from the salivary gland cavities into the skin of the host. This is immediately
followed by a rapid immuno-suppression of the host’s immune system, which subsequently
enables the establishment of early tolerance to pre-erythrocytic stages of the parasite
(Guilbride, Guilbride et al. 2012). The sporozoites continue to glide through the skin until
they reach a blood vessel where they then break the endothelial barrier to gain access to
the blood circulatory system (Vaughan, Aly et al. 2008). Once in the blood stream, the
sporozoites begin to migrate to the liver. The mechanism of locating the liver irrespective of
where the sporozoites entered the host is guided by the unique properties of liver blood
vessels that are rich in oxygen and nutrients (Vaughan, Aly et al. 2008). Once in the liver, the
sporozoites initially invade and pass through a Kupffer cell after which they glide through
several hepatocytes before finally taking residence in a hepatocyte, thus beginning the liver
stage of development (Krettli and Miller 2001; Miller, Baruch et al. 2002; Vaughan, Aly et al.
2008). This movement of  sporozoites through the hepatocytes leads to secretion of host
hepatocyte growth factor, which makes hepatocytes susceptible to infection (Carrolo,
Giordano et al. 2003).  The mechanism that guides selection of the final hepatocyte to
invade and take residence in to initiate the replication process is still not well understood
(Vaughan, Aly et al. 2008). This invasion of the hepatocytes marks the beginning of the
asexual exoerythrocytic schizogonic cycle, with each invading sporozoite developing into a
schizont that contains approximately 10,000 – 30,000 merozoites within the hepatocyte,
depending on the parasite species (Fujioka and Aikawa 2002).   Each merozoite is able to
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invade a red blood cell once released from the liver. A dormant stage called the hypnozoite
has the ability to remain in the liver for several weeks to months to years before initiation of
pre-erythrocytic schizogony occurs in P.vivax and P. ovale. These hypnozoites are
responsible for relapses which characterise infections of these specific Plasmodium species
(Fujioka and Aikawa 2002). Thus, malaria disease only occurs when the asexual parasite
stage multiplies within the host red blood cell (Weatherall, Miller et al. 2002).
A series of extracellular recognition events between the erythrocyte receptors and
merozoite ligands occur during the invasion process (Gaur, Mayer et al. 2004; Dvorin, Bei et
al. 2010; Crosnier, Bustamante et al. 2011). The attachment / docking of the merozoite to
the red blood cell occur between any of the surfaces of these two cells. A reorientation of
the merozoite occurs with its apical end placed against the cell and resulting in the
formation of a junction with the cell.  The merozoite then pulls itself into the cell and a
vacuole is formed in the process (Miller 1977; Krettli and Miller 2001; Fujioka and Aikawa
2002). When this attachment is occurring, the red blood cell undergoes a wave of
deformation, followed by another  resealing of the red blood cell membrane (Miller 1977;
Hadley 1986). As the merozoite pushes its way into its host red blood cell, a parasitophorous
vacuole is created that seals the invading merozoite from the host-cell cytoplasm to
facilitate its continued development in an environment that is separated from the host cell’s
normal processing and presentation of its antigen mechanisms (Miller 1977; Greenwood,
Fidock et al. 2008). This rapid invasion of the red blood cells by the merozoites ensures
minimal exposure of the invading parasite, thus protecting these parasite forms from any
host immune responses (Cowman and Crabb 2006; Greenwood, Fidock et al. 2008).
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Once the parasite has entered the red blood cell, it undergoes a trophic period in which the
parasite enlarges and this is followed by an asexual replication.  The early stage or immature
trophozoite is referred to as the ring form. The parasite continues its enlargement, losing its
“ring” structure to become a mature trophozoite. During this trophic period, the parasite
ingests the host cell cytoplasm and breaks down the haemoglobin into amino acids in a
process known as proteolysis (Goldberg, Slater et al. 1990). The trophozoite stage ends
when nuclear division begins and marks the beginning of the schizont stage (Bannister and
Mitchell 2003; Cowman and Crabb 2006).  During the process of red blood cell (erythrocytic)
schizogony, there are three to five cycles of nuclear replication depending on the parasite
species. The process of nuclear replication is followed by a budding process, in which the
merozoites bud from a mature schizont or segmenter (Bannister and Mitchell 2003;
Cowman and Crabb 2006). Once this process is completed, the infected red blood cell
ruptures, thus releasing the merozoites. During this process, the parasitophorous-vacuole
membrane ruptures first due to the action of proteases releasing the merozoites within the
intact red blood cell. This leads to swelling of the red blood cell and weakening of its
cytoskeleton resulting in rupture and subsequent release of the merozoites into free
circulation within the blood plasma (Fujioka and Aikawa 2002; Bannister and Mitchell 2003;
Cowman and Crabb 2006). The released merozoites invade new red blood cells initiating
another cycle of schizogony. The invasion of a red blood cell by a merozoite results in the
release of up to 32 new copies of itself in approximately 48 hours (Lew 2005). This dramatic
increase in the parasite burden explains the rapid pathogenesis of malaria (Miller, Good et
al. 1994; Miller, Baruch et al. 2002). The process of rupture of infected red blood cell occurs
in a synchronous manner, releasing suddenly accumulated antigens and waste products
from large numbers of parasites within hours or even minutes, thus causing the periodic
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rapid onset of fever paroxysm that are associated with malaria infection. In P. falciparum
infections, early ring stage and mature trophozoite - and schizont- infected red blood cells
are not found in peripheral blood circulation as they adhere to the capillary epithelial cells
and sequester in the microvasculature including that of vital organs, such as the brain, heart
and lungs (Miller, Good et al. 1994; Miller, Baruch et al. 2002; Clark and Cowden 2003).
Some of the parasites differentiate into large sexual forms with only one nucleus which fills
up the infected red blood cell, known as macro- or microgametocytes and are the infective
stages to mosquitoes (Bruce Chwatt 1985; Miller, Baruch et al. 2002; Moore, Surgey et al.
2002). Ingestion of gametocytes by the mosquito vector induces the emergence of gametes
from within these infected red blood cells (gametogenesis) (Ghosh, Edwards et al. 2000;
Baton, Ranford-Cartwright et al. 2005; Vlachou, Schlegelmilch et al. 2006). This process is
triggered by the decrease in temperature and dissolved carbon dioxide, the subsequent
increase in pH from 7.4 (blood) to above 7.8 (mosquito gut) and the mosquito metabolites
(mosquito-derived exflagellation factor) (Ghosh, Edwards et al. 2000; Baton, Ranford-
Cartwright et al. 2005; Vlachou, Schlegelmilch et al. 2006). The microgametocyte undergoes
several rounds of nuclear replication. The resulting nuclei become associated with flagella
that emerge from the body of the microgametocyte (Ghosh, Edwards et al. 2000; Baton,
Ranford-Cartwright et al. 2005; Vlachou, Schlegelmilch et al. 2006). These microgametes
seek out and fuse with mature macrogametes resulting in a zygote, which in turn develops
into an ookinete within 12-24 hours. The ookinete is motile and penetrates the mosquito
gut epithelial cells and develops into an oocyst in the extracellular space between the basal
lamina and the epithelial cells (Ghosh, Edwards et al. 2000; Baton, Ranford-Cartwright et al.
2005; Vlachou, Schlegelmilch et al. 2006). Sporogony then occurs, which is an asexual
replication of the parasite DNA and the formation of sporozoites within the oocyst. The
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length of the process of sporogony is dependent on the species and temperature and
usually takes 10-28 days (Ghosh, Edwards et al. 2000; Baton, Ranford-Cartwright et al. 2005;
Vlachou, Schlegelmilch et al. 2006).  Once mature, the oocyts ruptures releasing the
sporozoites into the body cavity (hemocoel) of the mosquito. The free sporozoites are
motile and migrate to the salivary glands, where they invade and transverse the salivary
gland epithelial cells and come to lie within its lumen, thus completing the life cycle (Ghosh,
Edwards et al. 2000; Baton, Ranford-Cartwright et al. 2005; Vlachou, Schlegelmilch et al.
2006). While the hemocoel and salivary gland sporozoites are morphologically similar, they
are functionally distinct. Salivary gland sporozoites efficiently invade liver cells, but cannot
re-invade the salivary glands, whereas the hemocoel sporozoites readily invade salivary
glands but are inefficient at invading liver cells (Ghosh, Edwards et al. 2000; Baton, Ranford-
Cartwright et al. 2005; Vlachou, Schlegelmilch et al. 2006).  During a blood meal some of the
sporozoites are expelled into the vertebrate host, thus reinitiating the infection of the host
(Bruce Chwatt 1985; Greenwood, Fidock et al. 2008).
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Figure 4.The life cycle of malaria causing Plasmodium parasites (Greenwood et al., 2008)
1.2.6 Clinical Manifestations of Malaria Infection
Malaria parasite infections result in a wide variety of clinical outcomes varying from
asymptomatic to mild to severe manifestations, and even to death. Depending on the
severity of these symptoms, malaria can be classified as simple/uncomplicated or
severe/complicated. All symptoms of malaria are caused by the erythrocytic stages of the
parasite, when erythrocytes are destroyed. This  results into the liberation of parasites and
erythrocyte material into circulation and a host reaction (Miller, Good et al. 1994; Miller,
Baruch et al. 2002) that destroys even more red blood cells than the parasite itself does
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through triggering of a strong immune turnover of the red blood cells (Phillips and Pasvol
1992; Jakeman, Saul et al. 1999; Chang and Stevenson 2004). The materials released into
the blood stream include toxins, such as haemozoin pigment and glucose phosphate
isomerase. These induce production of cytokines or immune-modulating agents (which
include among others, tumor-necrosis factor-a (TNF-a) and interferon-g (IFN-g) ) by the
macrophages and other immune cells, resulting in fever, rigors, and probably the other
severe pathophysiologies associated with malaria (Kwiatkowski, Cannon et al. 1989;
Karunaweera, Grau et al. 1992; Miller, Baruch et al. 2002; Clark and Cowden 2003; Clark,
Budd et al. 2006; Tuteja 2007). In addition to these cytokine cascades, the sequestration of
infected cells in tissue blood vessels also has a role in the manifestations of malaria
particularly in its severe form (Marsh and Snow 1997).  Severe or complicated malaria
manifestations are complex and can be grouped into severe anaemia, respiratory distress
and coma (Marsh and Snow 1997; Newton, Taylor et al. 1998). In a majority of cases, these
syndromes reflect underlying metabolic acidosis associated with lactic acidaemia resulting
from anaemia and anoxia compounded by the immune depletion of red blood cells (Marsh,
English et al. 1996; Marsh, English et al. 1996; English, Sauerwein et al. 1997). Metabolic
acidosis  in severe malaria infection often manifests as respiratory distress and is the best
independent predictor of a fatal outcome in all ages of patients (Taylor, Borgstein et al.
1993; Crawley and Nahlen 2004; Maitland and Marsh 2004; Maitland and Newton 2005). In
uncomplicated malaria infections, infected persons typically experience fever, shivering,
cough, respiratory distress, pain in the joints, headache, watery diarrhoea, vomiting and
convulsions (Karunaweera, Carter et al. 1992; Miller, Baruch et al. 2002). The severity of
these clinical attacks is dependent on various factors that include, the species and strain of
the infecting parasite, level of transmission,  age of the host, genetic constitution,
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nutritional status (particularly in children) and malaria specific immunity (Idro, Jenkins et al.
2005; Crawley, Chu et al. 2010). The latter tends to be short lived and partial, unable to
protect an individual against a new infection, due to the variability of the parasite proteins
expressed during its complex life cycle (Mendis, David et al. 1991; Gamain, Miller et al.
2001; Obi, Okangda et al. 2010).
Clinical immunity to malaria appears to be acquired in distinct stages under suitable
conditions. These stages include; (i) reduction of the likelihood of severe or fatal disease (
anti-disease immunity); (ii) limitation of the clinical impact of mild malaria through
conferring protection against parasitaemia (anti-parasite immunity); and (iii) maintaining a
low-grade parasite density, which generally results in asymptomatic infection (premonition)
(Schofield and Mueller 2006; Doolan, Dobano et al. 2009; Obi, Okangda et al. 2010; Van Den
Steen, Deroost et al. 2011).  This occurs in regions considered holo-endemic or hyper-
endemic, where populations are routinely exposed to infection (Obi, Okangda et al. 2010).
So acquired immunity is correlated to age of the host. Parasitaemia therefore often peaks in
young children and subsequently declines in an age-dependent manner in areas of high
endemicity (Baird 1995; Hviid 2005; Doolan, Dobano et al. 2009). This change in immunity is
expressed as an increase in recovery and/or a decrease in trophozoite density with age thus
reducing detectability by microscopy and /or decreasing susceptibility of the host. The
reduction in parasite and trophozoite densities does not occur as fast as that of the
gametocyte rate indicating that immunity reduces infectivity before increasing recovery
and/or detectability by microscopy (Dietz, Molineaux et al. 1974; Maire, Smith et al. 2006;
Smith and Schapira 2012). Thus, in such areas immunity reduces the frequency with which
infections progress to clinical or severe malaria but however does not affect the rate of
parasite infection itself (Hogh 1996; Smith and Schapira 2012). In regions of infrequent
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exposure, the lack of protective immunity results in the spread of cases across age groups
(Baird 1995; Hogh 1996; Doolan, Dobano et al. 2009). Malaria is then classified into two
epidemiological malaria transmission patterns, thus stable and unstable malaria.
Stable malaria transmission occurs when a population is continuously exposed to malaria
parasite inoculation (Kiszewski, Mellinger et al. 2004) leading to the development of a
protective clinical immunity from malaria early in life usually around the age of 4 to 5 years.
By contrast, in unstable malaria transmission areas immunity is gained slowly due to low to
moderate mean malaria inoculations. These areas tend to be prone to epidemics. (Carter
and Mendis 2002).  These differences in stability are primarily due to differences in
behaviours and other biological characteristics of the regional Anopheles vectors and their
environment (Lindsay, Wilkins et al. 1991; Lindsay, Parson et al. 1998; Carter and Mendis
2002; Hay, Guerra et al. 2005; Reyburn, Mbatia et al. 2005). Stable transmission occurs in
regions where strong human –biting preferences lead to uniform contact between the
vectors and humans (Smith, Corvalan et al. 1999). This is coupled with favourable climatic
conditions that are warm and humid supporting vector longevity and rapid development of
the parasite stages within them (Smith, Corvalan et al. 1999). In unstable transmission
regions the opposite is true with vectors preferring animal feeding sources and the climate
not being conducive to support vector longevity and rapid parasite development within
them. This leads to erratic contact between the vectors and humans and thus irregular
malaria inoculations (Carter and Mendis 2002).
1.2.7 Malaria Case Management
1.2.7.1 Treatment
For thousands of years, various herbal remedies have been used for treatment of fevers
associated with malaria. Quinine, as a component of the bark of the Cinchona (Quina-quina)
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tree, was used to treat malaria from as early as the 1600s (Achan, Talisuna et al. 2011). As a
result of their missionary work in Peru, the Jesuits learnt about the curative bark and
brought back the information to Europe.  The bark began to be referred to as the "Jesuits'
bark," "cardinal's bark," or "sacred bark" (Butler, Khan et al. 2010; Achan, Talisuna et al.
2011). Through the activities of Sir Robert Talbot, the use of the bark became established in
England. Talbot mixed the bark with rose leaves, lemon juice and wine (Butler, Khan et al.
2010).  In 1820, the work of Pierre Pelletier and Jean Caventou lead to the isolation of a
complex alkaloid structure, which they later named Quinine.  Quinine remained the main
treatment drug for malaria until the 1920s. During the First World War the supply of quinine
dropped, leading to a search for alternatives which could be used by troops. The Germans
offered the first alternative in the form of mepacrine, which was used for both treatment
and prophylaxis (Butler, Khan et al. 2010). Later German scientists developed another
antimalarial called sontoquine. The chemical variants of sontoquine were synthesized and
tested for efficacy. The resulting drug was chloroquine which was found to be more
effective and well tolerated. By the 1940s, chloroquine took over the role as the main
treatment for malaria as it was considered a safer and cheaper option than quinine (Bruce
Chwatt 1985; Achan, Talisuna et al. 2011). The efficacy of chloroquine begun to decrease
and parasite resistance to the drug begun to spread by the early 1970s (Talisuna, Bloland et
al. 2004). This was attributed to its wide and somewhat indiscriminate use particularly
during the malaria eradication program in the 1950s and 1960s (Talisuna, Bloland et al.
2004). The American military also developed drugs with antimalarial properties which
included primaquine, which was used for treatment of vivax malaria and much later
tafenoquine (Greenwood 1995). During the same period, the British military developed
proguanil which saved as a foundation for further development into pyrimethamine by
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Burroughs Wellcome (Greenwood 1995). Sulphadoxine which was developed in the 1950s,
had a long half life and improved toxicological profile compared to other sulphonamides
(Schlitzer 2007). By the 1970s, pyrimethamine was being combined with sulphadoxine,
resulting in a drug given the brand name fansidar and was widely used in Africa for
treatment of uncomplicated malaria and prophylaxis (Meshnick and Dobson 2001; Schlitzer
2007). This was the next alternative to chloroquine in a large number of endemic countries,
however the development of resistance rapidly hampered its efficacy (Black, Bygbjerg et al.
1981; Hurwitz, Johnson et al. 1981; Stahel, Degremont et al. 1982; Timmermanns, Hess et
al. 1982; Hess, Timmermans et al. 1983; Sibley, Hyde et al. 2001).
The search for an alternative drug lead the world to China, where  dating back over 2000
years ago, records showed the use of ginghaosu (Artemisia annua) for the treatment of
fevers, which are believed to have been associated with malaria (Wright, Linley et al. 2010).
A team lead by a Chinese scientist Professor Youyou Tu has been accredited with the
discovery of artemisinin which is now recommended to be used in combination with other
products as the mainstay of treatment of malaria (Miller and Su 2011).
Chemotherapy still remains a keystone of the full complement of malaria control activities.
The primary effect of antimalarial treatment is to inhibit the multiplication of the parasite.
Based on their chemical structure there are three main groups of antimalarials; i) the aryl
amino-alcohol compounds (quinoline related i.e. amodiaquine, chloroquine, halofantrine,
lumefantrine, mefloquine, piperaquine, pyronaridine, primaquine, quinine, quinidine,
tafenoquine), ii) the antifols (chlorproguanil, proguanil, pyrimethamine, trimethoprim), and
iii) the artemisinin compounds (artemisinin, artemether, artmotil, artesunate,
dihydroartemisinin).
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Of these, the artemisinin compounds produce the most rapid therapeutic responds due to
their broad window of action on the asexual and sexual stages of the malaria parasite
(Yayon, Vande Waa et al. 1983; ter Kuile, White et al. 1993; Drakeley, Jawara et al. 2004;
Sutherland, Ord et al. 2005; Stepniewska, Price et al. 2008). They predominantly act on early
trophozoites and schizonts before they can mature, therefore reducing infected
erythrocytes sequestration in the micro-vessels of vital organs, thus preventing obstruction
and subsequent associated complications (Schlitzer 2008; Dondorp, Fanello et al. 2010)
There has been no anti malarial therapy that targets the brief extracellular merozoite stage
of the parasite (Wilson, Langer et al. 2013). Anti malarial drugs can be further classified
based on their mode of action which essentially targets the various stages of the parasite
life cycle (Bruce-Chwatt 1962; Delves, Plouffe et al. 2012) as outlined in the table 4 below.
Table 4. Classification of antimalarial drugs based on mode of action (adapted from Bruce-
Chwatt 1962, Plouffe et al., 2012)
Classification Mode of action Drugs
Blood Schizontocides Anti-plasmodial activity is on the erythrocytic
stages, thus preventing  expansion of the
infections
Artemisinin and its derivatives,
chloroquine, quinine, mefloquine,
halofantrine, pyrimethamine and
sulphadoxine
Prophylactic Tissue
Schizontocides
Act against the liver forms of Plasmodium
occurring prior to the erythrocytic stage. Thus
they prevent the onset and development
thereafter of clinical symptoms
Primaquine and to some extent
pyrimethamine
Anti-relapse drugs or
secondary tissue
schizontocides
Act by targeting the hypnozoites /dormozoites
(dormant stages )
of P vivax and P. ovale within host liver cells that
lead to relapse and regeneration of disease
Primaquine
Gametocytocides Target the sexual forms of the
parasite in the blood thereby preventing
transmission of the infection to the mosquito
Chloroquine and quinine against P.vivax
and P. malariae ; artemisinin and its
derivatives has activity against P.
falciparum; primaquine
against all Plasmodia, including P.
falciparum
Sporontocides Target and cease growth and/or development of
the oocysts within the mosquito there by
preventing transmission. Delivered through a
mosquito blood meal
Primaquine, Ivermectin and
chloroguanide
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Due to the wide use of anti malarial therapies over time there has been great selective
pressure on P. falciparum and leading to the spread of resistant parasites with the
subsequent result of increased malaria morbidity and mortality (Bloland 2001; Barnes and
White 2005; Mita, Tanabe et al. 2009; Khamsiriwatchara, Sudathip et al. 2012; Satimai,
Sudathip et al. 2012) .  To date resistance to all the commonly used antimalarials, including
the most recent, artemisinin combination therapies has been reported (Delhaes, Benoit-
Vical et al. 2003; Mita, Tanabe et al. 2009). Chloroquine (CQ) and
sulphadoxine/pyrimethamine (SP) have been used for over 50 years for the treatment of
uncomplicated P. falciparum malaria (Talisuna, Bloland et al. 2004; Mita, Tanabe et al.
2009). Most countries in endemic areas revised their treatment guidelines in the early 2000s
to replace these two drugs with the more efficacious artemisinin combination therapies as
per WHO recommendation. Quinine still remains the recommended treatment for severe
malaria. However, there have been recommendations for the use of parenteral artesunate
as an alternative to quinine for treatment of severe malaria (Dondorp, Nosten et al. 2005;
Toovey 2006; Woodrow, Planche et al. 2006; Jones, Donegan et al. 2007; Dondorp, Fanello
et al. 2010; Sinclair, Donegan et al. 2011; Sinclair, Donegan et al. 2012) due to its
demonstrated quick reduction of mortality (Dondorp, Nosten et al. 2005; Dondorp, Fanello
et al. 2010; Sinclair, Donegan et al. 2011; Sinclair, Donegan et al. 2012) and tolerability
(Dondorp, Nosten et al. 2005). Additionally, the current recommendations promote the use
of parasite-based diagnosis prior to prescription of antimalarial therapy.
1.2.7.2 Diagnosis
Several methods are used for malaria confirmatory diagnosis, as summarised in Table 5
(Tangpukdee, Duangdee et al. 2009). However, the main methods used for routine
parasitological diagnosis are microscopy and rapid diagnostic tests (RDT). Microscopy is
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considered as a sensitive method and recognised as the historically established gold
standard for malaria diagnosis (Murray, Gasser et al. 2008), but it requires an appreciable
time of expertise and labour and is dependent on good techniques, reagents, equipment
and well-trained microscopists (WHO 1999). Some studies have shown that it has been a
challenge to maintain accuracy of microscopy particularly in hard to reach areas that are
usually poorly resourced (Durrheim, Becker et al. 1997; Kachur, Nicolas et al. 1998; Barat,
Chipipa et al. 1999; Bell, Wongsrichanalai et al. 2006; Reyburn, Mbakilwa et al. 2007;
Ngasala, Mubi et al. 2008; Batwala, Magnussen et al. 2010; Kahama-Maro, D'Acremont et al.
2011).
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Table 5. Summary of malaria diagnostic tools and modalities (Adapted from Tangapukdee et al., 2009)
Principal of method Sensitivity and
specificity
Time consumed (in
mins )
Detection limit
(parasites /µl)
Expertise require Instrument cost
Clinical diagnosis Malarial signs and
symptoms
Dependent on
malarial endemicity
Dependent on
physicians skills
Undermined High in non-endemic
areas
n/a
Microscopy Visualization of
distinct morphological
parasite stages under
light microscopy using
think & thin smears
Depends of good
technique, reagent
and microscopist skills
30-60 Expert 5-10, routinely
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High in non-endemic
areas
Low cost
QBC Detection using epi-
flourescent
microscope detection
after staining blood
with acridine
Higher than
microscopy
Less than 15 More than 5 Moderate Moderate
RDTs Detection of parasite
antigens or antibodies
Moderate if more
than 100 parasites / µl
10-15 50-100 Low Moderate
Serological tests Detection of
antibodies against
parasites
High but does not
correlate to clinical
symptoms of patients
30-60 Undermined Moderate Moderate
PCR Amplification of
parasite DNA
Very high 45-360, dependent on
methods utilized
Greater or equal to 1 High Expensive
LAMP Detection of using
turbidity test after
parasite DNA
amplification
Very high Less than 60 More than 5 High Moderate
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Micro assays Hybridization of DNA
isolate and quantified
by fluorescence based
detection
High Less than 60 Undetermined High Expensive
FCM Detection of
haemozoin by flow
cytometer
Variable sensitivity,
high specificity
Less 1 per sample /
automated
Poor correlation with
parasitaemia
High Expensive
ACC Detection of malarial
pigment in activated
monocyte
Variable sensitivity
and specificity
Less 1 per sample /
automated
5-20 High Expensive
MS Identification of heme
by LDMS
Undetermined Less 1 per sample /
automated
100 for whole blood High Expensive
QBC – Quantitative buffy coat , RDTs - Rapid diagnostic tests, PCR – Polymerase chain reaction, LAMP - Loop mediated  isothermal
amplification, FCM - Flow cytometry, ACC - Automated blood cell counters, MS - Mass spectrophotometry
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RDTs are immuno-chromatographic tests based on the detection of parasite antigen from
peripheral blood using monoclonal antibodies against a parasite antigen target (Forney, Magill
et al. 2001).They employ a lateral flow technology in which the liquid clinical sample, in this
case blood,  migrates using capillary action across a nitrocellulose membrane surface. On one
end of the nitrocellulose surface, one or two target specific indicator labelled antigens (Table 5)
are placed (Shiff, Premji et al. 1993; Piper, Lebras et al. 1999; Moody 2002; Murray, Gasser et
al. 2008; Abba, Deeks et al. 2011).  A control line is created by placing a specific antibody for the
indicator labelled antibody complex. To perform the test, a blood sample mixed with a buffer
solution is placed on one end of the nitrocellulose surface which contains a lysing agent and
labelled antibody. This sample is drawn up the strip and if the antigen is present the test and
control lines will trap some of the indicator-labelled antibody-antigen complexes and become
visible (Figure 5) (Murray, Gasser et al. 2008).
Figure 5.Rapid diagnostic test schematic (Adapted from Murray et al., 2008)
Blood Sample
Lysing agent and
labelled antibody
Bound antibody # 1 Bound antibody # 2 Control
Nitrocellulose strip
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There are currently 3 malaria antigens targeted by the available RDTs due to their abundance in
all asexual and sexual stages of the parasite life cycle (Moody 2002). These are described in
table 6.
Table 6.Parasite antigens targeted by RDTs (Schiff, Premji et al.,1993;Piper,Lebras et al., 1999;
Moody 2002; Abba,Deeks et al., 2011)
Antigen Description
histidine-rich protein II (HRP-II) produced by trophozoites and young gametocytes of P.
falciparum only and expressed in the erythrocyte membrane
Lactate dehydrogenease (pLDH) Intracellular metabolic enzyme produced by all human
infecting Plasmodium species and by all blood stage parasites
(i.e. both asexual and sexual). Can distinguish P. falciparum
from the non-falciparum species, but cannot differentiate
between P. vivax, P. ovale and P. malariae.
Aldolase Intracellular metabolic enzyme produced by all human
infecting Plasmodium species however cant not differentiate
between them
The most commonly targeted of the parasite antigens for RDTs are HRP-II and pLDH. HRP-II
antigenaemia persistence after malaria treatment leads to false RDT positive results limits the
use of this antigen for the clinical monitoring of the therapeutic response monitoring (Humar,
Ohrt et al. 1997; Wongsrichanalai 2001; Gerstl, Dunkley et al. 2010). Further, HRP-II can only
detect infections of P. falciparum (Gerstl, Dunkley et al. 2010). Assays based on pLDH only
represent viable parasites and as such overcome this challenge (Moody 2002). However,
production of pLDH from the gametocytes after clearance of asexual stages may lead to some
tests giving  falsely positive results for several days (Gerstl, Dunkley et al. 2010).  pLDH assays
parasite detection is closely related to malaria microscopy diagnosis as it is more specific but is
however not as sensitive as HRP-II tests (Abba, Deeks et al. 2011). Thus RDTs provide a
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qualitative result of infection as they do not information such as parasite stages and
parasitaemic load (Marx, Pewsner et al. 2005; Hendriksen, Mtove et al. 2011).  Studies have
shown that RDTs are able to detect P. falciparum with sensitivities greater than an estimated
85% and with specificity of approximately  100% at parasitaemia greater than  100 parasites/µl
of blood (Hanscheid 1999; Forney, Magill et al. 2001; Wongsrichanalai 2001; Moody 2002;
Murray, Bell et al. 2003; Abba, Deeks et al. 2011). Some studies have demonstrated that RDTs
have a higher sensitivity and specificity compared with microscopy (Beadle, Long et al. 1994;
Craig and Sharp 1997; Makler, Palmer et al. 1998; Mendiratta, Bhutada et al. 2006; Ashley,
Touabi et al. 2009). An advantage RDTs have over microscopy is that they do not require
complex training, electricity, running water or any special equipment. Additionally, it has been
demonstrated that RDTs can be utilized by community health workers with minimal supervision
and ease (Bell, Go et al. 2001; Harvey, Jennings et al. 2008; Chanda, Hamainza et al. 2011;
Counihan, Harvey et al. 2012; Rutta, Francis et al. 2012). In addition to those alluded to earlier,
RDTs have some other limitations that include the lack of ability to detect all the species of
Plasmodium and low concentrations of infections (Reyburn, Mbakilwa et al. 2007).The
usefulness of RDTs in malaria case management has been demonstrated to reduce misdiagnosis
and enhance cost savings through rational use of malaria treatments (Chanda, Hamainza et al.
2011; Yukich, Bennett et al. 2012).
Clinical diagnosis still remains the most wide spread method of malaria diagnosis particularly in
the most peripheral health facilities in Africa. This has lead to an over estimation of malaria
burden and over prescription of anti malarial drugs (Mkawagile and Kihamia 1986; Bassett,
Taylor et al. 1991; O'Dempsey, McArdle et al. 1993; Font, Alonso Gonzalez et al. 2001; Nsimba,
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Massele et al. 2002; Masanja, Selemani et al. 2012) due to the non – specific signs and
symptoms that can be similar to those of many other febrile conditions (Redd, Bloland et al.
1992; Richens, Smith et al. 1992; O'Dempsey, McArdle et al. 1993; Berkley, Mwarumba et al.
1999; Kallander, Nsungwa-Sabiiti et al. 2004). There have been several efforts to improve
clinical diagnosis of malaria based on signs and symptoms alone, leading to development of
various clinical algorithms across all age groups and varying malaria endemicity (Gomes, Espino
et al. 1994; Marsh, English et al. 1996; Olaleye, Williams et al. 1998; Bojang, Obaro et al. 2000;
Oster, Krause et al. 2000; Chandramohan, Jaffar et al. 2002; Mwangi, Mohammed et al. 2005).
However, remains unsatisfactory and reinforces the need for parasitological confirmation of
infection to ensure accuracy of malaria diagnosis based on clinical symptoms alone (Mwangi,
Mohammed et al. 2005).
1.2.8 The Vector and its distribution
Mosquitoes, family Culicidae, are made up of a taxon descended from a common evolutionary
predecessor or ancestor  (monophyletic) (Harbach and Kitching 1998) belonging to the order
Diptera, Class Insecta, phylum Arthropoda (Darsie and Ward 2005). Culicidae is divided into the
three subfamilies Toxorhynchitinae, Anopheline, and Culicine, collectively comprising 38
genera, 1 in subfamily Toxorhynchitinae,3 in Anopheline and 34 in Culicine (Foster and Walker
2002). There are some 3,490 species currently formally recognized (Harbach and Howard 2007),
but some 3–5 times this number may exist if most of  the known species, like many well studied
Anopheles, prove to comprise species complexes morphologically (isomorphic) identical (Foster
and Walker 2002; Fontenille and Simard 2004; Harbach 2011). All human malaria vectors
belong to the genera Anopheles (Cellia) Myzomyia. These have been distributed globally in six
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geographical regions, which include Palaearctic, Oriental, Australasian, Afro-tropical, Neo-arctic
and Neo-tropical regions (Bruce Chwatt 1985). Of the 460 Anopheles mosquito species
identified globally, only approximately 80 species are physiologically competent hosts for
human malaria parasites , 70 species are known to act as vectors in natural conditions and 45
are dominant vector species/species complexes that are able to  transmit malaria at a level of
concern to public health (secondary vectors) (Foster and Walker 2002). In Africa there are
Anopheles species that are considered the major vectors for malaria transmission are;
Anopheles gambiae sensu stricto Giles, Anopheles arabiensis Patton and Anopheles funestus
Giles (Gillies and Meillon 1968; White 1974; Gillies and Coetzee 1987; Levine, Peterson et al.
2004; Mouatcho, Hargreaves et al. 2007). Anopheles moucheti, An. (Cel.) melas, An. (Cel) merus
and An.(Cel) nili are also considered locally important primary vectors in some regions of Africa
with the former two occurring mostly in coastal areas (Awono-Ambene, Kengne et al. 2004;
Fontenille and Simard 2004; Fontenille and Carnevale 2006; Sinka, Bangs et al. 2010).
Anopheles gambiae and An. arabiensis belong to the Anopheles gambiae complex  of 7 sibling
species (Hunt, Coetzee et al. 1998). An. gambiae is considered the most widespread throughout
sub-Saharan Africa and the world’s leading vector for P. falciparum because of its longevity,
preference for  blood meal from human hosts (anthropophagic)  and indoor resting behaviour
(endophilic), resulting in it having great efficiency in transmission (Gillies 1955; Kiszewski,
Mellinger et al. 2004).Through often found in the same geographical range with An. gambiae,
An. arabiensis is able to tolerate higher temperatures and humidity (Kirby and Lindsay 2004), is
widely distributed in arid areas (Coetzee, Craig et al. 2000) and tends to prefer to rest outside in
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the open (exophilic) and blood meals from both animals (zoophagic) particularly cattle and
humans (Gillies 1955).
The other members of the complex include An. melas (West Africa), An. merus (East Africa), An.
bwambae (Hot springs of Uganda), An. quadriannulatus species A and B (White 1974; Gillies
and Coetzee 1987; Fettene, Hunt et al. 2004; Parmakelis, Slotman et al. 2008; Parmakelis,
Moustaka et al. 2010). All members of the complex are probable vectors of human malaria
except An. quadriannulatus subspecies A and B which is primarily zoophilic or zoophagic (White
1974; Coetzee, Craig et al. 2000; Prior and Torr 2002; Coetzee 2004; Pates, Takken et al. 2006).
Anopheles funestus Giles is a significant malaria vector which is very focally distributed in many
locations all across sub Saharan Africa and plays a more important role in malaria transmission
than An. gambiae or An. arabiensis (Fontenille, Lochouarn et al. 1997; Cohuet, Dia et al. 2004).
The Anopheles funestus group  has nine members which are divided into two African subgroups
i.e. the funestus subgroup (Anopheles aruni Sobti, Anopheles confusus Evans and Leeson,
Anopheles funestus sense strico Giles, Anopheles parensis Gillies, Anopheles vaneedeni Gillies
and Coetzee) and the rivulorum subgroup ( Anopheles brucei Service, Anopheles fuscivenosus
Leeson, Anopheles leesoni Evans, Anopheles rivulorum Leeson, and an “An. rivulorum-like”
species)(Gillies and Coetzee 1987; Hargreaves, Koekemoer et al. 2000; Brooke, Kloke et al.
2001; Koekemoer, Kamau et al. 2002; Spillings, Brooke et al. 2009). From within this group
there are two species implicated in malaria transmission, An. funestus (Mostly found in
southern Africa) and An. rivulorum, a secondary vector in Tanzania (Wilkes, Matola et al. 1996;
Coetzee, Craig et al. 2000). An. funestus prefer feeding indoors (endophagic) and are both
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endophilic and anthropophilic. The other members of the group are typically limited in
distribution and abundance and prefer feeding upon animals to humans (Bruce-Chwatt 1954;
Hackett, Gimnig et al. 2000). However they have been known to act as secondary vectors in
circumstances of scarcity of the preferred hosts (Gillies and Meillon 1968). An. rivulorum is
primarily zoophilic and is the second most abundant and widespread species in the funestus
group (Wilkes, Matola et al. 1996; Hackett, Gimnig et al. 2000).
Where both An. gambiae and An. funestus occur there are high levels of transmission (Coetzee,
Craig et al. 2000; Mbogo, Mwangangi et al. 2003; Coetzee and Fontenille 2004; Hay, Guerra et
al. 2005), primarily due to their different breeding habitats and preferences which peak at
different times of the year (Mosha and Petrarca 1983; Bogh, Pedersen et al. 1998; Mwangangi,
Mbogo et al. 2003; Mwangangi, Mbogo et al. 2004; Mwangangi, Mbogo et al. 2007). An.
gambiae are most abundant during the rainy season (Coetzee, Craig et al. 2000; Coetzee and
Fontenille 2004), while An. funestus is most abundant when the rainy season subsides and the
dry season initiates, and thus has the   potential to elongate the malaria transmission period
where both species occur (Coetzee, Craig et al. 2000; Coetzee and Fontenille 2004). An. nili and
An. moucheti are the major vectors of malaria in West and Central Africa (Awono-Ambene,
Kengne et al. 2004; Fontenille and Simard 2004; Fontenille and Carnevale 2006).
The distribution of all malaria vectors is governed greatly by environmental and climatic factors,
which influence their abundance and survival (Figure 6) (Lindsay, Parson et al. 1998; Smith,
Corvalan et al. 1999; Kiszewski, Mellinger et al. 2004; Kaga and Ohta 2012) and ultimately
impact malaria transmission intensity (Kiszewski, Mellinger et al. 2004; Kaga and Ohta 2012).
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Many of the vector species occur in sympatry and their importance to malaria transmission is
governed by their biting, feeding and resting preferences, in addition to seasonal prevalence
and vectorial capacity. These differences are responsible for the varied malaria epidemiological
patterns across Africa and result in a need for varied vector control approaches (Coluzzi 1984;
Fontenille and Simard 2004).
Figure 6. Global distribution of dominant or potentially important malaria vectors (adapted
from Kiszewski et al., 2004)
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1.2.9 Early efforts to control the causes of malaria
1.2.9.1 Larval source management and therapeutic approaches
The observations by Laveran and Ross shaped the beginning of modern preventive strategies to
control malaria (Bruce-Chwatt 1977; Guillemin 2002).  Ross and others postulated that studies
on malaria and its eventual control, should be centred on what he referred to as the third and
last phase, prevention, through the extermination of the malaria bearing mosquitoes primarily
by locating their breeding sites and applying measures to suppress their development (Jeffery
1976; Bruce-Chwatt 1977; Najera 2000). This source reduction leads to decrease in vector
density to a level where vectorial capacity and subsequently,  transmission is  reduced
significantly (Coosemans and Carnevale 1995). There are basically two main techniques in larval
source management (LSM) and these include environmental management (temporary or
permanent removal of Anopheline larval habitats) and larviciding with chemical or biological
agents (Walker and Lynch 2007). The focus on aquatic stages was primarily due to the fact that
these stages are less mobile compared to the adult ones and control measures could be
instituted where breeding sites where identified (Killeen, Fillinger et al. 2002).   This approach in
certain areas showed some good results, particularly in Europe (Najera 2000). However these
initial strategies evolved over time and prompted Ross in 1911 to propose an integrated
approach to malaria eradication including personal protection, mosquito reduction, and
treatment (Ross 1911). Ross further stated that it would be challenging for any general
community to apply these measures in totality and noted that each could be useful alone under
certain circumstances (Ross 1911). Confidence in this strategy was reinforced by the
development of effective chemotherapeutic and chemoprophylactic agents and, the promise of
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vector control through then modern insecticides (Beausoleil 1984). One of the most
outstanding demonstrations of anti larval complimented with other interventions was in
Havana, Cuba during the construction of the Panama Canal in 1904 to 1914. These efforts
where overseen by William Gorgas and was an integrated program that was strictly enforced
and included; drainage of pools and brush and grass cutting (rationale was that mosquitoes
could not cross open areas more than 100 yards) in the environs surrounding residential areas;
oiling of ponds and swamps to kill larvae ; larviciding using a mixture of carbolic acid, resin and
caustic soda was used when oiling was considered insufficient; prophylaxis with quinine ;
screening of buildings and; killing adult mosquitoes (Gorgas 1910; Marshall 1913).  These
interventions lead to the eradication of yellow fever and a dramatic decline in malaria
morbidity and mortality.  Similar large scale  control efforts were conducted during the first
world war which involved draining (pontine marshes in Italy), larval control using paris-green
dust and oil (Brazil and Egypt) and spraying of houses with pyrethrum (Natal and Zululand)
(Rieckmann 2006). The cost of these interventions was beyond what could be afforded by most
communities in these malarious regions. The larval stage targeted interventions required
locating breeding sites and targeting them with the appropriate interventions on a regular and
indefinite time frame, which proved to be a challenge in most malarious areas (Killeen, Fillinger
et al. 2002).
1.2.9.2 The Global Malaria Eradication Program using indoor residual spraying and drug
therapy
The first global effort to eradicate malaria was initiated in the 1950s and 1960s, with the World
Health Organization (WHO) spearheading the effort which was called the Global Malaria
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Eradication Program (GMEP). Technically the program departed from the earlier larval control
strategies to those providing for (a) an establishment of pilot projects in which methods were
tested for their local suitability, (b) an attack phase where of dichloro-diphenyl trichloroethane
(DDT) or other comparable long lasting residual insecticides were used for indoor residual
spraying (IRS) and the resultant insecticidal coverage maintained for several years, (c) a
consolidation phase during which insecticide spraying would be discontinued and any
remaining infections would be actively sought out by screening whole populations for infection
and treating all positive cases, and lastly (d) establishment of eradication, followed by
strengthened surveillance until the risk of reinvasion disappeared (Macdonald 1965). The
strategy essentially depended on chloroquine for treatment and prevention, DDT for vector
control targeting adult mosquitoes and surveillance (Garrett-Jones 1964). Thus the targeting of
adult mosquitoes and the knowledge of resting and feeding behaviours lead to the adoption of
IRS as the key vector control intervention to suppress vector capacity by reducing their
longevity and potentially disrupting the sporogonic stage of the parasite (Garrett-Jones 1964;
Garrett-Jones and Shidrawi 1969; Mabaso, Sharp et al. 2004). IRS is defined as the application
of long-acting chemical insecticides on the walls and roofs of all houses and domestic animal
shelters in a given area, in order to kill the adult vector mosquitoes that land and rest on these
surfaces (WHO 2006). The resulting application of IRS is thought to both repel mosquitoes from
entering the house as well as kill fed female mosquitoes that rest on the walls of dwellings
(Pluess, Tanser et al. 2010). However, there was an oversight in the strategy of targeting adult
mosquitoes as it did not take into consideration the mobility of this stage and variability in
behaviour between vectors (Killeen, Fillinger et al. 2002).
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The GMEP, however, excluded most of sub-Saharan Africa due to the lack of infrastructure to
implement the program, wars, post independence destabilization and the fact that the intense
transmission in this region was likely to defeat eradication as a goal (Bruce-Chwatt 1987; Trigg
and Kondrachine 1998). However by 1978, the program had successfully eliminated malaria in
37 (27 in the Americas or Europe) of the targeted 143 endemic countries (Bruce Chwatt 1985;
WHO 2008). The success of the program in these areas which were mostly temperate,
subtropical and had unstable transmission, engendered undue optimism that malaria
elimination could be achieved anywhere. This stifled any additional thoughts on further
research to improve anti malarial activities for almost 4 decades (Alilio, Bygbjerg et al. 2004).
The initial goals of malaria eradication where not achieved as in some areas there was a
resurgence of malaria to previous or higher levels in areas where it was thought malaria had
been eliminated (Bruce-Chwatt 1987; Feachem and Sabot 2008). With the development of
vector resistance to DDT, vector behavioural pre-existing resilience to the spraying programs,
the emergence of resistance to the available anti malarial drugs, subsequent economic
challenges and the realization that a time limited eradication campaign was not feasible in all
areas, the elimination effort was abandoned by 1969 (Wright, Fritz et al. 1972; WHO 1974;
Bruce-Chwatt 1987; Roberts and Andre 1994; Litsios 1996; Trigg and Kondrachine 1998;
Feachem and Sabot 2008). This lead to a re-examination of the program focus to one of
sustained control as opposed to that of eradication (Wright, Fritz et al. 1972; Bruce-Chwatt
1987; Trigg and Kondrachine 1998; WHO 2008).
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1.2.9.3 Roll Back Malaria the role of insecticide treated bed nets, indoor residual spraying and
drug therapy
The post global eradication campaign era, in the 1970s and '80s, saw the weakening of malaria
programs due to challenges in integration into the mainstream health sector without a
corresponding increase in resources (Nabarro and Tayler 1998). The growing increase in
parasite and vector resistance to anti malarial drugs and insecticides respectively, coupled with
the development of conflicts and humanitarian crisis in some endemic countries further
exacerbated the problem. This period also saw a continued increase in the burden of malaria
particularly in sub-Saharan Africa (Alilio, Bygbjerg et al. 2004). With increased knowledge of the
transnational nature of malaria, Ministers of Health from malarious nations lead the process to
develop the Global Malaria Control Strategy (GMCS) in 1992, which called for less focus on
vector control and emphasis on case detection and treatment. This was a result of a realization
that primary health systems had failed to deliver positive results and that new efforts were
required to control malaria, particularly in Africa which was most affected (Alilio, Bygbjerg et al.
2004).  The strategy further called for full integration of malaria control activities  into general
health services with reflection on the various socioeconomic development objectives (Roberts,
Laughlin et al. 1997). There were various meetings and declarations that followed all calling for
an accelerated implementation of malaria control efforts (Alilio, Bygbjerg et al. 2004). This
provided a framework for the eventual creation of the roll back malaria (RBM) partnership to
coordinate global efforts in combating malaria, initially, particularly in the deployment of
insecticide treated bed nets (ITN) as a key strategy in proving child survival (Nabarro and Tayler
1998; Alilio, Bygbjerg et al. 2004; Breman, Alilio et al. 2004; Lengeler 2004). An ITN is a
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mosquito net that repels disables and/or kills mosquitoes coming into contact with insecticide
on the netting material. The ITN also provides a physical barrier thus preventing vector –
human contact (Lines, Myamba et al. 1987; Lindsay, Wilkins et al. 1991; WHO 2007).  The
practice of applying insecticides to fabrics for personal protection against vector borne diseases
began in the Second World War by German, Soviet and US military personnel.  In the late
1970s, pyrethroids were the insecticide of choice for this, due to the low toxicity to humans and
their high insecticidal activity. In the 1980s, studies were instituted to assess the use of this
technology for disease control in the form of bed nets (Lengeler and Snow 1996).  The rationale
of ITNs was based on the understanding of vector behaviour of indoor biting late at night, the
provision of both a physical barrier preventing man-vector contact and repellent/killing
insecticide effect, thus impacting the vector feeding success, vector capacity and human –biting
rates (Bermejo and Veeken 1992; Curtis and Mnzava 2000; Lengeler 2004). Various ITN trials
conducted in Gambia, Burkina Faso, Kenya and Ghana demonstrated positive impact of ITNs on
reducing morbidity and mortality in children (Alonso, Lindsay et al. 1991; Picard, Aikins et al.
1993; Binka, Kubaje et al. 1996; Cham, Olaleye et al. 1997; D'Alessandro, Olaleye et al. 1997;
Binka, Indome et al. 1998; Phillips-Howard, Nahlen et al. 2003). These findings contributed to
the reinvigoration of malaria control efforts through increased funding, scale up of both
effective preventive and curative interventions with particular prioritisation of malaria
prevention in pregnancy, and focus on under five children and vector control efforts. Much
later in the early 2000s, the development of more efficacious treatments in the form of
artemisinin combination therapies further strengthened the resolve that malaria could be
controlled and eventually eradicated (White 2008).
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Since the launch of the RBM, the global goals and approaches for malaria control have been
modified to address expected positive impacts on disease transmission and respond quickly to
any unexpected situations arising from social, economic, political or environmental trends
among others in endemic areas (Nabarro and Tayler 1998; WHO 2005; WHO 2009). The revised
focus is to expand coverage of cost effective key intervetions such as indoor residual spraying,
insecticide treated bed nets, intermittent presumptive therapy  and case management using
artemisinin combination therapies (WHO 2005; WHO 2009; Eisele, Larsen et al. 2012). As a
result of increased global resources (US$ 149million in 2000 to US$1.2 billion in 2008), coupled
with renewed attention by governments  towards malaria, these scale up efforts and high
coverage  have begun to show dividends, resulting into notable declines in malaria disease
burden globally (WHO 2010; Eisele, Larsen et al. 2012; Murray, Rosenfeld et al. 2012); however
more investments are required to achieve the goal of malaria eradication (WHO 2010; Murray,
Rosenfeld et al. 2012).
1.2.10 Modern Era of Malaria Control Interventions
According to the World Health Organization, there are two main priorities of a malaria
elimination programme which include: (i) to identify and treat malaria patients and all people
carrying parasites, including those carrying gametocytes, to ensure that they become non-
infectious as early as possible; and (ii) to sustainably reduce human–vector contact and the
vectorial capacity of the local Anopheles mosquito population, to prevent new infections from
occurring (WHO 2005; WHO 2006; WHO 2007; WHO 2009; WHO 2012; WHO 2012). These
priority areas are therefore very broad based on and encompass provision of curative and
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preventive interventions to all at risk populations. Essentially these interventions would include
appropriate confirmatory diagnosis, prompt and effective treatment, provision of prophylaxis
where appropriate and universal coverage of vector control measures (Bhattarai, Ali et al. 2007;
Okiro, Hay et al. 2007; Ceesay, Casals-Pascual et al. 2008; Noor, Kirui et al. 2009; D'Acremont,
Lengeler et al. 2010).
1.2.10.1 Contemporary Vector Control
Vector control methods are deﬁned as measures of any kind directed against a vector of
disease and intended to limit its ability to transmit the disease (Karunamoorthi 2011).
Insecticide treated bed nets and indoor residual spraying are currently considered the most
effective of these currently available (Okumu and Moore 2011). The universal coverage of these
two interventions is considered as the key preventive strategy under the global malaria control
and elimination plan (WHO 2005; WHO 2006; WHO 2009). Both IRS and ITNs primarily target
adult stages of the mosquito thus reducing overall transmission and providing a community
protective effect by reducing abundance and infectivity of malaria vectors (Lengeler 2004;
Killeen, Smith et al. 2007; Okumu and Moore 2011).
They exploit behaviours of vector mosquitoes and have shown to be very effective in
controlling An. gambiae s.s and An. funestus than An. arabiensis primarily due to its resting and
feeding preferences (Gillies 1955; Mosha and Petrarca 1983; Bradley 1991; Lines and Nassor
1991; Bogh, Pedersen et al. 1998; Lengeler and Sharp 2003; Kiszewski, Mellinger et al. 2004).
During the Pare-Taveta scheme, it was demonstrated that there was a dramatic decline of An.
gambiae s.s and An. funestus populations in the area after implementation of IRS using dieldrin
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(Bradley 1991). An.arabiensis tends to be more adaptive to interventions that focus particularly
on residual insecticides and tends to alter its behaviour (Sharp, Le Sueur et al. 1990; Fettene,
Hunt et al. 2004; Geissbuhler, Chaki et al. 2007) with variations in its host, feeding and resting
preferences, replacing An. gambiae s.s. in some settings and becoming the sole malaria vector
(Lindblade, Gimnig et al. 2006).
ITNs have been shown to reduce malaria morbidity and all causes of malaria mortality across a
variety of transmission profiles (D'Alessandro, Olaleye et al. 1995; Binka, Indome et al. 1998;
Hawley, Phillips-Howard et al. 2003; Lengeler 2004; Lengeler 2004; Killeen, Smith et al. 2007;
O'Meara, Bejon et al. 2008; Kleinschmidt, Schwabe et al. 2009). IRS has similar impact on
malaria mortality and morbidity (Payne, Grab et al. 1976; Curtis 1999; Misra, Webber et al.
1999; Curtis and Mnzava 2000; Bhatia, Fox-Rushby et al. 2004). IRS was initially mainly
implemented in areas with seasonal transmission and epidemic prone, principally due to the
logistical and resource aspects of conducting a spraying campaign, however with the
development of longer lasting insecticides this has changed to allow for spraying in areas of
perennial transmission (WHOPES 2007). Pyrethroids are the only permitted insecticide group
for treating bed nets because of their low mammalian toxicity, a quick knock down rate and
repellence effect. However, most modern insecticide formulations have very little repellency
effect making the physical barrier the key deterrent. Repellency may have a negative effect on
the community wide effect that results from high coverage of ITNs and IRS, as mosquitoes are
not killed thus introducing the possibility of them diverting to non-protected communities
(Killeen and Moore 2012). Thus, non repellent insecticides will not deter mosquitoes and will
most likely only kill them after they have fed. In order to achieve high coverage, this implies
73
establishing aggressive campaigns to emphasize the nature of communal protection where such
insecticides are utilized (Killeen, Chitnis et al. 2011). Insecticides used for IRS include
organochlorines, pyrethroids, carbamates and organophosphates (Pemba and Namangale
2009). These four classes of insecticides are the most important in public health (WHO 1997).
The effect of these insecticides is dependent on their intrinsic toxicity to the mosquito and
residual effect which is dependent on the formulation used, stability, volatility and nature of
surface sprayed (Najera and Zaim 2001). Due to selection pressure since the introduction of
these insecticides, more than a hundred species have developed resistance to one or more of
these insecticides (Hemingway and Ranson 2000; Najera and Zaim 2001; Coleman, Sharp et al.
2006). This poses a great challenge to malaria control as the essential characteristic of selection
of an insecticide is the susceptibility of the vectors in the area of concern. This is compounded
by the choice of insecticides suitable for IRS (dependent on local resistance profile) and the fact
that only pyrethroids are the only class of insecticides that can be used for ITNs (Coleman,
Sharp et al. 2006; Pluess, Tanser et al. 2010).
With the current scale up of both ITNs and IRS in sub-Saharan Africa, it is apparent that most
communities will be protected by both these interventions (RBM 2010). Several studies have
demonstrated that combing these interventions yields better results than singular
implementation (Yadav, Sampath et al. 1998; Curtis and Mnzava 2000; Lengeler 2004;
Kleinschmidt, Schwabe et al. 2009; Bekele, Belyhun et al. 2012) particularly in areas of perennial
malaria transmission (Hamel, Otieno et al. 2011). Some other studies have demonstrated little
or no positive impact of combining IRS and ITNs (Protopopoff, Van Bortel et al. 2007). Largely,
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the optimal combination of ITNs and IRS still remains an area that requires further research to
elucidate further (Okumu and Moore 2011).
With the focus on IRS and ITNs, LSM is often dismissed as a reliable vector control method in
Africa (Kitron and Spielman 1989; Killeen, Fillinger et al. 2002; Killeen, Fillinger et al. 2002; Gu
and Novak 2005). However some studies have shown that larval control is able to reduce the
malaria mosquito larvae abundance and adult female populations by more than 90% including
outdoor biting species (Fillinger and Lindsay 2006; Fillinger, Ndenga et al. 2009). Thus LSM has
the capacity to supplement IRS and ITNs in sustaining low malaria transmission as it attacks
both the indoor feeding mosquitoes and those less likely to be affected by IRS or ITNs such as
Anopheles arabiensis (Killeen, Fillinger et al. 2002; Walker and Lynch 2007; Fillinger and Lindsay
2011; Worrall and Fillinger 2011).  Some key challenges with large scale LSM deployment put
forward included; the difficulty of estimating impact using a randomised control trail, which is
impractical for this intervention; the belief that greatest impact on malaria transmission
reduction should focus on reducing longevity of mosquito vectors through targeting adults and;
spatial and temporal distribution of vector larvae may inhibit LSM efforts due to high cost and
management (Fillinger, Kannady et al. 2008; Fillinger and Lindsay 2011). Thus, LSM has been
relegated to be only implemented in specific circumstances as a compliment to IRS and ITNs.
These settings have been described as those with few mosquito breeding sites that are easily
identifiable and accessible (Fillinger and Lindsay 2006; WHO 2011).  Additionally, these areas
should be in moderate to low transmission, ideally in the consolidation phase towards control
and elimination to allow for targeting in space and time (Fillinger and Lindsay 2006; Fillinger,
Kannady et al. 2008; Fillinger, Ndenga et al. 2009; Fillinger and Lindsay 2011).
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1.2.10.2 Scaling up access to case management beyond the facility: community case
management
There are a substantial number of deaths that occur in homes in endemic areas due to poor
access to health care services (Black, Morris et al. 2003; Rutebemberwa, Kallander et al. 2009;
Black, Cousens et al. 2010; Kinney, Kerber et al. 2010). The concept of primary health care
stresses the need to intergrate both preventive and curative interventions with close
involvement of the community due to these access limitations (Haegeman, Wyffels et al. 1985;
Riji 1992; O'Meara, Noor et al. 2009). Thus community based approaches built around the
principal of providing prompt diagnosis and treatment for malaria as close to home as possible
by community health workers become all the more important (Chanda, Hamainza et al. 2011;
Counihan, Harvey et al. 2012; Kisia, Nelima et al. 2012; Rutta, Francis et al. 2012; Thiam, Thwing
et al. 2012). In the 1970s,  community based health workers were used as a condiut for delivery
of chemoprophylactic treatment to communities. This at the time, in addition to treatment of
symptomatic cases, was considered a key malaria control intervention in endemic areas
(Haegeman, Wyffels et al. 1985; Haegeman, Wyffels et al. 1985; Greenwood, Greenwood et al.
1988). Based of this initial concept, various studies demonstrated the use of community based
health workers in malaria control using variations of the initial concept.  These variations
included training community health workers to recognise and refer all patients with danger
signs and treat all simple forms of malaria (Spencer, Kaseje et al. 1987; Spencer, Kaseje et al.
1987; Delacollette, Van der Stuyft et al. 1996) and /or training mothers to recognise danger
signs and seek drugs from community health workers (Pagnoni, Convelbo et al. 1997; Sirima,
Konate et al. 2003). These community-based treatment interventions were based on clinical
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diagnosis based on fever and other common signs and symptoms (Font, Alonso Gonzalez et al.
2001; Othnigue, Wyss et al. 2006) which lead to over diagnosis of malaria. The current
recommendations for malaria case management advocate for confirmatory diagnosis prior to
initiation of malaria chemotherapy (WHO 2006; Shillcutt, Morel et al. 2008; WHO 2010) and for
strengtherning of community based interventions as a cornerstone of increasing case
management coverage (WHO 2006; WHO 2012).  Several studies have shown that community
health workers are able to use and interprete malaria rapid diagnostic tests and subsequently
provide treatment or refer appropriately (Harvey, Jennings et al. 2008; Chanda, Hamainza et al.
2011; Counihan, Harvey et al. 2012; Ratsimbasoa, Ravony et al. 2012). Community health
workers have also shown ability to provide integrated treatment for malaria, pneumonia and
diahorea (Yeboah-Antwi, Pilingana et al. 2010; Kalyango, Rutebemberwa et al. 2012). This offers
an oppurtunity to scale up malaria case management to the peripheral areas using
commmunity health workers as part of the routine health system outreach in detecting mildly
symptomatic malaria cases (Harvey, Jennings et al. 2008; Chanda, Hamainza et al. 2011;
Counihan, Harvey et al. 2012; Ratsimbasoa, Ravony et al. 2012). Additionally, community case
management is useful to achieve and sustain control and thus is a prerequisite to elimination of
malaria (WHO 2012).
1.2.11 Eliminating cryptic malaria infections – The Role of Community Health Workers
Even though most countries have been successful in reducing the burden of malaria it still
remains high in many remote and historically holoendemic areas. This variation occurs between
countries, within short distances in same local areas and between age groups (Snow, Bastos de
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Azevedo et al. 1994; Giha, Rosthoj et al. 2000; Snow and Marsh 2002; Bousema, Drakeley et al.
2010). The exposure to infected mosquitoes is likely the major reason for this variation
(Bousema, Drakeley et al. 2010). This is exemplified in the anology of “draining the pond”,
which illustrates that the bottom of a pond is not always even and as such when water is
drained out of it, some places within the pond continue to have water while others are dry. The
areas with water represent areas where malaria transmission still occurs,  thus intuitively, as
transmission of malaria drops it becomes more focal (Figure 7) (Newman 2012).
Figure 7."Draining the pond" (Adapted from Newman 2012)
With most countries adopting an elimination agenda for malaria due to scale up of high impact
interventions, these malaria hot spots are increasing becoming more important (Barnes,
Application of malaria
interventions
Focal malaria transmission
The Malaria “Pond” The Malaria “Pond”
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Durrheim et al. 2005; Bhattarai, Ali et al. 2007; O'Meara, Bejon et al. 2008). Several studies
have shown that in areas of low and seasonal malaria burden, transmission is usually sustained
by clustered populations that are  semi immune who are infectious to mosquitoes, carry
asymptomatic infection for long periods of time and remain undetected and thus untreated
(Hogh 1996; Freeman, Laserson et al. 1999; Drakeley, Akim et al. 2000; Abdel-Wahab, Abdel-
Muhsin et al. 2002; Alves, Durlacher et al. 2002; Coleman, Kumpitak et al. 2004; Bousema,
Schneider et al. 2006; Shekalaghe, Bousema et al. 2007; White 2008; Okell, Ghani et al. 2009;
Ogutu, Tiono et al. 2010; Gosling, Okell et al. 2011). Currently malaria control curative activities
are essentially targeted at symptomatic patients and are reliant on  passive detection of
patients reporting to health facilities, seeking care when they are unwell (Najera 2001).
Strategies for control using chemotherapy  are being revisited as they can be complimentary to
the other primary interventions to further accelerate declines of disease burden (Bhattarai, Ali
et al. 2007; Okell, Drakeley et al. 2008; Gosling, Okell et al. 2011; Kern, Tiono et al. 2011; Huho,
Killeen et al. 2012) particularly in areas of low and seasonal transmission (Freeman, Laserson et
al. 1999; von Seidlein, Walraven et al. 2003).  Thus in order to reduce malaria transmission,
populations with cryptic infections and associated parasitic biomass must be targeted
(Drakeley, Akim et al. 2000; Okell, Ghani et al. 2009; Gosling, Okell et al. 2011; Shekalaghe,
Drakeley et al. 2011). In high transmission areas, the burden of these infections is in the older
age groups, while the young harbour the burden of clinical disease (White 2008; Gosling, Okell
et al. 2011). This is due to the vector biting rates being dependent on the host biomass and
hence age (Smith, Killeen et al. 2004) and development of immunity due to exposure over time.
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In order to target asymptomatic parasite with curative drugs populations there are two
plausible broad strategies that can be considered:  mass drug administration (MDA) or mass
screening & treatment (MSAT), historically referred to as mass blood examination (WHO 1963;
Gosling, Okell et al. 2011). MDA is the administering of antimalarials to each member of a
population, regardless of the presence of malaria detectable parasitaemia or symptoms, while
MSAT targets only confirmed parasitaemic individuals after parasitological testing for infection
status (refer to table 7).  The success of these interventions lies in their ability to reduce
prevalence of parasitaemia to thresholds where re-emergence is improbable and control
maintained. The possibility of success increases when parasite prevalence in low in the general
population and vector population density is also low. This usually occurs towards the end of the
dry season in most endemic areas (Okell, Griffin et al. 2011) or can occur as a result of effective
implementation of such as LLIN deployment and/or IRS (Gosling, Okell et al. 2011). MDA as
opposed to routine malaria case management, is a high coverage intervention and may
accelerate the spread of drug-resistant strains particularly when sub-therapeutic doses of
antimalarials are administered leading to  pressure on the parasite populations (Greenwood
2010; Kaneko 2010).  MSAT has been proposed as a better alternative due to the addition of a
confirmatory diagnostic tool which leads to provision of treatment only to those found positive
for infection thus reducing selection pressure on the drugs (Ogutu, Tiono et al. 2010; Crowell,
Briet et al. 2013). However, a challenge with MSAT is lies in the missing of sub patent infections
which, as alluded to contribute to the reservoir of infection and its higher cost and logistical
demands compared to MDA (Crowell, Briet et al. 2013). With increasing availability of more
sensitive diagnostic tools such as RDTs, the possibility of implementing MSAT is logistically
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possible using community based health workers (Kaneko 2010; Ogutu, Tiono et al. 2010). MSAT
has been recommended for small, isolated communities as it relies on explicit, accurate
population data and the ability to monitor the movements of people with access to a
confirmatory diagnostic tool which is the essential foundation of a successful MSAT program
(Macauley 2005) as an “end game” intervention in the overall continuum of malaria elimination
Table 7.Acronyms and strategies for mass drug administration (Adapted from Gosling, Okell
et al., 2011)
Acronym Name Definition
MDA Mass drug administration Simultaneous drug administration, without testing,
to the total population of an island, country, region
or district
TMDA Targeted mass drug administration Drug administration to all people living within a small
high-risk area, without testing, such as the
population surrounding a case
MSAT or MBS Mass screening and treatment or
mass blood survey
Screening of all persons irrespective of symptoms
and treatment of positives only
FSAT Focal screening and treatment As MSAT, but in a localized area such as a household,
neighbourhood, or village
MFT Mass fever treatment Treatment of all people with fever, irrespective of
diagnosis
ACD or MSFAT Active case detection or mass
screening of fever and treatment
Screening of all people with fever and treatment of
positives
IPT Intermittent preventive treatment Giving a full treatment dose of an antimalarial to an
asymptomatic individual, regardless of infection
status, at an opportunistic time
IPTi Intermittent preventive treatment
of malaria in infants
IPT of infants (under the age of 1 year) at times of
vaccination
IPTp Intermittent preventive treatment
of malaria in pregnancy
IPT of pregnant women at times of antenatal visits
IPTc or SPC Intermittent preventive treatment
of malaria in children or
seasonal prophylaxis in children
IPT of children at defined time periods during the
malaria season in seasonal transmission sites.
Usually applies to children under the age of 5 years
The concept of community based management of malaria stems from the recognition that,
there is a human resource deficit amongst clinically trained cadres, thus requiring interventions
outside centralised, facility based health system services  to improve access to appropriate
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malaria case management (WHO 2004; WHO 2004; WHO 2005; WHO 2012). Community health
workers have demonstrated the capacity to diagnose malaria and provide treatment according
to the local guiding guidelines (Cunha, Piovesan-Alves et al. 2001; Harvey, Jennings et al. 2008;
Elmardi, Malik et al. 2009; Hawkes, Katsuva et al. 2009; Mmbando, Segeja et al. 2009; Chanda,
Hamainza et al. 2011; Counihan, Harvey et al. 2012; Kalyango, Rutebemberwa et al. 2012). The
community approach has also been shown to be cost effective (Pang and Piovesan-Alves 2001;
Chanda, Hamainza et al. 2011), improve delivery of malaria case management overall (Yeung,
Van Damme et al. 2008; Elmardi, Malik et al. 2009; Hamer, Brooks et al. 2012) and is well
accepted by communities where it has been implemented (Ajayi, Falade et al. 2008; Mukanga,
Tibenderana et al. 2010; Yeboah-Antwi, Pilingana et al. 2010). The demonstrated decline in
malaria burden in most parts of sub-Saharan Africa, has made the reliance on fever as a marker
for diagnosis of malaria undesirable and hence the need for confirmatory diagnostic tests at all
levels of care (Rutta, Francis et al. 2012).   Community health workers have shown that they are
able, with minimal training, of using and interpreting  RDTs correctly (Counihan, Harvey et al.
2012), which is key to establishing effective high quality surveillance data (Hopkins, Talisuna et
al. 2007; D'Acremont, Lengeler et al. 2010; WHO 2010) which can be used for decision making
(Hopkins, Talisuna et al. 2007; WHO 2012)
1.2.12 The potential role of Community Health Workers in public health surveillance
Public health surveillance has been defined as the "ongoing systematic collection, analysis, and
interpretation of data critical to the planning, implementation, and evaluation of public health
interventions, and is closely integrated with timely dissemination of data generated to all
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stakeholders" (WHO 1962; Thacker and Berkelman 1988). Timeliness is a key performance
measure of public health reporting systems and may vary by disease, intended use of the data,
and public health system level (Jajosky and Groseclose 2004).  Surveillance stresses the need to
collect routinely a limited amount of data relevant to describing the  population’s health status
(Nelson, Thompson et al. 1997),  primarily to detect any changes over time  resulting from
changes in health practices, infectious and environmental agents and  control methods. There
are four main areas of measurement in health information systems are; (1) Health
determinants, (2) Health system inputs, (3) Health system outputs and (4) Health outcomes (as
illustrated in Figure 8)(WHO 2008; WHO 2008). Thus the core indicators selected should be able
to reflect changes over time and should be valid, reliable, specific, sensitive, feasible/affordable
to measure, relevant and comparable (Lippeveld, Sauerborn et al. 2000; WHO 2008; WHO
2008)
Figure 8.Domains for measurement for health information systems (Adapted from WHO
2008; WHO 2008)
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 Environmental and behavioural risk factors
Health system
Inputs Outputs Outcomes
 Policy
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resources
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and
management
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 Service
availability and
quality
 Service
coverage
 Utilization
Health Status
 Mortality
 Morbidity / Disability
 Well being
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Thus public health surveillance aids in decision making, priority setting, targeting interventions
and management of health problems through the tracking of set indicators (de Savigny and
Binka 2004; Jajosky and Groseclose 2004; Odhiambo-Otieno 2005; Thacker, Qualters et al.
2012). In sub-Saharan Africa these routine information systems are inadequate and weak. A
major reason for this is that, monitoring and evaluation is not considered an integral part of the
information pathway and this lack of verification has lead to stakeholders having little or no
confidence in utilising this information for decision making and planning . Often, the available
information is also poorly packaged and communicated making its use for decision making a
challenge by the health system (de Savigny and Binka 2004).  This has been compounded by the
lack of financial investment, human resources, infrastructure and institutional capacities,
particularly in low income countries (St Louis 2012). For evidence based decision making to
have a positive impact on the health system there must a translation of the data into
information which subsequently needs to be packaged to reveal the evidence it embodies. This
evidence adds to the body of knowledge which warrants some action by stakeholders which
drives change or impact. This “change” alters the data and the cycle begins again (Figure 9) (de
Savigny and Binka 2004).
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Figure 9.Pathway for evidence based planning (Adapted from de Savigny & Binka 2004) –
(M&E = Monitoring and evaluation, MIS= Management of information systems)
In poorly resourced countries, community-based surveillance systems (CBSS) can compliment
health facility based public health surveillance. They are able to provide quantitative estimates
of disease burden in a defined population and service delivery indicators (Baker and Ross 1996).
This they have been able to demonstrate as part of their curative functions particularly for
community based management of malaria and pneumonia predominantly in their local
communities that are usually rural and hard to reach (Yeboah-Antwi, Pilingana et al. 2010;
Kalyango, Rutebemberwa et al. 2012). Community health workers (CHWs) have also
demonstrated that they are able to collect epidemiological data on various diseases provided
they have the appropriate training (Hopkins, Talisuna et al. 2007; Alba, Hetzel et al. 2011;
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Kalyango, Rutebemberwa et al. 2012). Studies have shown that CHWs are also able to
implement routine programmatic community based mosquito surveillance (Chaki, Mlacha et al.
2012; Sikaala, Chinula et al. 2014). Information generated from community level efforts can be
utilised to describe spatial and temporal discrepancies in health status and/or access to services
which would in turn allow for targeted interventions and resource allocation on programmatic
scales (Tatem, Campiz et al. 2011; Barclay, Smith et al. 2012).
1.2.13 Technology and Public Health Surveillance – What part can mobile phones play?
The effective control of most diseases, particularly malaria require a wide range of timely and
routinely collected data which should encompass, (1) surveillance, monitoring and evaluation
activities, (2) health commodities and consumables supply chain monitoring and (3)
pharmacovigilance, safety and quality of antimalarial therapies monitoring (Zurovac, Talisuna et
al. 2012). In most developing countries, health related information is collected routinely,
usually passively, shared at intervals of a month or two at best,  of poor quality, incomplete and
contributes to poor management, resource allocation, priority setting and provision of health
services (Safaie, Mousavi et al. 2006; Braa and Sahay 2012). It is important here to note that
health information has a positive recurring endogenous relationship between timeliness, use,
correction and quality (de Savigny and Binka 2004).  These deficits certainly lead to delayed
responses to threats and emergencies such as disease outbreaks, supply stock-outs of and
undetected occurrences of severe adverse drug reactions and treatment failures (Talisuna,
Staedke et al. 2006; Rowe, Kachur et al. 2009; Maokola, Willey et al. 2011). This has been
primarily attributed to limitations in human, infrastructural and institutional capacity (Chretien,
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Burkom et al. 2008; Ranck 2011). Perhaps the greatest challenge surveillance systems need to
overcome is the need to relay data to and from the collection points in a timely manner
(Mawudeku, Ruben et al. 2007). Unlike conventional public health surveillance which is
dependent on the health worker with/without laboratory confirmation reporting data which
may initiate a manual analysis (Siegrist 1999; Soto, Araujo-Castillo et al. 2008),  electronic
systems dramatically accelerate the collation, availability of health data and increase the
automation of many standard analysis required for decision making (Soto, Araujo-Castillo et al.
2008; Ranck 2011).  An electronic approach to surveillance may address principally four
important objectives of surveillance which include: (1) outbreak detection, (2) strengthen local/
focal responses to outbreak detection, (3) monitoring and evaluation of disease patterns and
trends and/or intervention effectiveness or impact, and (4) facilitate data-driven policy decision
making through hypothesis testing (Henning 2004). In order to efficiently implement an
electronic surveillance system, it is essential to have sufficiently trained specialist staff,
infrastructure, technical support and equipment. There several proposed platforms that can be
used in these types of electronic surveillance systems and which could provide real-time data
collation and access (Johnson and Blazes 2007; Mawudeku, Ruben et al. 2007; Morse 2007;
Siswoyo, Permana et al. 2008; Keller, Blench et al. 2009; Chunara, Freifeld et al. 2012; Morse
2012; Free, Phillips et al. 2013).These platforms compliment classical control, verification and
analysis found in traditional surveillance, through increased  coverage, transparency, timeliness
and scalability (Freifeld, Chunara et al. 2010). However, most of these are largely based on
email and internet availability, which still remains a challenge in many developing countries
particularly in isolated rural settings (Johnson and Blazes 2007).  In the recent past there has
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been dramatic growth in mobile phone networks globally and Africa particularly, where
approximately two-thirds of the population is covered by a mobile network with an estimated
penetration rate of 50%, representing over half a billion mobile phone subscribers across the
continent (ITU 2010). While third generation mobile phone networks capable of supporting
high speed internet exchange have followed this trend, these lag behind regular second
generation mobile phone networks, making the later the most important communication
infrastructure for supporting surveillance reporting in the developing world (Johnson and Blazes
2007). Evidence shows that access and use of mobile phones is not strongly influenced  by
socio-economic lines, which is not the case with access to other communication technologies
such the internet (Forestier, Grace et al. 2002). Thus, mobile phones can play a complimentary
role in the provision of health system information needs in developing countries (Deglise, Suggs
et al. 2012) such as data collection, training and access to reference material, communication
between health workers, decision support, supervision, and health behaviours promotion
(Derenzi, Borriello et al. 2011) including disease surveillance (Diero, Rotich et al. 2006; Fynn, de
Jager et al. 2006; Shirima, Mukasa et al. 2007; Skinner, Rivette et al. 2007; Blake 2008; Ma,
Zhou et al. 2009; Tatem, Qiu et al. 2009). However, the use of mobile phones in public health
still remains in its infancy in most of the developing world (Krishna, Boren et al. 2009).
Similar to other electronic platforms, mobile phones can be used to directly record digital data
at  the point of collection, potentially adding efficiency, through automated aggregation and
analysis, and versatility by accommodating various data forms for divergent purposes based on
need (Fjeldsoe, Marshall et al. 2009; Whittaker, Borland et al. 2009; Wei, Hollin et al. 2011).
Mobile phone technologies are now considered important communication infrastructures
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across  health, finance, education and marketing sectors (Tufano and Karras 2005; Levine,
McCright et al. 2008; Fjeldsoe, Marshall et al. 2009; Lefebvre 2009; Ackerman, Filart et al. 2010;
Derenzi, Borriello et al. 2011; Lim, Xue et al. 2011; WHO 2011). A summary of both the
attractions and barriers of mobile phone technology based data collection tools is provided in
table 8.
Table 8.Attractions and barriers to use of mobile phone technology based data collection
systems
Property Description
Attraction
Low start up costs Costs less to rollout over a large area has
low training costs, can be used by any
cadre and running costs are low (cheaper
than voice)
User friendly Data inputting is relatively easy using SMS
or any predefined tools on the mobile
phone.
Payment forms Using the prepaid module allows for users
to control their usage of airtime and
indeed have access to more if need be.
Barriers
Cost issues High cost of penetration of the mobile
phones to remote parts of many
developing countries
Information carrying capacity Particularly in SMS reporting where
characters are limited to 160 and in areas
on low band width
Language and illiteracy Particularly when information has to be
transmitted in the form of text
Mobile phones can transmit information via both verbal and non-verbal methods (Fynn, de
Jager et al. 2006; Patnaik, Brunskill et al. 2009), however the former is considered cost
inhibitive, prone to errors  and generally impractical in most developing countries (Fynn, de
Jager et al. 2006). The most common types of non-verbal based data capture applications are
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short messaging system (SMS),  Java Micro Edition Platform (J2ME) and internet /web-based
forms (Table 9)(Loudon 2009).
Table 9.Characteristics of client applications and data transmission (Adapted from Loudan
2009)
Client
Application
Type of phone Requirements for data collection Data transfer methods
available
Fixed format
SMS
All SMS capable
phones
No additional software needs. The user
writes and SMS in a predefined format,
representing answers to successive
questions
SMS only
Java Micro
Edition
Platform
(J2ME)
application
All java phones Data capture application has to be
downloaded onto the phone via the web or
bluetooth or cable. The data collector
navigates through questions in an
application on the phone, which saves the
responses and transmits the completed form
to a server.
SMS or General packet
radio service (GPRS)
(these can be
asynchronous allowing for
data saving and
transmission when web
access is available)
Web based
form
All phones with a
web browser
Phone must have access to the internet. The
data form is filled out online, and saved
directly online
GPRS
Of these three applications, the most readily available in many rural parts of most developing
countries, cost effective and feasible is SMS, (Fynn, de Jager et al. 2006; Safaie, Mousavi et al.
2006; Fjeldsoe, Marshall et al. 2009; Cole-Lewis and Kershaw 2010; Wei, Hollin et al. 2011)
particularly in resource constraint settings due to its minimal running costs and availability on
almost all inexpensive “feature” or smart mobile phone handsets (Zurovac, Sudoi et al. 2011;
Zurovac, Talisuna et al. 2012). J2ME has a higher set up cost, but due to its ability to transfer
more data, tends to be cheaper as a long term investment compared to SMS which can send a
maximum of 160 characters per single SMS message, thus inhibitive depending on the amount
of data required to be transmitted (Cole-Lewis and Kershaw 2010).
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Frequent and rapid inflow of data improves the understanding of local mapping of disease
burden and decision-making abilities, enabling efficient targeting of interventions and
commodities, particularly for diseases such as malaria (Kamanga, Moono et al. 2010). As the
malaria burden becomes increasingly focal, community-level mapping techniques become
important in order to be able to identify these “hot spots” of transmission (Bousema, Drakeley
et al. 2010; Chizema-Kawesha, Miller et al. 2010; Davis, Kamanga et al. 2011; Bousema, Griffin
et al. 2012). Mobile phones thus, offer a practical complimentary tool, that can be utilized for
reporting data collected by community-based surveillance staff, in order to describe spatial and
temporal malaria transmission in real time and guide timely programming (Kamanga, Moono et
al. 2010; Zurovac, Talisuna et al. 2012). Figure 10 below illustrates some possible applications of
mobile phone technology in malaria programmes.
Figure 10.Applications of mobile phone technology in malaria programming (Adapted from
Zurovac, Talisuna et al., 2012)
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1.2.14 A brief context of public health surveillance in Zambia
As part of the national health reforms, Zambia decentralised its health system in 1994 which
receives support from government (37%), cooperating partners/donors (26%), households
(21%), and private entities (13%) (Bossert, Chitah et al. 2000; Heywood, Nielsen et al. 2005;
Mutemwa 2006; WHO 2006). The Zambian health care delivery system consists primarily of 4
levels; the Ministry of Health (MOH) (national coordination of the health service delivery
systems); the provincial medical offices (liaisons between the MOH and the districts); the
district medical office (oversee the district health facilities and manages the district health
team); and the hospital (first, second and third level) management boards (management of
primary, secondary and tertiary level hospitals)(Hoppenbrouwer and Kanyengo 2007). At health
centre level, each facility has facility committees and neighbourhood committees to encourage
community participation in their management (WHO 2006). As part of the health
decentralisation process, the health information management system (HMIS) was adopted as a
significant element of district-level health management practice, to ensure that concerns about
long term sustainability, performance, proficiency and effectiveness were addressed
(Mutemwa 2006; MOH 2008). The initial roll out of the HMIS had various challenges which led
to several review processes (Heywood, Nielsen et al. 2005; MOH 2007). These reforms mainly
considered reorganization of key performance indicators for measurement of the millennium
development goals and national strategic plans and associated goals, including providing for
local self-assessment at all levels of health care provision for evidence based decision making
(Heywood, Nielsen et al. 2005; Mutemwa 2006).   The current HMIS has been scaled up to all
formal public health facilities in the country and integrates routine service activities, specialist
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vertical  programs including the malaria control programs and selected aspects of
epidemiological surveillance for notifiable disease (Heywood, Nielsen et al. 2005; MOH 2008).
Generally, HMIS has largely failed to deliver on its ultimate goals primarily because of, the lack
of complete and timely reports, inadequate skilled labour and reporting infrastructure and
negligible quality control or even quality assurance (Evans and Stansfield 2003; WHO 2013).
Additionally, HMIS do not routinely report on laboratory, environmental health and
administrative data such as finances, human resources and transport among others (Heywood,
Nielsen et al. 2005; MOH 2008). Fundamental health decisions are made based on rough
incomplete poor quality estimates of disease and treatment burdens (Siaga 1993; UNFPA 1995).
1.2.15 Study Design Considerations
The study was part of a larger multi country study, called the Malaria Transmission Consortium
(MTC) which was funded by the Bill and Melinda Gates Foundation. The overall goal of this
consortium project was to “develop a standardized set of tools that can be used to rapidly and
accurately measure the malaria transmission intensity in a manner that will be suitable for use
by control programs”. The objectives of the MTC were  “(1) The development of a set of
standardized measures of malaria transmission (and the biological factors that contribute to
transmission) that can be used across the range of malaria epidemiology, (2) The evaluation of
the effectiveness of different transmission-reducing malaria control interventions, both alone
and in various combinations in environments with varying parasite transmission levels, and (3)
An assessment of the impact of biological factors associated with vector populations, such as
variable levels or different mechanisms of insecticide resistance or variation in vector
behaviours, on the effectiveness of malaria control interventions.”. This study aimed to address
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objectives 1 and 2, although some data collected to address objective 3 was also included as
background descriptive data that strongly supports the selection of IRS with non-pyrethroid
insecticides as the vector control measure to be evaluated. Malaria infection burden was
assessed through using longitudinally in 14 clustered cohorts, each comprising of 165
households, centred around a selected health facility, so that the incremental impact of
supplementary vector control with IRS could be evaluated by assigning them experimentally to
these clusters using a randomised design. While CHWs were required to actively visit each
household every month, and to test and treat all consenting and assenting individuals present
at the time, no effort was made to insist that each individual participated in testing and
treatment during each visit or that the CHW conduct follow up visits to ensure participation by
all household members. These deliberate choices to ensure relatively easy, flexible interactions
between the CHWs and the residents were driven by programmatic logistical considerations
that aimed at obtaining valid data that were both (1) adequate for the purposes of monitoring
and characterizing malaria infection burden, as well as the impact of experimentally-introduced
supplementary IRS upon it, and (2) practically applicable routinely on national scale by the
control programmes. The rigidity of control exerted by the research team was minimized so
that the relevance of the results to programmatic applications under representative condition
of management on much larger scales by the Ministry of Health was maximized (Habicht,
Victora et al. 1999; Glasgow, Lichtenstein et al. 2003; Boffetta 2011). ,
While every effort was made to randomly assign the specific IRS treatments to these clusters in
a controlled fashion, it was obvious from the outset that NMCC did not have full control over
either the availability of insecticide products, nor over all the actual implementation operations
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within these districts, because both procurement and implementation were both partially
executed by contractors engaged directly by the funding agency. Given this situation, as well as
the limited capacity of NMCC for conducting research at the time, it was decided to implement
as closely controlled an experimental study as possible but accept that it failed to satisfy the
criteria required to have it formally registered as a randomized controlled trial. Despite the
effort to experimentally control the assignment of IRS treatments, it was therefore decided to
nevertheless classify the study a priori as an observational study designed to deliver evidence of
impact plausibility rather than probability. As an observational study, the inherent
methodological limitations of vulnerability to selection bias and confounding variables, which
may cause under-estimation or over–estimation of intervention impact must be accepted
(Carlson and Morrison 2009; Boffetta 2011), even though many of the latter were recorded and
taken into consideration during the implementation and analysis phase of the study. As many
potential confounding variables as possible were recorded so that their contribution to the
primary outcome, which in this study was malaria infection diagnostic positivity, could be
parsimoniously (Sober 1981) accounted for in post hoc regression model analyses (Carlson and
Morrison 2009; Starks, Diehr et al. 2009), thus minimizing biases in the estimation of the
treatment effects (Starks, Diehr et al. 2009). .
However the study was conducted as an experimental evaluation of the adequacy,
effectiveness and plausibility of a community based surveillance system that used both passive
and active malaria testing and treatment participant contact mechanisms in a programmatically
relevant setting. This approach as opposed to an efficacy evaluation which would require
optimal conditions with sufficient resources, financial and otherwise allowed for an
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understanding of program implementation in a real programmatic setting (Habicht, Victora et
al. 1999; Glasgow, Lichtenstein et al. 2003; Flay, Biglan et al. 2005). So while the observational
nature of the study has some disadvantages in terms of delivering evidence of impact
plausibility, rather than probability, it also has the advantage of quantifying effectiveness under
programmatically relevant conditions, rather than merely efficacy under controlled conditions
of questionable relevance to the NMCC. In fact, this approach also has the advantage of
identifying limitations in these prototype implementation systems by , in terms of coverage and
utilization of these interventions in a real life setting (Carlson and Morrison 2009). Lessons
learnt with regard to the practicality, scalability, generalizability and resource input
requirements for program implementation may be highly valuable and relevant as they were
evaluated in representative programmatic conditions (Habicht, Victora et al. 1999; Glasgow,
Lichtenstein et al. 2003; Flay, Biglan et al. 2005).
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CHAPTER TWO
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2.0 Abstract
Background
Active, population-wide mass screening and treatment (MSAT) for chronic Plasmodium
falciparum carriage to eliminate infectious reservoirs of malaria transmission have proven
difficult to apply on large national scales through trained clinicians from central health
authorities.
Methodology
Fourteen population clusters of approximately 1,000 residents centred around health facilities
(HF) in two rural Zambian districts were each provided with three modestly remunerated
community health workers (CHWs) conducting active monthly household visits to screen and
treat all consenting residents for malaria infection with rapid diagnostic tests (RDT). Both CHWs
and HFs also conducted passive case detection among residents who self-reported for
screening and treatment.
Results
Diagnostic positivity was higher among symptomatic patients self-reporting to CHWs (42.5%)
and HFs (24%) than actively screened residents (20.3%), but spatial and temporal variations of
diagnostic positivity were highly consistent across all three systems. However, most malaria
infections (55.6%) were identified through active home visits by CHWs rather than self-
reporting to CHWs or HFs. Most (62%) malaria infections detected actively by CHWs reported
one or more symptoms of illness. Most reports of fever and vomiting, plus more than a quarter
of history of fever, headache and diarrhoea, were attributable to malaria infection. The
minority of residents who participated >12 times had lower rates of malaria infection and
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associated symptoms in later contacts but most residents were tested <4 times and high
malaria diagnostic positivity (32%) in active surveys, as well as incidence (1.7 detected
infections per person per year) persisted in the population. Per capita cost for active service
delivery by CHWs was US$5.14 but this would rise to US$10.68 with full community compliance
with monthly testing at current levels of transmission, and US$6.25 if pre-elimination
transmission levels and negligible treatment costs were achieved.
Conclusion
Monthly active home visits by CHWs equipped with RDTs were insufficient to eliminate the
human infection reservoir in this typical African setting, despite reasonably high LLIN/IRS
coverage. However, dramatic impact upon infection and morbidity burden might be attainable
and cost-effective if community participation in regular testing can be improved and the
substantial, but not necessarily prohibitive, costs are affordable to national programmes.
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2.1 Background
A relatively large proportion of malaria infections are only mildly symptomatic, especially in
endemic countries where acquired immunity moderates both parasitaemia and pathology
(Smith, Schellenberg et al. 1994; Bottius, Guanzirolli et al. 1996; Alves, Durlacher et al. 2002).
Even in areas with only modest, seasonally sporadic transmission where little immunity exists
among the human populations, the many mildly symptomatic infections that persist chronically,
often at sub-patent parasite densities below thresholds of detectability, are responsible for
sustained malaria transmission (Babiker, Abdel-Muhsin et al. 1998; Bousema, Gouagna et al.
2004). As early as the 1930s, these populations have been targeted for treatment with anti-
malarial drugs as a control measure for malaria transmission, particularly during the era of the
Global Malaria Eradication Programme initiated in the 1950s (Molineaux and Gramiccia 1980;
Jeffery 1984; Killeen 2013). Due to the emergence of drug resistance, which was attributed to
mass drug administration campaigns (Kouznetsov 1987; Wellems and Plowe 2001; Parija and
Praharaj 2011) and evidence that the impact on transmission may be limited, the use of
therapeutic approaches to control transmission rather than burden was not considered as
effective (Molineaux and Gramiccia 1980; Jeffery 1984; Wernsdorfer 1992; WHO 2010) until
recently when interest in malaria elimination was rejuvenated (Moonen, Cohen et al. 2010;
WHO 2010; Maude, Socheat et al. 2012).
Currently curative drugs are predominantly targeted at symptomatic individuals based on
passive detection of acute infections among patients seeking care for fevers through the formal
and informal health system (McCombie 1996; Tanner and Vlassoff 1998; Najera 2001).
Strategies for control of human-to-mosquito transmission by providing chemotherapy to
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chronic parasite carriers are now being revisited as they may be complimentary to front-line
interventions for preventing mosquito-to-human transmission, such as long-lasting insecticidal
nets (LLINs) and indoor residual spraying (IRS) of houses, to further accelerate declines in
malaria burden (Okell, Drakeley et al. 2008; Okell, Ghani et al. 2009; Gosling, Okell et al. 2011)
in areas of low and seasonal transmission (Molineaux and Gramiccia 1980; von Seidlein,
Walraven et al. 2003; WHO 2010).
However, most of the infected fraction of the human population only exhibits sub-acute
symptoms so they do not always obtain medical care, even where it is readily available
(Lalchhuanawma and Murhekar 2012; Xu, Xu et al. 2012).  These carriers of chronic, mildly
symptomatic malaria infection thus act as the silent reservoir of infection because even low,
often sub-patent levels of parasitaemia are sufficient to infect mosquitoes (Dunyo, Milligan et
al. 2006; Bousema and Drakeley 2011; Okell, Bousema et al. 2012). Additionally, asymptomatic
individuals risk developing chronic anaemia and symptomatic malaria (Prentice, Cox et al. 2010;
Tiono, Ouedraogo et al. 2013).  Across all levels of transmission, the majority of infections and
onward transmission to mosquitoes occurs in older age groups, even though the young often
harbour the highest parasite densities, because the former comprise the bulk of the human
population and vector biting rates increase with host biomass and therefore age (Drakeley,
Akim et al. 2000; Smith, Killeen et al. 2004; Gosling, Okell et al. 2011). In such populations,
many individuals remain parasitaemic and infectious for one or more years (Bruce-Chwatt,
Southgate et al. 1974; WHO 1987; Bretscher, Maire et al. 2011). Thus, in order to eliminate
human-to-mosquito transmission with therapeutic drugs, all cryptic or asymptomatic infections
within a human population must be successfully terminated, necessitating comprehensive
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coverage of targeted communities (Okell, Ghani et al. 2009; Gosling, Okell et al. 2011;
Shekalaghe, Drakeley et al. 2011; Tiono, Ouedraogo et al. 2013).
Essentially two broad strategies for taking malaria chemotherapy beyond routine case
management have been described: mass drug administration (MDA) or mass screening &
treatment (MSAT), historically referred to as mass blood examination (WHO 1963; Gosling,
Okell et al. 2011). MDA entails administering anti-malarials to every traceable consenting
member of a population, regardless of whether their malaria infection status is known or
whether they exhibit symptoms (WHO 1963; WHO 2010; Gosling, Okell et al. 2011), while MSAT
targets only confirmed parasitaemic individuals after parasitological testing for infection status
(WHO 1963; Gosling, Okell et al. 2011).   MDA necessitates comprehensive coverage and failure
may accelerate the spread of drug-resistant strains selected by strong but incomplete selection
pressure on the parasite populations (Greenwood 2010; Kaneko 2010).  MSAT has been
proposed as a better alternative because treatment is limited to those diagnostically confirmed
to be infected, thus lowering treatment costs and risks of selection for resistance (Ogutu, Tiono
et al. 2010; Crowell, Briet et al. 2013). However, the major limitation of MSAT lies in the
challenge of detecting low-density infections, which contribute substantially to the reservoir of
infection (Crowell, Briet et al. 2013). With increasing availability of more sensitive, scalable
malaria rapid diagnostic tests (RDTs) that can be used by non-specialist community based
health workers in low-resource settings, MSAT is now logistically feasible (Harvey, Jennings et
al. 2008; Kaneko 2010; Ogutu, Tiono et al. 2010; Counihan, Harvey et al. 2012).
The concept of community-based management of malaria stems from the recognition that
human resource deficits amongst clinically-trained professional cadres are commonplace, so
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extending service delivery beyond centralized health facilities, by mobilizing through
community health workers (CHW) will be required to improve access to appropriate
management of uncomplicated malaria (WHO 2005; WHO 2012). CHWs have demonstrated the
capacity to effectively diagnose malaria with RDTs and provide treatment according to the
locally relevant policy and guidelines (Harvey, Jennings et al. 2008; Hawkes, Katsuva et al. 2009;
Chanda, Hamainza et al. 2011; Counihan, Harvey et al. 2012). The community-based diagnosis
and treatment approach has also been shown to be cost-effective (Pang and Piovesan-Alves
2001; Chanda, Hamainza et al. 2011), improve delivery of malaria case management overall
(Yeung, Van Damme et al. 2008; Elmardi, Malik et al. 2009; Hamer, Brooks et al. 2012), is well
accepted by communities (Ajayi, Falade et al. 2008; Mukanga, Tibenderana et al. 2010; Yeboah-
Antwi, Pilingana et al. 2010) and also provides a potentially valuable population–wide platform
for monitoring trends in human parasitaemia (Rutta, Francis et al. 2012).
However, this approach remains grossly underutilized and understudied, with only 15 million
RDTs utilized at community level globally, mostly in India (WHO 2013). This study therefore
evaluated the effectiveness of paid CHWs providing improved access to blood screening and
treatment services to community members, not only when they self-reported because they felt
ill, but also through regular monthly active visits to their homes.
2.2 Methods
2.2.1 Study areas
The study was conducted in two adjacent rural districts of Zambia, Luangwa District in Central
province and Nyimba District in Eastern province (Figure 11) where perennial transmission of
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Plasmodium falciparum is predominantly mediated by Anopheles funestus (Seyoum, Sikaala et
al. 2012; Sikaala, Killeen et al. 2013) at an entomologic inoculation rate (EIR) of approximately
70 infectious bites per unprotected person per year (Sikaala CH, Chinula D, Chanda J, Hamainza
B,Mwenda M, Mukali I, Kamuliwo M, Lobo N, Seyoum A and Killeen GF, personal
communication).
Figure 11.Map indicating location of health facilities and associated catchment populations
enrolled in the study
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Nyimba is located 350 kilometres east of the capital city Lusaka and covers an area of 10,943
km2 with a population of approximately 86,000 residents, most of whom are involved in
agriculture as their main livelihood. Nyimba is drained by three perennial rivers the Luangwa
and its two tributaries the Lunsemfwa and the Lukusashi, as well several streams. Nyimba spans
a range of altitudes from 400m to 1,200m along the Luangwa valley with temperatures
averaging 30°C and mean annual rainfall of 1,000 mm (Kasali 2008). The population of Nyimba
is served by 17 health centres and one first-level hospital located in the centre of Nyimba town.
Luangwa district is located at the confluence of the Zambezi and Luangwa rivers, 325 kilometres
south-east of Lusaka. The population of the Luangwa is 25,000 residents, most of whom are
settled along the river where the main economic activities are fishing and agriculture. The
district covers a surface area of 3,468 km2 and lies 350 to 500 metres above sea level. Luangwa
has an average temperature in above 35°C and a mean annual rainfall of approximately 800mm
(Kasali 2008). Luangwa has nine health centres, of which two have inpatient services, one of
which is located in the district capital at Luangwa Boma and another at Katondwe Mission
located about 40km further north.
2.2.2 Community health workers
In Zambia, community health workers (CHWs) are a formally accepted part of the health service
delivery system and are selected by the communities they serve. In order to qualify, they must
reside within the community, be literate in English, and be available and willing to provide basic
care to their communities. Once selected, they are trained for a period of six weeks in basic
primary healthcare, mainly focusing on aspects of prevention and treatment of common
ailments as part of their health promotion duties. The major disease focus areas are the simple
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forms of malaria, pneumonia and diarrhoea. When care is sought from the CHWs, the patient’s
symptoms are assessed and the CHWs follow the guidelines for diagnosis and treatment. The
CHWs are also trained how to recognize clinical danger signs and facilitate referral of these
cases to the HFs for further management (MOH 2010).  Each CHW is attached to the HF nearest
to their community and is normally responsible for approximately 500 of the resident
inhabitants. The clinically-trained HF staff are responsible for supervising and mentoring the
CHWs, and for supplying all their equipment and consumables. The CHWs that participated in
this study were selected from available CHWs in their specific catchment areas and recruited
through their supervising HFs. These recruited CHWs were remunerated at a rate of 350
Zambian Kwacha (approximately US$64) per month. A total of three CHWs per cluster (42
active CHWs) were selected to participate in the study and re-trained for a week in malaria
diagnosis (use and interpretation of RDTs), treatment (prescription and dosage of AL), referral
procedures (recognition of danger signs) and reporting.
2.2.3 Study design
This longitudinal study was conducted, from January to December 2011. In each study district,
seven clusters of approximately 165 consenting households (average number of resident
members per household was estimated at approximately six (CSO 2011)), each of which was
selected and enrolled in order of proximity to the public-sector HF that defined the centre of
the cluster. All members of the household were eligible to participate except pregnant women
and children below six months of age. The exclusion of these groups was stipulated in
accordance with national guidelines that CHWs are not allowed to manage any condition in
these select groups. Each cluster received the standard Ministry of Health interventions for
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malaria control in Zambia, which included long-lasting insecticidal nets (LLINs), diagnosis by
either microscopy or rapid diagnostic tests (RDTs), treatment with artemether-lumefantrine
(AL) and intermittent presumptive treatment with sulphadoxine-pyrimethamine. The LLINs
were distributed through mass distribution campaigns in 2006, 2008 and again 2009 (Eisele,
Miller et al. 2011), following a project-based distribution to selected villages in Luangwa in 2005
(Keating, Hutchinson et al. 2012) and routine delivery for pregnant women and under five
children through the antenatal clinics at each of the health facilities in the study (NMCC 2011;
NMCC 2012). Intermittent presumptive therapy in pregnancy IPTp) was also routinely provided
through the antenatal clinics with a target of 3 doses during each pregnancy (NMCC 2011;
NMCC 2012).
2.2.4 Data collection
Each CHW recorded all patient diagnoses and responses to pre-set questions in a malaria
register book which detailed RDT outcomes, as well as details of age, symptoms, use of IPTp or
LLINs, and treatment of their house with IRS in the previous six months. Information on access
and use of interventions was collected at an individual level among all participants for those
who gave consent to participate in the study. Active case detection was achieved through
monthly home visits by the CHWs to each enrolled household within their assigned catchment
areas, during which all consenting and assenting members were screened for malaria infection
using HRP2-based RDTs from ICT Diagnostics (ICT Malaria Pf cassette test).  Between these
visits, passive case detection was accomplished by encouraging those who had symptoms to
seek care from either their assigned local CHW or the nearest public sector HF. Individuals that
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escorted patients who sought care were also tested if they were identified as members of the
study clusters. During both active and passive visits, all study participants found to be positive
for malaria by RDT received standard AL treatment for uncomplicated malaria. Those found to
be febrile and negative by RDT through either active or passive testing systems were referred to
the nearest healthcare facility. In both the active and passive systems, the CHWs reported
weekly summaries via mobile phone short messaging system of the number of patients tested,
RDT test results, AL and RDT stock status and the numbers of treatments of each pack size (6,
12, 18 or 24 tablets) they had dispensed.
2.2.5 Data management and statistical analysis
The principal data sources for this study were the CHW malaria registers and health facility
reports sent to NMCC through the malaria rapid reporting system platform (NMCC 2011) via
the AirtelTM mobile phone network in the two districts. To ensure data quality and full
disaggregation, the line-listed data from the malaria registers were double-entered and
verified, reconciled and then cleaned following descriptive frequency analysis of the
distributions of values for each variable. Statistical analysis was accomplished using SPSS
version 20 (IBM) and R version 2.14.1 augmented with the lattice, Matrix and LME4 packages.
2.2.6 Association of malaria infection with age, sex, symptoms, interventions, cluster and
season
Generalized linear mixed models (GLMM) were used to evaluate the association between
observed RDT-determined malaria infection status as a binary dependent variable with an
intercept, age category (<1, 1 to 4, 5 to 10, 11 to 14, 15 to 24, 25 to 44 and >45 years of age),
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sex, access to an LLIN, use of an LLIN, having slept in a house that had been treated with IRS in
the previous six months, and the three seasons (hot and wet from December to April, cool and
dry from May to August, and hot and dry from September to November) as categorical
independent variables. All models included household identity number nested within CHW
catchment nested within cluster, as well as date of participant contact, as random effects, with
the exception of one model lacking an intercept in which cluster was treated as a categorical
independent variable to determine the mean diagnostic positivity of each cluster. The final
model presented in Table 10 was selected by building the model through adding explanatory
variables to the model one at a time, assessing improvements of the goodness of fit using log-
likelihood tests and retaining only those parameters that either had significance in the model or
which significantly improved the goodness of fit as per principle of parsimony (Sober 1981).
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Table 10.Association of malaria infection with age, sex, symptoms, interventions, geographical location and season i ii
Category Passive Surveillance Active Surveillance
DP%a n/Nb (I) OR [95%CI]c Pd DP%a n/Nb (I) OR [95%CI]c Pd
Overall
Age
42.50 2236/5261(3804) 0.74[0.68,0.79] <0.001 20.26 11851/58500 (17543) 0.25[0.23,0.27] <0.001
<1
1-4
5-10
11-14
15-24
25-44
≥45
Sex
Male
Female
Interventions
ITN
IRS
Number of preceding testsf
Clusters
Luangwa district
Sinyawagora RHC
Kasinsa RHC
Chitope RHC
Luangwa High School RHC
Mphuka RHC
Mandombe RHC
Luangwa Boma RHC
27.88
42.11
59.10
53.55
39.85
27.32
20.41
44.32
40.99
39.02
42.03
45.1f
44.56
33.95
28.94
44.14
39.10
36.22
22.03
58/208 (145)
480/1140 (768)
799/1352 (935)
294/549 (410)
263/660 (510)
244/893 (713)
79/387 (323)
1058/2387 (1699)
1164/2840 (2042)
1480/3793 (2738)
759/1806 (1224)
2236/5261(3804)
86/193 (178)
184/542 (454)
68/235 (179)
644/1459 (732)
217/555 (278)
205/566 (469)
39/177 (160)
1.27[0.76,1.78]
3.38[3.04,3.72]
8.40[8.06,8.73]
7.05[6.68,7.43]
3.43[3.07,3.79]
1.81[1.46,2.17]
1[NA]e
1[NA]e
0.83[0.67,0.99]
0.71[0.50,0.92]
1.32[1.06,1.58]
0.92[0.90,0.93]f
2.76[1.59,3.94]
4.46[3.43,5.49]
1.71[0.64,2.78]
1.93[0.94,2.91]
2.79[1.72,3.87]
1.22[0.22,2.22]
1[NA]e
0.352
<0.001
<0.001
<0.001
<0.001
0.001
NAe
NAe
0.019
0.002
0.036
<0.001
0.090
0.005
0.325
0.191
0.062
0.695
NAe
12.82
22.47
26.40
25.19
18.84
13.63
11.70
21.92
18.74
17.14
15.39
30.7f
23.23
13.51
17.58
18.57
23.07
9.69
5.90
204/1591 (635)
2211/9841 (2797)
3794/14369 (3920)
1813/7198 (2265)
1690/8969 (3031)
1470/10787 (3265)
617/5275 (1630)
5802/26475 (7703)
5901/31481 (8285)
7197/41978 (12295)
2429/15788 (4323)
11851/58500 (17543)
809/3482 (1207)
684/5063 (1243)
1163/6614 (1030)
1342/7225 (999)
1249/5414 (1327)
606/6252 (1206)
368/6241 (1304)
1.28[1.08,1.48]
3.03[2.92,3.15]
4.16[4.04,4.27]
3.97[3.85,4.09]
2.26[2.14,2.38]
1.36[1.25,1.48]
1[NA]e
1[NA]e
0.86[0.81,0.92]
0.79[0.72,0.85]
1.25[1.14,1.35]
0.91[0.88,0.95]f
1.75[0.96,2.54]
2.39[1.61,3.18]
4.71[3.93,5.50]
2.08[1.30,2.86]
1.59[0.81,2.37]
1.14[0.37,1.92]
1[NA]e
0.015
<0.001
<0.001
<0.001
<0.001
<0.001
NAe
NAe
<0.001
<0.001
<0.001
<0.001
0.164
0.030
<0.001
0.066
0.243
0.734
NAe
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Nyimba district
Kacholola RHC
Hofmeyer RHC
Mtilizi RHC
Mtilizi RHP
Chinambi RHC
Mkopeka RHC
Chipembe RHC
42.34
51.99
66.94
50.00
57.35
54.90
45.71
94/222 (194)
157/302 (280)
164/245(193)
19/38 (37)
39/68 (59)
112/204 (179)
208/455 (333)
10.76[9.62,11.91]
46.94[45.87,48.02]
11.34[10.23,12.46]
9.24[7.89,10.58]
10.44[9.01,11.86]
12.03[10.89,13.16]
7.56[6.50,8.61]
<0.001
<0.001
<0.001
0.001
0.001
<0.001
<0.001
24.65
47.23
36.51
22.72
29.11
35.41
27.19
1198/4860 (1038)
1050/2223 (1394)
782/2142 (847)
573/2522 (1227)
560/1924 (947)
1004/2835 (753)
463/1703 (897)
6.87[6.09,7.66]
13.25[12.46,14.04]
5.93[5.16,6.70]
5.08[4.36,5.80]
6.90[6.02,7.78]
6.27[5.43,7.11]
5.89[5.07,6.71]
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
Season
Hot & wet (Dec – April)
Cool & dry (May - Aug)
Hot & dry (Sept – Nov)
50.47
46.26
24.72
1082/2144 (1865)
929/2008 (1749)
224/906 (858)
8.11[7.78,8.44]
4.99[4.67,5.31]
1[NA]e
<0.001
<0.001
NAe
20.79
25.38
9.05
4615/22195 (9843)
6125/24137 (12025)
1091/12056 (7745)
4.92[4.71,5.13]
4.00[4.71,5.13]
1[NA]e
<0.001
<0.001
NAe
i a – Diagnostic positivity, b – (n – Number RDT positive, N – Total number of testing events ), I – number of individuals that
participated , c – odds ratio with 95% confidence intervals, d – p-value,NA e –Not applicable /reference group,f – An integer
continuous covariate so the diagnostic positivity presented represents that for the first visit calculated as the intercept of the model
and the odds ratio presented represents proportional change of diagnostic positivity per additional preceding test.
ii The association of malaria infection with age, sex, symptoms, interventions, cluster, number of tests conducted per individual and
season was determined using GLMM; with observed malaria RDT determined status as a binary dependent outcome with the
independent categories of age, sex, symptoms, access and use of ITNs and/or IRS and seasons. The  models included date and
individual nested within CHW catchment nested within cluster as random effects except for one in which cluster was treated as a
categorical variable to determine the effects of each cluster. Symptoms were removed from the final model for logical reasons, as
they are effects and not causes of infection. The final model consisted of age, sex, access and use of ITNs and/or IRS, season, number
of tests conducted per individual and geographical location as the determinants of malaria infection.
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2.2.7 Association of malaria infection with clinical symptoms
While several symptoms were indeed positively associated with P. falciparum infection, these
were excluded from the final model that captures the effects of most of the variables presented
in Table 10 simply because they are an effect, rather than a cause, of malaria so they cannot be
regarded as underlying independent determinants of malaria risk. Instead, the association of
these symptoms with malaria infection was assessed as follows, using separate GLMMs treating
the presence or absence of each symptom as the binary dependent variable and malaria
infection diagnostic result as a binary, categorical, independent explanatory variable (Table 11).
Each model also included age, sex and season as additional categorical independent variables
and individual study participants nested within CHW catchment, nested again within clusters as
random effects. Each model was selected to include only variables, which were significant or
significantly improved the goodness of fit, as described above for the models of malaria
infection risk described in Table 11.
Table 11.Association of symptoms of illness with RDT positivity, age and seasonality iii iv
Symptom Passive surveillance Active surveillance
OR [95%CI]c Pd OR[95%CI]c Pd
Fever 5.98[5.79,6.16] <0.001 14.63[14.55,14.71] <0.001
History of fever 2.16[1.93,2.40] <0.001 2.86[2.77,2.95] <0.001
Headache 2.31[2.15,2.47] <0.001 6.83[6.77,6.90] <0.001
Cough 0.74[0.58,0.90] <0.001 1.85[1.77,1.93] <0.001
Diarrhoea 1.47[1.15,1.79] 0.017 2.04[1.86,2.21] <0.001
Vomiting 3.01[2.74,3.27] <0.001 6.61[6.43,6.80] <0.001
Chest pain 0.88[0.56,1.20] 0.447 1.47[1.31,1.64] <0.001
Breathing problems 1.78[1.40,2.16] 0.914 7.99[6.47,9.52] 0.008
Other symptoms 0.87[0.46,1.28] 0.510 0.98[0.81,1.15] 0.809
iii c – odds ratio with 95% confidence intervals, d – p-value.
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iv The association of clinical symptoms with malaria infection as determined by RDT positivity was
determined by logistic regression with GLMMs controlling for age and seasonality as fixed effects and
for date, individual nested in CHW and CHW nested in cluster location as random effects.
2.2.8 Cost per case diagnosed and treated
The approximate cost of diagnosis and treatment of malaria parasite infection through either
the CHW or health facility systems was calculated separately. For the CHWs, this was split into
two arms: active and passive. The costs incorporated into our calculations were personnel time,
RDTs, microscopy where available, anti-malarial drugs and sundry maintenance, transport and
consumables. Personnel time included an assumed 30% full time equivalent (FTE) contribution
to malaria diagnosis and treatment by all personnel based at the HF and the CHWs were
assumed to have allocated 90% and 10% FTE contributions to the active and passive service
delivery arms.  The cost of diagnosis was estimated by the multiplying the unit cost (US$0.31
per RDT and US$1.30 per microscopy test) (Uzochukwu, Obikeze et al. 2009; USAID 2012) of
each diagnostic method by the number of tests done. The cost of drugs was estimated by
multiplying the total number of treatments dispensed by the average Zambian malaria
programme unit cost of US$1.55. Annual remuneration costs for all the CHWs are calculated
based on their monthly remuneration of US$71.58 (ZMW 350) per month per CHW and the
number of person months for which they were engaged over the course of the study. Annual
costs of remuneration for health facility staff were collated from the medium term expenditure
frameworks of the two district medical offices, totalling US$281,150 (ZMW 1,377,600). Total
personnel and other facility maintenance costs were calculated by dividing the total number of
times all study participants/patients were appropriately diagnosed and treated. Subsequent
estimates of cost per case diagnosed and treated were made by adding personnel time, costs of
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diagnosis and treatment per case and facility maintenance costs. It was not possible to estimate
capital costs for either the CHW or health facility systems, so these were excluded from these
calculations. Calculations of directly observed costs were based on those recorded over the six
months from April to September 2011 when all the CHW and HF were fully functional but
before IRS was introduced as a possible confounding effect. A projected per capita cost
estimate for a year was then estimated by doubling these six month cost estimates.
Furthermore a projected potential cost per capita for implementing such an equivalent CHW
programme but complete compliance of the catchment population with monthly testing was
also calculated. Annual per capita cost estimates for the actual and enhanced-participation
scenarios were also calculated for scenarios in which transmission is reduced to levels where
treatment costs were negligible.
2.2.9 Population attributable fraction of symptoms to malaria infection
The proportion of cases of each specific clinical symptom identified within the population by
the CHWs that could be attributed to RDT-detectable malaria infections was estimated as
follows (Smith, Schellenberg et al. 1994): = ( − 1)/
Where is the attributable fraction, is the diagnostic positivity and is the odds ratio of
symptom associated with malaria infection. This formula was separately applied to both the
active and passive surveillance data obtained through the CHWs.
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2.3 Ethical approval
Ethical approval was obtained from the University of Zambia, Biomedical Research Ethics
Committee (Reference 004-05-09) and the Research Ethics Committee of the Liverpool School
of Tropical Medicine (Approval 09.60). Authority to conduct the study was also obtained from
the Ministry of Health in Lusaka, Zambia.
2.4 Results
2.41Rates of participation and testing through health facilities and community health workers
From a combined catchment population of 77,754 for Luangwa and Nyimba, there were
approximately 7, 5791 outpatients visits attended to at the 14 enrolled HFs in 2011. Seasonal
patterns of testing for malaria at HFs were roughly similar and peaked at approximately the
same time of the year in both districts, with an overall mean rate of testing for malaria infection
of 56%. Mean monthly testing rates were 36.9% (range = 0% to 100%) for patients in Luangwa
and 69.3% (range =0% to 100%) in Nyimba (Figure 12A and C) so the proportion of patients in
which malaria was suspected and tested for was approximately twice as high in Nyimba as
Luangwa.
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Figure 12.Proportion of catchment population tested (A and C) and diagnostic positivity for
malaria infection among residents (B and D) in Luangwa (A and B) and Nyimba (C and D)
A total of 14 population clusters centred around these HFs, with enrolled populations that
ranged from 753 to 1,243, were established and followed up over a period of one full calendar
year in 2011 from January to December for Luangwa District, and April to December for Nyimba
district. A total of eight and 12 monthly rounds of active household visit surveys were
conducted by each CHW in Nyimba and Luangwa, respectively, to test and treat all consenting
residents within these population clusters. A total population of 17,543 individuals participated
by consenting to testing during the active monthly household visits, of whom 20% were under
the age of five. During the same period a total of 3,804 individuals, of whom 24% were under
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the age of five, sought care and were tested when they self-reported to the CHW, the results of
which were then recorded as a passive surveillance indicator (Table 10). Slightly more females
participated in both the active and passive visits than males (Table 10), presumably because
females were more accessible during the active household visits, and sought care more
frequently from CHWs through their passive service provision role, than males because they
spent most of their time at home (Diallo, Nadam et al. 2012).  The CHWs referred a total of 577
and 631 patients detected through passive and active surveillance systems, respectively, to the
health facilities for further management. The main reasons provided for referral were the
inability by the CHWs to manage some of the conditions presented to them by the patients,
RDT positive results for pregnant women, lack of patient improvement while on malaria
treatment and insufficient AL stocks in the hands of that CHW for him or her to provide
treatment directly. Over the same period 42,389 and 932 suspected malaria cases were tested
by RDT and microscopy, respectively, and 20,794 were treated for malaria through the health
facilities in these clusters.
Introduction of CHWs for screening and treating of residents captured a higher proportion of
the populations they covered than the HFs they were based near to, overwhelmingly through
active monthly visits to the household rather than passive reporting (Figures 12A and C). This
can be readily explained by the fact that these 14 HFs covered a total catchment population of
77,754 people, equivalent to 58.8% of the combined population of the two districts, while a
total of 42 CHWs were assigned a total of 17,543 people or only 13.3 % of the combined
population of the two districts. The introduction of this CB extension of primary healthcare
services had no obvious impact upon attendance rates at health facilities in Luangwa, and a
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simultaneous drop in HF attendance in Nyimba resembled seasonality patterns from the
previous year (Figures 12A and C). Thus no obvious impact of CHW services upon the rates of
reporting of suspected malaria to the local health facility was apparent.
The proportion of enrolled participants who actually consented to testing during active
household visits rose rapidly and then peaked at approximately half during March in Luangwa
(Figure 12A) and June in Nyimba (Figure 12C).  The proportion of enrolled individuals who
sought care and were passively tested for infection by CHWs was generally far lower, only
exceeding 5% in an early peak in Luangwa but not in Nyimba (Figure 12A and C). In both CHW
survey arms, older children (5-14 years) and the adults (≥15 years) comprised the highest
proportion of those tested while young children (<5 years) comprised a minority, presumably
because they comprise a small demographic proportion of the overall population (Figure 13).
The age distribution of participants in testing and treatment were approximately  comparable
to data from the nationally representative malaria indicator surveys (MOH 2010; MOH 2012)
but rigorous assessment of participation biases would require comparison with detailed census
data.
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Figure 13.Age and proportion of covered population tested for malaria infection each month
as contacted passively (A and B) and actively (C and D) by community health workers in
Luangwa (A and C) and Nyimba (B and D)
Overall, less than 20% of the enrolled population was tested more than once by CHWs through
either the active or passive surveys but the mean number of tests per individual (2.3) was much
higher than the median (1 [range=1 to 24]) because the frequency distributions for the
numbers of times individuals were tested through either mechanism were highly skewed
(Figure 14A).  The average number of tests per individual participant through both surveillance
systems combined was understandably somewhat higher in Luangwa (4.4) than in Nyimba (3.2)
because they were operational for 12 months in the former but only eight months in the latter.
The number of passive patient contacts per individual through self-reporting to CHWs ranged
from 0 to 24 times in both districts over the course of the study period, with a median of only
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once, and an average of 1.2 times per individual. The number of active patient contacts per
individual through monthly household visits by CHWs ranged from 1 to 12 times in both
districts over the course of the study period, with a median of only once, and an average of 2.6
times per individual.
Figure 14.Frequency histogram of the number of study participant contacts for each total
number of preceding malaria infection tests by community health workers per individual
study participant (A), the relationship between the proportion of those participants
diagnosed as being infected and the cumulative number of diagnostic tests for malaria
infection per individual participant for all participants (B) and for the minority subset who
had more than 10 cumulative diagnostic tests (C)
0
2
4
6
8
10
12
14
16
18
11 12 13 14 15 16 17 18 19 20 21 22 23 24
0
1000
2000
3000
4000
5000
6000
7000
8000
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 19 20 21 22 23 24
0
5
10
15
20
25
30
35
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Fitted by generalized linear
mixed model (Table 1)
Observed
NU
MB
ER
 OF
 PA
RT
ICI
PA
NT
 CO
NT
AC
TS
NUMBER OF TESTS PER INDIVIDUAL
A
B
Negative
Positive
Passive Active
RDT result
Participant contact type
PR
OP
OR
TIO
N D
IAG
NO
SED
 IN
FEC
TED
AM
ON
G P
OP
UL
AT
ION
 TE
STE
D (
%)
Mean = 2.3
Fitted by generalized linear
mixed model (Table 1)
Observed
NUMBER OF TESTS PER INDIVIDUAL
C
PR
OP
OR
TIO
N D
IAG
NO
SED
 IN
FEC
TED
AM
ON
G P
OP
UL
AT
ION
 TE
STE
D (
%)
120
2.42 Comparative rates of malaria infection diagnosis by health facilities and community
health workers
Overall, the majority of occasions when residents sought care through the passive detection
systems of the HFs (44%) and CHWs (57.5%) did not have malaria parasite infections (Figure 2B
and D). Nevertheless from the total study population, more than 14,000 uncomplicated malaria
infections were identified by CHWs over the course of 2011 with the vast majority (84.1%) of
these being detected through the active household visits rather than through self-reporting to a
CHW for passively offered service (Table 10). While the HFs detected even more malaria
infections over the course of the same year (37,204), these were drawn from much larger
catchment populations so the overall rate of detection of cases of malaria infection per head of
population covered was highest for the active surveys of the CHWs, followed by passive surveys
at the HFs and CHWs (1.16, 0.40 and 0.14 diagnostically confirmed malaria infections per
person per year) (Table 12). The overall incidence rates for detected and diagnostically
confirmed malaria infections, broken down by district were 1.13 and 1.51 cases per person per
year for Luangwa and Nyimba, respectively.
The overall diagnostic positivity, or proportion of diagnostic tests which confirmed malaria
infection, was generally far higher among patients seeking diagnosis and treatment through the
routine services offered passively by either the HF or the CHWs than among those screened
actively through the monthly household visits of the CHWs (Table 10, Figure 12B and 12D). This
was presumably because self-reporting patients obviously present a sample that is strongly
biased towards those who are actually ill at the time. Diagnostic positivity observed at the
healthcare facilities fluctuated seasonally, peaking at the end of the rainy season in April and
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May and reaching its lowest point at the end of the dry season in September and October, with
a mean of 17.2% in Luangwa (range 4.8% to 34.1%) and 31.0% in Nyimba (range 8% to 67%).
The wide range of diagnostic positivity in these study sites is comparable to what has been
observed in other malarious parts of Zambia (MOH 2010; MOH 2012) and may be considered
reasonably representative of the range of transmission across most endemic parts of the
country. Considerable geographical heterogeneity was also observed in the diagnostic positivity
rates obtained through the CHWs, especially those from their active household surveys that
were less biased towards infected individuals, with the lowest being in the two most urbanized
clusters in the Luangwa Boma, the district capital at the south of Luangwa District (Table 10).
Seasonal patterns of diagnostic positivity at HFs, expressed as the proportion of all patients
tested diagnostically with RDTs or microscopy who were confirmed to be infected, differed
appreciably between the two districts with no particularly consistent similarities or
dissimilarities from 2010 to 2011 (Figure 12B and C). The seasonality patterns of diagnostic
positivity among residents tested by CHWs closely paralleled those tested by HFs in Luangwa
and even preceded them by a month or two in Nyimba (Figure 12) where access to HFs was is
more challenging, especially during the rains. Furthermore, the estimated mean diagnostic
positivity of both passive and active surveillance of the CHWs were positively correlated with
those observed through passive surveillance at the HFs across both districts (Figure 15) and
were, therefore, highly consistent with each other as measures of malaria infection.
Interestingly, diagnostic positivity rates reported by CHWs were much more closely associated
with those reported by HFs in Luangwa than in Nyimba (Figure 15) where access to HFs is far
more difficult for this more scattered population.
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Figure 15.Association of diagnostic positivity for malaria infection among patients attending
health facilities with diagnostic positivity recoded by community health workers through
passive (A) and active (B) participant contacts
2.43 Demographic, geographic and vector control determinants of malaria infection burden
Malaria infection among residents tested by the CHWs was associated with age, sex, season,
geographical location and coverage with vector control in the form of LLINs and IRS, as well as
the number of times each individual had been tested previously and, in most cases, treated for
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malaria (Table 10). Malaria infection burden among patients self-reporting to the CHW through
the passive surveys peaked in exactly the same age category as those tested during their active
monthly household visits (Table 10), confirming that essentially the same population was being
monitored by both systems. Risk of infection peaked in older children and was least among
infants and the oldest adults and females were slightly at less risk than males (Table 10).
Malaria infection probability was far higher in the hot and wet season, and the cool and dry
season, than in the hot and dry season (Table 10).
The majority of study participants who reported using an LLIN when they were tested by a CHW
(72% (2738/3804) for passive contacts and 70.1% (12295/17543) for active contacts) had lower
diagnostic positivity, consistent with the protective effect expected. However, individuals living
in the 9 clusters that were treated with IRS towards the end of 2011, whose houses were
actually sprayed, had higher diagnostic positivity, even when time, location and household
effects were controlled for (Table 10).  Rather than conclude that IRS actually increases malaria
risk, it may be presumed that these estimates from best-fit models are probably a spurious
artefact arising from endogeneity caused by logically and deliberately biased deployment of IRS
to areas within each cluster with highest disease burden by the District Medical Offices tasked
with implementing malaria control activities. Specifically, the IRS teams in both districts
deliberately started spraying the most isolated villages at the fringes of the enrolled population
clusters first so that these could be completed before arrival of the rains and associated limited
access.
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2.44 Association of malaria infection with clinical symptoms of illness
A substantial proportion of all residents who reported no symptoms whatsoever were found to
carry malaria parasite infection; 12% (5123/42881) and 27% (286/1062) of the active and
passive contacts, respectively. Discussions with CHWs confirmed that essentially all
asymptomatics who were tested through passive contacts were those friends, relatives and
caregivers who had escorted a patient to see the CHW and were also tested during such a visit.
The overall number and proportion of all patient contacts which were classified as
asymptomatic malaria infection detected by CHWs was approximately twice as high among
residents tested through in active surveillance [8.8% (5,123/58,500)] rather than passive [5.4%
(286/5,261)]. The proportion of confirmed malaria cases identified through active monthly
surveys by CHWs who apparently exhibited no symptoms whatsoever was only 43%
(5123/11851), confirming that most detectable malaria infections are chronic, but nevertheless
associated with substantial, if non-severe, symptoms at the time they are surveyed. Malaria
infection was associated with all specifically assessed symptoms, and even with the “other
symptoms” category among residents screened during active household visits by CHWs, and
most of these associations could also be detected using data collected passively from self-
reporting patients (Table 10). The symptoms most strongly associated with malaria infection
were fever, a history of fever in the last month, headache and vomiting, with the former being
the highest reported in both surveillance arms (Table 10). The reverse was also found to be true
as all symptoms were associated with RDT-detected malaria infection in both active and passive
CHW surveys, except for breathing problems and sundry other symptoms, using the passive
surveys data with limited sample size (Table 12). More than half of all cases of fever and
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vomiting, and more than a quarter of all cases history of fever, headache and diarrhoea, among
residents tested during active CHW visits to their households were attributable to malaria
infection (Figure 16). The positive association of cough with detectable infection in the active
visits, contrasting with a negative association in passive surveys that is more difficult to
rationalize (Tables 10 and 12), may reflect an interactive effect upon patient reporting rather
than the manifestation of the symptom itself, resulting in under-reporting of cough among
patients reporting to CHWs because they were infected with malaria.
Figure 16.Fractions of risk for reported clinical symptoms which are attributable to malaria
infection detected by community health workers through active (A) and passive (B) contact
events
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2.45 Association of malaria infection status and clinical symptoms of illness with malaria
testing frequency
Only one study participant was tested 24 times by CHWs during both active and passive visits
combined. Diagnostic positivity for malaria was negatively associated with the number of times
that participant had been previously tested, and in most cases, treated (Table 10, Figure 14B).
Sub-analysis of this relationship among the minority subset of 2376 participants who had more
than 10 cumulative diagnostic tests for malaria infection (Figure 14C) confirmed this association
(P=0.07) so diagnostic positivity does appear to decline continuously and indefinitely with
intensity of testing and treatment. For the small proportion of individuals who received 12
tests during a single calendar year, diagnostic positivity through active surveys was estimated to
be 5.4% in their last test, compared with 32% for those tested for the first time. Diagnostic
positivity was therefore proportionally 83% lower for the 12th test of those who participated at
least that often, and this trend towards lower diagnostic positivity continued downward for
who were tested even more frequently (Figure 14B). A similar phenomenon was observed with
regard to manifestation of symptoms, with much lower rates of occurrence observed for all
reported clinical symptoms except cough among individuals who had been repeatedly tested
and treated for malaria (Figure 17). Interestingly, even when RDT-diagnosed infection status is
accounted for by adding this independent variable to the models depicted in Figure 17, the
number of times an individual had been previously tested remained predictive of fever (P
<0.001), history of fever (P <0.001), headache (P < 0.001), diarrhoea (P < 0.001), chest pain (P
< 0.001), breathing problems, vomiting (P < 0.001) and other symptoms (P < 0.001). Taken at
face value, these observations appear to suggest that screening and treatment may not only
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reduce probability of infection with malaria at detectable parasite densities (Figure 14B), but
also persistent sub-patent infections that contribute to symptoms of illness despite parasite
densities too low to be detected (Figure 17). However, testing frequency was not assigned to
distinct treatment groups or experimentally controlled in any other way so these associations
are purely observational and causality cannot be directly inferred. For example, these
observations might also be explained by co-association of testing frequency, malaria infection
and symptoms of illness with unrecorded health-conscious behaviours that are not accounted
for in the model described in Table 10. Indeed, the test results at first active visit did seem to
slightly influence of the number of subsequent tests so the trends observed in Figures 14B and
17 should be cautiously interpreted: individuals whose first test yielded a negative result had a
slightly greater mean number of tests over the course of the study (4.65±0.03 versus 4.11±0.05,
P<0.001 by GLMM).
Figure 17.Relationship between the proportion of participant contacts with community
health workers in which they experienced fever (A), history of fever (B), headache(C), cough
(D), diarrhoea (E), vomiting (F), chest pain (G) and breathing problems  (H) and the cumulative
number of preceding diagnostic tests for malaria infection per individual participant
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Despite the impressive negative association of repeated testing and treatment with the
probabilities of infection and symptoms among individuals, no dramatic impact upon these
parasitological and clinical outcomes were obvious and a total incidence rate of 1.7 detected
infections per head persisted (Figure 12,Table 12). As illustrated in Figure 14A, the mean
number of times participants were tested was 2.3, so even if the relationship between number
of preceding tests and diagnostic positivity is causal, rather than merely co-associated, too few
participants were tested regularly enough for any dramatic impacts to be observed at
population level: Those who had the mean number of tests would be expected to maintain a
mean diagnostic positivity of  23.7% at the end of the year, only 17.9% lower proportionally
than those tested only once (Figure 14B). Even if direct impact of testing and treatment upon
infection probability is assumed, and comprehensive monthly testing could be achieved in the
future, this would still be expected to leave sufficient levels of parasitaemia at population level
to maintain endemic transmission (Figure 14A and 14B) (Smith and Hay 2009). The intensity of
persisting transmission reflected in the measured EIR, despite considerable levels of vector
control, is also reflected in measured rates of re-infection among humans: Over the course of
the study period, CHWs detected as many as eight malaria infections in a single study
participant detected through passive surveillance, while the maximum was nine infections in
single participant as detected through active surveillance (Figure 14A).
2.46 Adherence of CHWs to diagnosis and treatment guidelines
Patterns of diagnosis and treatment differed between patients seeking care at HFs or from
CHWs, as well as residents consenting to being tested by CHWs during their active household
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visits (Figure 18, Table 12). Adherence to national guidelines for diagnosis and treatment were
generally good among CHWs with 78% of all contacts that resulted in an RDT test being
followed by an appropriate decision to treat or not (Figure 18). The remainder was primarily
accounted for by diagnostically confirmed cases of malaria infection that could not be treated
because the CHW had run out of the drug, and also because small proportions of patients were
treated in the absence of a diagnostic result or despite a negative diagnostic result (Figure 18,
Table 12).  More worryingly, only 53% of patients attending HFs were tested and then treated
or not treated appropriately to the test result, primarily because a substantial proportion were
neither tested nor treated but also because small proportions were treated in the absence of a
test or despite a negative test (Figure 18, Table 12). So, consistent with reports from other
settings in Zambia (Harvey, Jennings et al. 2008; Chanda, Hamainza et al. 2011; Littrell, Gatakaa
et al. 2011; Counihan, Harvey et al. 2012) and beyond (Pagnoni, Convelbo et al. 1997; Yeung,
Van Damme et al. 2008; Thang, Erhart et al. 2009), the CHWs had greater adherence to policy
guidelines on treatment practices in relation to diagnostic test results than specialist staff at
HFs (Figure 18, Table 12). The proportion of patient contacts resulting in a negative RDT test
result, or assessed only clinically without a confirmatory diagnostic test, that were treated with
AL were both at least six times higher at HFs than CHWs (Figure 18). CHW provision of
treatment to patients with a negative test result was twice as high in the active compared with
passive but in both cases this occurred only very rarely. All confirmed cases of malaria infection
reporting to health facilities received treatment with AL and the same was true for 92% of
those identified passively by CHWs but only 59% among those identified through active
household visits (Table 12, Figure 18). In most cases where CHWs did not provide treatment for
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RDT-positive patients, this was because they lacked AL and those patients were referred to the
HFs to collect curative drugs.
Figure 18.Community health worker and health facility staff treatment and diagnostic
practice in relation to national guidelines
Table 12.Compliance to diagnostic and treatment policy - Community based and Facility
Based (April to September 2011) v
Facility based Community based Community & facility
based
Passive Passive Active Passive and active Passive and active
Al dispensed No Yes Total No Yes Total No Yes Total No Yes Total No Yes Total
Tested by test result
RDT negative 11,024 3,046 14,070 1,518 16 1,534 24,878 517 25,395 26,396 533 26,929 374,20 3,579 40,999
positive 0 15,306 15,306 111 1,260 1,371 7,012 10,149 17,161 7,123 11,409 18,532 7,123 26,715 33,838
Microscopy negative 204 55 259 n/a n/a n/a n/a n/a n/a n/a n/a n/a 204 55 259
positive 0 262 262 n/a n/a n/a n/a n/a n/a n/a n/a n/a 0 262 262
RDT or
microscopy
negative 11,228 3,101 14,329 1,518 16 1,534 24,878 517 25,395 26,396 533 26,929 37,624 3,634 41,258
positive 0 15,568 15,568 111 1,260 1,371 7,012 10,149 17,161 7,123 11,409 18,532 7,123 26,977 34,100
Not tested 17,541 3,158 20,699 185 3 188 2,845 18 2,863 3,030 21 3,051 20,571 3,179 23,750
Total 39,997 40,496 80,493 3,443 2,555 5,998 66,625 21,350 87,975 70,068 23,905 93,973 110,065 64,401 174,466
v Treatment practice based on confirmatory RDT result was assessed between April and September as
this was the period of time when all the CHW based active & passive surveillance and the health facility
based passive system were all fully functional.
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2.47 Testing and treatment service delivery, cost and cost-effectiveness
As detailed in Table 13, expenses associated with personnel and commodities are important
components of the overall cost of providing malaria diagnosis and treatment services through
either HFs (49%) or CHWs (25%).   Sundry transport and maintenance expenses also contributed
substantially to the overall cost of the HFs but not the CHWs. The overall cost of HFs was three-
fold higher than the CHW approach but was less expensive than CHWs per head of population
covered, because the HFs were assigned to cover far larger catchment populations while the
CHWs simply provided far more frequent testing and treatment service to each resident
through the active surveys conducted through monthly household visits (Table 13). If the same
frequency of testing were implemented in a pre-elimination scenario (WHO 2007; WHO 2007)
where improved vector control reduced drug treatment requirements to negligible levels, this
would save only a quarter of the overall costs of providing these HF or CHW services. Because
of the lower personnel, transport and maintenance costs of the CHWs, combined with their
better compliance with national guidelines, both the passive and active services provided by
the CHWs were almost twice as cost-effective in terms of cost per diagnostically confirmed case
identified and treated.
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Table 13.Observed and potential cost-effectiveness of cases appropriately diagnosed and
treated vi vii viii ix
Health
Facility
Community based
Directly observed process indicators over 6 months Passive Active Total
Covered community based cluster or facility catchment 77754 17543 17543 17543
Diagnostic tests carried out over six months 29897 2652 42556 45208
Diagnostically confirmed and treated cases of malaria infection over 6 months 15568 1260 10149 11409
Diagnostically confirmed and treated malaria case per head population over 6
months
0.20 0.07 0.58 0.65
Diagnostic tests per head of population over 6 months 0.38 0.15 2.43 2.58
Directly observed costs over 6 months
RDT tests conducted 29,376 2,652 42,556 45,208
Cost per test (US$) 0.31 0.31 0.31 0.31
Total RDT cost (US$) 9,113 823 13,201 14,024
Microscopy tests 521 n/a n/a n/a
Cost per test (US$) 1.30 n/a n/a n/a
Total cost of microscopy (US$) 676 n/a n/a n/a
AL treatments 21,827 1,279 10,684 11,963
Cost per treatment (US$) 1.38 1.38 1.38 1.38
Total cost of AL (US$) 30,069 1,762 14,718 16,480
Total personnel costs (US$) 281,150 18,001 18,001 18,001
Time commitment (% FTE) 30 10 90 100
Personnel costs of malaria testing and treatment 84,345 1,800 16,201 18,001
Sundry maintenance, transport and running costs for six months (US$) 43,201 103 926 1,029
Total cost for Six months (US$) 167,404 4,488 45,046 49,533
Total non-treatment costs over 6 months (US$) 137,335 2,726 30,328 33,053
Projected annual summaries at observed rates of testing & treatment
Total cost per head of population covered per year (US$) 4.31 0.51 5.14 5.65
Total non-treatment costs per head of population covered per year (US$) 3.53 0.31 3.46 3.77
Total cost per confirmed case treated (US$) 10.75 3.56 4.44 4.34
Projected potential summaries at optimized rates of active testing & treatment
Total cost per head of population covered per year (US$) 10.68
Total non-treatment costs per head of population covered per year (US$) 6.25
Total cost per confirmed case treated (US$) 8.09
vi US$ 1 = ZMW 4.89, exchange rate has been rebased to fit current Zambian currency.
Source: http://www.boz.zm/(S(keg4bza3j0p4fx2uixtmnibq))/FinanciaMarkestReport.aspx. Accessed 1st
October 2013
vii FTE - Full Time Equivalent.
viii In the projected annual summaries, cost per head of population was calculated by dividing the total
costs by the catchment population. The cost of non treatment is the cost of only testing such as in an
elimination scenario. The cost per confirmed case if the total costs divided by the diagnostically
confirmed and treated cases of malaria infection.
ix Projected potential summaries developed from assumptions that the HF and CHW passive will not
change even in an optimized environment. Cost/head of population calculated by addition to observed
cost of an average 9 missed active visits per person and 2 passive visits per person by the cost of RDTs
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and Treatment respectively. The cost per confirmed case treated is the total cost per head divided by
the mean number of infections per year of 1.3.
If community participation could be dramatically improved to ensuring the average resident is
tested at least once per month, and the trend observed in Figure 14B is assumed to represent
impact of frequent testing and treatment upon infection status, the cost and cost-effectiveness
of detecting and treating this diminishing case load would approximately double, even in a pre-
elimination scenario where improved vector control would negate treatment costs (Table 13).
2.5 Discussion
Despite the fact that only a quarter of the covered resident population agreed to be tested in
each monthly round of household visits by the CHWs, these active surveys by modestly
remunerated paid CB staff identified >11,000 malaria parasite infections in a population of
<18,000 residents in a single calendar year, of whom more than half were symptomatic in or
around the time they were visited and may not have otherwise sought care (Table 10). The far
higher sensitivity with which these active household surveys by the CHWs detect cases of
malaria infection is also reflected in the observation that this surveillance arm captured twice
as high an incidence rate as the passive surveillance activities of the HFs and CHWs combined.
The strong association of many symptoms, especially fever, headache and vomiting with
malaria infection, particularly among individuals tested during active household visits by the
CHWs, confirms previous reports that illustrate just how inaccurate the term asymptomatic is in
relation to widespread chronic malaria infections (Bisoffi, Gobbi et al. 2012; Cucunuba, Guerra
et al. 2013; Lindblade, Steinhardt et al. 2013) that clearly cause very large proportions of the
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overall burden of clinical illness in the community (Table 12, Figure 16). Clearly a large
proportion of the population are infected with malaria, and suffering from a range of mild
symptoms of clinical illness as a consequence, but do not feel ill enough to report to a HF or
even to a nearby CHW to seek care. In addition to representing a major proportion of overall
morbidity burden among the population, these chronic infections also act as a reservoir for
continued transmission (Babiker, Abdel-Muhsin et al. 1998; Bousema, Gouagna et al. 2004;
Schneider, Bousema et al. 2007; Okell, Bousema et al. 2012; Lindblade, Steinhardt et al. 2013).
Regularly scheduled household visits by CHWs, who presumably will need to be paid for such a
full time commitment, may therefore be extremely useful for identifying, treating and mapping
the individuals who harbour chronic malaria infections and constitute the infectious reservoir
that sustain transmission (Kaneko 2010; Campbell and Steketee 2011; Sturrock, Hsiang et al.
2013).
However, as implemented in this study, even these monthly active household visits, repeated
on a continuous monthly survey cycle, had no obvious impact on malaria infection burden,
possibly because most participants did not consent to testing often enough to benefit from any
impact upon malaria infection and associated symptoms that are suggested, but not proven by,
Figures 14 and 17, respectively. While the AL treatment used here has well-documented
gametocidal properties (Drakeley, Jawara et al. 2004; Sutherland, Ord et al. 2005; Delves,
Plouffe et al. 2012), the limited sensitivity of RDTs or microscopy and considerable natural
density fluctuations of circulating P. falciparum blood stages mean that approximately half of all
malaria infections are sub-patent and escape detection by a single testing event (Dietz,
Molineaux et al. 1974; Bousema, Schneider et al. 2006; Okell, Bousema et al. 2012). Such test-
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and-treat approaches would undoubtedly benefit from the availability of more sensitive nucleic
acid-based testing technologies to detect all infections in the given community (Bousema, Okell
et al. 2014). However, this was not a feasible option at the time of this study because the
potential of technologies such as loop-mediated isothermal amplification remain uncertain
(Abdul-Ghani, Al-Mekhlafi et al. 2012). Furthermore, mosquito-to-human transmission
remained remarkably high in the study area, measured as a mean EIR of approximately 70
infectious bites per unprotected person per year (Seyoum, Sikaala et al. 2012; Sikaala, Killeen et
al. 2013). The most likely explanation of the persistence of such intense transmission, despite
reasonably high rates of LLIN use, supplemented with IRS in selected clusters towards the end
of this study, is probably the emergence of pyrethroid resistance among local populations of
An. funestus (Chanda, Hemingway et al. 2011). The high rates of re-infection suggested by these
entomological surveys are consistent with and confirmed by the high rates of infection
incidence (Smith, Drakeley et al. 2010) recorded here (Table 13) despite the imperfect
sensitivity of RDTs (Bisoffi, Sirima et al. 2010; Abba, Deeks et al. 2011). Given the imperfect
detection sensitivity of RDTs (Bisoffi, Sirima et al. 2010; Abba, Deeks et al. 2011) and the rapid
rates of re-infection that can be expected in a setting with such a high EIR (Charlwood, Smith et
al. 1998; Beier, Killeen et al. 1999; Smith, Killeen et al. 2004; Smith, Dushoff et al. 2005; Smith,
Maire et al. 2006), it is unsurprising that at least monthly screening and treatment is required
to achieve dramatic reductions of malaria infection burden (Figure 14B), associated symptoms
(Figure 17, and presumably transmission (Brenner and Gefeller 1997; Missinou, Lell et al. 2003;
Okell, Bousema et al. 2012), even assuming these two Figures reflect genuine impact rather
than mere association. However, it is certainly encouraging that the apparent impacts among
136
residents consenting to such frequent testing and treatment, which these associations suggest,
compare very well with simulations and field data from annual mass screen and treat
programmes (Crowell, Briet et al. 2013), and even simulations and field observations of year-
long mass drug administration programmes with treatment cycles of only four or even two
weeks (Okell, Drakeley et al. 2008). It may also be encouraging that, despite their known limited
sensitivity, RDTs appear to be sensitive enough to detect persistent malaria infections if each
individual is tested often enough (Figure 14B) so that the frequent sporadic surges of
detectable parasitaemia characteristic of P. falciparum are captured (Collins and Jeffery 1999;
Eichner, Diebner et al. 2001). If the observed association of parasitaemia with testing and
treatment (Figure 14B) reflects genuine impact, this also suggests patient compliance with the
AL treatment regime used in this study was probably comparable with high estimates (84.5%)
from previous evaluations in Zambia (NMCC 2006).
While evaluating the efficacy of the anti malarial drug was beyond the scope of this study,
another I conducted with colleagues from the NMCC shows that the AL product used here
remained an efficacious drug for the treatment of uncomplicated P. falciparum malaria in
Zambia at that time (Hamainza, Masaninga et al. 2014). Resistance to this drug is therefore
most probably of negligible relevance to this study so the limitations of impact upon diagnostic
positivity are probably largely determined by rates of testing and treatment, as well as the
absolute sensitivity of the RDT tests, relative to the rate of re-infection mediated by the vector
population.
Beyond extending delivery of diagnostic and therapeutic services to the grass roots community
level, the CHWs also provided a remarkably informative source of surveillance data, including
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the overall burden and distribution of malaria and associated clinical symptoms, a number of
important demographic and geographic determinants of risk, and the rates utilization of
preventive interventions, such as IRS and ITNs. It is particularly encouraging that, despite their
known sensitivity limitations, RDTs (Bisoffi, Sirima et al. 2010; Abba, Deeks et al. 2011) appear
to be more than adequate for monitoring disease burden through CHW extension systems that
can guide programme implementation. Latent antigenaemia several weeks after successful
clearance of infection can cause false positive results when using HRP2 based RDTs, and
therefore over-prescription of anti-malarial drugs (Mayxay, Pukrittayakamee et al. 2001;
Swarthout, Counihan et al. 2007; Baiden, Webster et al. 2012), so it is possible that estimates of
cost and cost-effectiveness described in table 13 may be improved upon with better diagnostic
technology. If scale up of such CHWs is affordable beyond this research setting and could be
scaled up across entire districts, provinces or even whole countries, such routinely collected
data reported in disaggregated form from such small population subdivisions could be
invaluable at all levels of programmatic monitoring and evaluation.
The costs of providing this CB extension of primary health care services, to provide both active
and passive screening and treatment for malaria were substantive (Table 13), corresponding to
11.1 % of the annual per capita health budget of Zambia in 2011 ($96) (WHO 2011).
Furthermore, to achieve the full potential of this service by ensuring community-wide
engagement in screening and treatment on at least a monthly basis (Figure 14B), these costs
are likely to double, even if baseline levels of transmission were reduced to pre-elimination
levels so that the costs of drug treatment were negated (Table 13). It is highly unlikely, or
desirable, that such a cadre of CHWs would be mobilized to deal with surveillance and control
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of malaria alone so these CB personnel would also be required to deal with uncomplicated
forms of other common illnesses like diarrhoea and pneumonia (Yeboah-Antwi, Pilingana et al.
2010; Hamer, Brooks et al. 2012; Seidenberg, Hamer et al. 2012). Even the passively provided
malaria diagnosis and treatment services described here would need to be augmented with a
range of other clinical services to be supported at programmatic level (Yeboah-Antwi, Pilingana
et al. 2010; Hamer, Brooks et al. 2012). It is therefore difficult to envisage CHWs effectively or
sustainably taking on such substantive commitments on a purely voluntary basis with no
remuneration whatsoever. Barely more than a third of the overall costs of the active household
surveys by the CHWs were accounted for by the cost of their meagre remuneration, and this
Figure would reduce to less than a fifth if the increased commodity costs of full compliance with
monthly screening and treatment were to be incurred through improved community
participation. Paying these CHWs is therefore not only likely to be essential to ensure their
retention and effectiveness as full time agents of malaria infection surveillance and control, it is
also a relatively minor fraction of the overall cost of actively delivering extended CB primary
healthcare services.
Apart from its observational design, the most obvious limitation of this study is that the
majority of enrolled residents were tested and, where appropriate, treated far less than once a
month (Table 10, Figures 12A and C, 13C and D, and 14A) as originally envisaged. Future
evaluations of CHWs, especially those engaged to conduct frequent active household surveys of
their entire assigned populations, should include operational research studies to better
understand and address the limitations of service uptake by community members observed in
this study.
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As described earlier, it was hoped that this study would demonstrate successful reduction of
diagnostic positivity across entire populations, and by inference human-to-mosquito
transmission, by frequent testing and treatment, especially through active contacts by CHWs to
seek out chronic infections that would otherwise go undetected (Okell, Bousema et al. 2012).
Under the near-programmatic conditions of this study, these procedures failed to achieve
sufficient frequency of testing and treatment. It is therefore understandable that the goal of
suppressing the infectious parasite reservoir was not achieved. If these procedures are to be
developed further so that this strategy constitutes a transmission control intervention in its
own right, several aspects have to be improved upon: (1) Dramatically improved community
engagement and sensitisation to enable consistent acceptance by the target population of
participation in testing and treatment during monthly household visits, (2) Incorporation of
more sensitive point-of-care confirmatory diagnostic tests, which would probably need to be
nucleic-acid based in nature(Perandin, Manca et al. 2004; Okell, Ghani et al. 2009; Veron, Simon
et al. 2009), (3) Improved supply chain management to enable timely and sufficient provision of
all commodity requirements of the CHWs, (4) Consistent incorporation of additional,
complementary vector control measures beyond LLINs alone, such as IRS with
organophosphates, which was only applied to some selected population clusters too
infrequently to maintain effectiveness all year round (Chapter 4), and (5) Institutionalised
supportive supervision (Macauley 2005). While the experimental allocation of IRS treatments,
and participant recollections of whether their houses had been sprayed or not, were recorded
and accounted for in this study (See also Chapter 4), none of these other issues were assessed
so these all merit substantive operational research investigation in their own right.
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2.6 Conclusions
The monthly active household visits to entire communities by CHWs equipped with existing
field-compatible diagnostic tools were not sufficient to eliminate the human reservoir of
malaria infection from this rural African setting with intense transmission despite reasonably
high LLIN/IRS coverage. However, observed negative associations between infection status and
frequency of testing and treatment suggest that dramatic impact upon malaria parasite
infection risk and associated disease burden may be achievable through far more regular
testing and treatment. Substantive alleviation of malaria may be attainable and cost-effective if
the substantial, but not necessarily prohibitive, costs of implementing frequent active CB
surveys for chronic malaria infections are affordable to national programmes and higher levels
of community participation in regular testing opportunities are achievable.
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CHAPTER THREE
A COMPARISON OF MOBILE PHONE-BASED MALARIA REPORTING
SYSTEM WITH ROUTINE PATIENT REGISTER DATA FOR CAPTURING
SPATIAL AND TEMPORAL TRENDS IN EPIDEMIOLOGICAL INDICATORS
IN RURAL ZAMBIA
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3.0 Abstract
Background
Timeliness, completeness, and accuracy are key requirements for any surveillance system to
reliably monitor disease burden and guide efficient resource prioritization. Evidence for the
effectiveness of electronic reporting of malaria cases by community health workers (CHWs)
remains limited.
Methodology
Residents of two adjacent rural districts in Zambia were provided with malaria testing and
treatment services, through both passive and active mechanisms, by 42 CHWs who were
provided with malaria rapid diagnostic tests (RDTs) and artemisinin-based combination
therapy, and served 14 population clusters centred around public sector health facilities.
Reference data describing total numbers of RDT- detected infections and diagnostic
positivity (DP) were extracted from detailed participant register books kept by CHWs. These
were statistically compared with equivalent weekly summaries relayed directly by the CHWs
themselves through a mobile phone short messaging system (SMS) reporting platform.
Results
Slightly more RDT-detected malaria infections were recorded in extracted participant
registers than were reported in weekly mobile phone summaries but the difference was
equivalent to only 19.2% (31,665 versus 25,583, respectively). The majority (81%) of weekly
SMS reports were received within one week and the remainder within one month. Overall
mean [95% confidence limits] difference between the numbers of register-recorded and
SMS-reported RDT-detected malaria infections per CHW per week as estimated by the Bland
Altman method was only -2.3 [-21.9, 17.2]. The mean [range] for both the number of RDT-
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detected malaria infections (86 [0, 463] versus 73.6 [0, 519], respectively)) and DP (22.8%
[0.0 to 96.3%] versus 23.2% [0.4 to 75.8%], respectively) reported by SMS were generally
very consistent with those recorded in the reference paper-based register data and
exhibited similar seasonality patterns across all study clusters. Overall, mean relative
differences in the SMS reports and reference register data were more consistent with each
other for DP than for absolute numbers of RDT-detected infections, presumably because
this indicator is robust to variations in patient reporting rates by location, weather, season
and calendar event because these are included in both the nominator and denominator.
Discussion/Conclusion
The SMS reports captured malaria transmission trends with adequate accuracy and could be
used for population-wide, continuous, longitudinal monitoring of malaria transmission.
144
3.1 Background
Zambia, like many endemic countries, is going through an epidemiological transition with
regard to malaria disease burden, with a notable national decline in parasite prevalence and
incidence (Masaninga, Chanda et al. 2013). Public health surveillance, which has been
defined as the "ongoing systematic collection, analysis, and interpretation of data critical to
the planning, implementation, and evaluation of public health interventions and is closely
integrated with timely dissemination of data generated to all stakeholders" (WHO 1962;
Thacker and Berkelman 1988) therefore has an increasingly important role to play as
malaria control steadily progresses towards malaria elimination (Wetterhall, Pappaioanou et
al. 1992; Barclay, Smith et al. 2012; WHO 2012).
A viable surveillance system for malaria in Zambia needs to routinely collect sufficient data
to describe the population’s health status (Nelson, Thompson et al. 1997), for the purpose
of detecting temporal and spatial variations in epidemiological profile, including those
arising directly from changes in clinical and public health practices. In Zambia, the standard
national surveillance system is the integrated health management information system
(HMIS) (MOH 2008). Currently the HMIS is operational at all established health facilities in
the country and requires monthly reporting from all medical office teams that aggregate
and summarize these facility reports. Currently, there are 22 malaria-specific indicators
reported through the HMIS which encompass disease burden, as well as use and availability
of commodities for prevention, diagnosis and treatment (MOH 2008). As in most countries
in sub-Saharan Africa, the completeness, accuracy and timeliness of HMIS in Zambia are
often inadequate or, at the very least, questionable (WHO 2013).These systematic
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weaknesses undermine stakeholder confidence in the reliability of data and, consequently
lead to under-utilization for decision-making and planning (de Savigny and Binka 2004).
In poorly-resourced countries, community-based surveillance systems (CBSS) can
complement health facility (HF)-based surveillance. This is of particular relevance to malaria
control because the infectious human reservoir is primarily comprised of chronic infections
associated with sub-acute symptoms distributed across entire at-risk populations
(Hamainza, Moonga et al. 2014) and both rapid diagnostic tests (RDTs) and artemisinin-
based combination therapies (ACTs) for uncomplicated malaria can be utilised appropriately
by community health workers (CHWs) with minimal general education and technical training
(Delacollette, Van der Stuyft et al. 1996; Yeboah-Antwi, Pilingana et al. 2010; Chanda,
Hamainza et al. 2011; Mukanga, Babirye et al. 2011; Counihan, Harvey et al. 2012; Kalyango,
Rutebemberwa et al. 2012). CBSS can provide quantitative estimates of disease burden in a
defined population and service delivery indicators  for disease control measures (Baker and
Ross 1996) but remain under-exploited in relation to malaria, with only 12 million RDTs
being used by CHWs globally, 11 million of which are accounted for by India alone (WHO
2013). Several studies have demonstrated the ability of CHWs to collect epidemiological
data on a variety of diseases, including malaria, provided they have appropriate training and
can relay their observations through appropriately tailored reporting systems (Hopkins,
Talisuna et al. 2007; Alba, Hetzel et al. 2011; Counihan, Harvey et al. 2012; Kalyango,
Rutebemberwa et al. 2012; Rutta, Francis et al. 2012; Hamainza, Moonga et al. 2014). Data
from CBSS can be utilised to describe spatial and temporal patterns of variation in infection
or disease incidence, as well as access to and use of preventive services, so that
interventions and resources can be rationally allocated at fine scales across large-scale
programmes (Tatem, Campiz et al. 2011; Barclay, Smith et al. 2012; Hamainza, Moonga et
146
al. 2014). While there is widespread consensus about benefits of the use of electronic
reporting systems for relaying and collating data from CBSS in programmatic contexts
(Freifeld, Chunara et al. 2010; Deglise, Suggs et al. 2012; Zurovac, Talisuna et al. 2012),
evidence to support this view remains limited to remarkably few studies (Oak 2007; Freifeld,
Chunara et al. 2010; Randrianasolo, Raoelina et al. 2010).
This study describes and evaluates a prototype mobile phone reporting platform for a CBSS
in  rural Zambia that was initially established as a program implemented by CHWs for
community-wide passive and active testing with RDTs and treatment of all confirmed cases
with Artemether-Lumefantrine (AL), which also allowed monitoring of malaria parasite
infection burden as a secondary objective (Hamainza, Moonga et al. 2014).
3.2 Methods
3.2.1 Study sites
A CBSS was established in the rural districts of Luangwa and Nyimba, respectively located in
Lusaka and Eastern provinces of Zambia (Figure 19) (Hamainza, Moonga et al. 2014).
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Figure 19.Map showing the selected health facilities around which the community health
workers and the catchment population they served were located
In these districts, perennial, intense transmission of Plasmodium falciparum was mediated
by Anopheles funestus Giles at an estimated entomological inoculation rate of
approximately 70 infectious bites per unprotected person per year (Sikaala, Chinula et al.
2014). Luangwa (3,468 km2) is located 325 kilometres south-east of Lusaka, the capital city
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of Zambia. The district’s total population is approximately 27,560 residents and it has an
annual estimated population growth rate of 2.9% (CSO 2011). Nyimba is a larger district
(10,943 km2), located 350 kilometres east of Lusaka, with an approximate population of
108,637 inhabitants and an estimated annual population growth rate of 3.4 % (CSO 2011).
3.2.2 Testing and treatment
As described in detail elsewhere (Hamainza, Moonga et al. 2014), 14 population clusters (7
in each district), consisting of the nearest consenting 165 households to a selected public
sector HF were selected and enrolled to participate in longitudinal parasite surveys
conducted by paid CHWs. Each cluster had 3 CHWs, resulting in a total of 42 CHWs, and thus
a corresponding number of reporting units, distributed across the study area. Parasitological
assessments were conducted continuously from January 2011 to March 2013 in Luangwa
and from April 2011 to March 2013 in Nyimba district in all the selected clusters. All
consenting households received monthly active visits from CHWs, which included
parasitological surveys using RDTs detecting histidine-rich protein antigen (Malaria Pf
cassette test, ICT Diagnostics ), coupled with registers designed in a pre-defined
questionnaire format (Hamainza, Moonga et al. 2014). Consent for household participation
was given by the head of the household and then consent for participation in the RDT test
was obtained from individual study participants, or guardians in the case of assenting
minors. If they developed any symptoms in between these active visits, study participants
were encouraged to seek care through passively-offered diagnosis and treatment services,
either from the CHWs at their place of residence or at the nearest HF. All participants found
positive for malaria infection were treated with AL as per national policy (NMCC 2010).  All
participants encountered in either the active or passive visits that were found to be negative
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for malaria infection, but were febrile or complained of any other symptom of illness, were
referred to the nearest HF.
3.2.3 Questionnaire surveys
The CHWs’ primary method of collecting study participant information was through the use
of a paper-based, pre-defined questionnaire provided in the physical form of a register
book. A total of 16 data elements were captured through this method and these included
date, cluster, participant identification number, sex, age, visit type (active/ passive), village,
axilliary temperature, RDT results, clinical symptoms of illness (fever, history of fever,
headache, cough, diarrhoea, vomiting, breathing problems, chest pain and any other
symptoms), treatment provided and participant outcome, in addition to access and
utilization of specific preventive measures, namely long-lasting insecticidal nets (LLINs),
indoor residual spraying (IRS) and intermittent preventive therapy. All the entries in the
registers, with each line of data corresponding to a single participant contact, were made in
duplicate with carbon paper. During the monthly supervisory visits, original copies of these
reports were collected and transported to the NMCC for entry into a correspondingly
structured Microsoft excel spreadsheet in fully explicit, line-listed electronic database
format, while the CHWs retained the duplicate copies for their own records. All data from
the registers were double-entered and verified, reconciled, and then cleaned following
descriptive frequency analysis of the distributions of values for each variable.
3.3 Weekly summary reporting of aggregate data via short message service
In addition to the paper-based participant registers, weekly aggregate summary reports of
these data were collated through mobile phone short messaging service (SMS) via the
Airtel® network (Figure 20).
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Figure 20. Screenshot examples of Community Health Worker mobile phone short
messaging service (SMS) text before transmission to the National Malaria Control Centre
and an Illustration of the interpretation of the code sent through the SMS reporting
system. A: example of an SMS code for study participants that were attended to through
the passive system when they self-reported to the CHW, B: example of an SMS code for
study participants contacted through active monthly household visits, C: Example of an
SMS code for reporting on use and availability of AL and RDTs, D: Schematic Illustration of
the format and syntax of reports for diagnostic results from both passive and active visits,
and E: Schematic Illustration of the format and syntax of reports for the  availability of AL
and RDTs. REG refers to passive participants data, SCR refers to active participant data,
ACT refers to Artemether-Lumefantrine combination therapy stocks, RDT refers to rapid
diagnostic test stocks, OPD refers to passive participant contact, and Y or N – refer to
stock availability (Yes or No).
A paper-based form summarizing the aggregated data elements to be transmitted via SMS
was completed by each CHW each week, based on the fully explicit data recorded in the
participant register books. These weekly summaries were then transmitted to a mobile
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phone at the NMCC via SMS text in a pre-determined format, every Friday where that was
possible (Figure 20). A paper-based form summarizing the aggregated data elements to be
transmitted via SMS was completed by each CHW each week, based on the fully explicit
data recorded in the participant register books. These weekly summaries were then
transmitted to a mobile phone at the NMCC via SMS text in a pre-determined format, every
Friday (Figure 20). A total of 25 data elements were transmitted through this method, which
included the total number of participants in both active and passive visits, number of
positive and negative cases disaggregated by age and type of visit, number with and without
fever, in addition to summaries of various AL pack sizes dispensed and remaining, and
similar indicators for the use and availability of RDTs (Table 14).
Table 14.Data element definitions for all data transmitted through the SMS mobile
reporting system
DATA ELEMENT DEFINATION
REG (A)TOTAL OPD Total number of study participants that sort care from the CHWS
REG (B) TOTAL SUSPECTED Total number of study participants that sort care from the CHWs and were
suspected of having malaria
REG (C) UNDER 5 RDT +VE Total number of study participants that sort care from CHWs under the age of five
and had a positive rapid diagnostic test result
REG (D) UNDER 5 RDT -VE Total number of study participants that sort care from CHWs under the age of five
and had a negative rapid diagnostic test result
REG (E) OVER 5 RDT +VE Total number of study participants that sort care from CHWs over  the age of five
and had a positive rapid diagnostic test result
REG (F) OVER 5 RDT -VE Total number of study participants that sort care from CHWs over  the age of five
and had a negative rapid diagnostic test result
REG (L) FEVER UNDER 5 Total number of study participants that sort care from CHWs under  the age of five
who were febrile
REG (M) FEVER OVER 5 Total number of study participants that sort care from CHWs over  the age of five
who were febrile
SCR (A) TOTAL SCREENED Total number of study participants that consented to actively being tested for
malaria by CHWs
SCR (B) UNDER 5 +VE Total number of study participants that consented to actively being tested for
malaria by CHWs under the age of five and had a positive rapid diagnostic test
result
SCR (C) UNDER 5 RDT -VE Total number of study participants that consented to actively being tested for
malaria by CHWs under the age of five and had a negative rapid diagnostic test
result
SCR (D) OVER 5 RDT +VE Total number of study participants that consented to actively being tested for
malaria by CHWs over the age of five and had a positive rapid diagnostic test result
SCR (E) OVER 5 RDT -VE Total number of study participants that consented to actively being tested for
malaria by CHWs over the age of five and had a negative rapid diagnostic test result
SCR (K) FEVER UNDER 5 Total number of study participants that consented to actively being tested for
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malaria by CHWs under the age of five who were febrile
SCR (L) FEVER OVER 5 Total number of study participants that consented to actively being tested for
malaria by CHWs over the age of five who were febrile
(A) 6S PRESCRIBED Total number of AL 6 packs prescribed and provided to study participants
(B) INSTOCK Total available AL 6 packs
(C) 12S PRESCRIBED Total number of AL 12 packs prescribed and provided to study participants
(D) INSTOCK Total available AL 12 packs
(E) 18S PRESCRIBED Total number of AL 18 packs prescribed and provided to study participants
(F) INSTOCK Total available AL 18 packs
(G) 24S PRESCRIBED Total number of AL 24 packs prescribed and provided to study participants
(H) INSTOCK Total available AL 24 packs
(J) RDT AVAILABLE Total available  individual rapid diagnostic tests
(K) RDT USED Total used individual rapid diagnostic tests
Once each data message was received by the NMCC, an acknowledgement message was
manually sent back to the sender by a data entry associate. The data was reviewed by the
study team and the CHWs were contacted by voice via mobile phone for verification or
correction of the data if any clarifications were required. Once the verification process was
complete, the data were then compiled into a Microsoft Excel® spreadsheet in database
format. The Mobile phones were also used for communication among the CHWs and staff at
their supervising health facility. In addition to provision of a basic mobile phone at a cost of
ZMW 50 (approximately US$9.47 based on the 2012 average annual exchange rate of ZMW
5.23 to US$1 (BOZ 2012)) for each CHW, a monthly air time top-up worth ZMW20 (US$3.32)
was electronically sent to each CHW in order to facilitate transmission of the SMS reports
and any other communication requirements.
3.4 Concordance evaluation
The explicit, unaggregated, line-listed, manually double-entered reference data from the
participant registers were independently aggregated by the NMCC into weekly estimates of
total numbers malaria infections seen by each CHW and the corresponding diagnostic
positivity (DP) of tests associated with those participant contacts. The weekly DP was
estimated as outlined in the formula below:
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The strength of association of the overall number of malaria infections recorded in the
reference register data with those reported via SMS was expressed in terms of the
correlation coefficient (r) between the two data capture methods, which were also
disaggregated by type of patient contact. Even through the relationship between the
reporting systems was expected to be linear, the study took into consideration the
fundamental limitation of pure correlation analysis that does adjust the value of r even
when a linear transformation of either variables compared occurs, implying a focus on the
degree of association and not agreement, as it is possible to obtain high correlation even
when the absolute values of the variables are different (Taylor and Taylor 1990; Bland and
Altman 2003). Thus in order to estimate the degree of agreement of these data sets, the
numbers of infections detected by each CHW each week were subjected to Bland-Altman
statistical analysis, which is a graphical analysis method whereby the difference between
the weekly total number of study participant contacts from each reporting system was
plotted against the mean across the two reporting systems to allow for measurement of the
magnitude of the errors, as well as the trends in magnitude of the errors, relative to the
magnitude of the total number of malaria infections recorded in the patient registers and
reported through the SMS reporting system (Bland and Altman 1995).Time trend analysis
was also applied to summarised reference register data compared to the SMS-reported total
number of malaria infections data and DP in order to further assess the correlation between
these datasets as a function of time lag. The total number of malaria infections time series
data were further analysed by cluster using a bivariate local polynomial regression,
specifically the locally-weighted scatter-plot smoother (LOESS) to provide a visually
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smoothened fit of time series from each of the two reporting systems by identification of,
and minimization of influence, of possible outlier data (Cleveland 1979; Jacoby 2000).
Additionally this analysis also provided a qualitative comparison of the mean relative
difference, both overall and disaggregated by type of participant contact, as well as time
trends and seasonality of data provided from the reference paper-based records versus
those reported in the SMS system.
3.3 Ethical approval
Ethical approval was obtained from the University of Zambia, Biomedical Research Ethics
Committee (Reference 004-05-09) and the Research Ethics Committee of the Liverpool
School of Tropical Medicine (Approval 09.60). Authority to conduct the study was also
obtained from the Ministry of Health in Lusaka, Zambia.
3.4 Results
The reference paper-based register recorded an overall total of 129 weeks of data, while the
SMS reporting system reported only 120 weeks of data, due to delayed initiation and earlier
termination of the latter when funding ran out towards the end of the study. Out of an
expected 5040 SMS weekly summaries, only 2934 (58.2%) were submitted by the CHWs.
This may have been due to the lack of power sources for charging the mobile phones
because most of the study sites were not connected to the national power grid. This
resulted in the CHWs travelling long distances to charge their phones. Additionally this may
also have been due to unstable mobile phone network coverage particularly in the most
rural of the study sites. Of the 2934 SMS weekly summaries submitted by the CHWs, 81%
(2375/2934) were submitted according to the timeliness targets at the outset (weekly) and
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the remainder (19% (559/2934)) within one month. These delays in reporting a minority of
weekly summaries may have been due a lack of access to mobile phone network coverage,
particularly in the most remote parts of the study area. However, CHWs were encouraged to
transmit any missing reports whenever they had access to mobile phone coverage. In some
limited situations, this lead to a few CHWs choosing to transmit all their data at the end of
the month when they travelled to areas of good mobile phone coverage, such as when they
visited the HFs to collect supplies and submit the reference paper-based register records. All
analyses of concordance reported here were based only on comparisons of data summaries
from the reference paper-based register records and SMS reports where both were
available for the same CHW in the same week which ranged from 40 to 100 weeks. All
detected malaria infections considered in the analyses of these data refer only to infections
which were detected parasitologically by RDT, rather than by clinical symptoms alone.
An overall total of 31,665 and 25,583 detected malaria infections were recorded through
the paper-based participant register and reported through the SMS platform, respectively.
The mean weekly number of RDT-detected malaria infections recorded by each CHW in the
reference paper-based register was 7.1 (1.1 and 6.0 from the passive and active participant
contacts, respectively), while that reported in the SMS systems was 9.0 (2.3 and 6.7 from
passive and active contacts, respectively).
There was a clear association between the overall number of RDT-detected malaria
infections recorded by the reference paper-based register and reported by SMS platform (r
[95%CI] = 0.64 [0.61, 0.66], p<0.001). This association was also clear when the data was
disaggregated by participant contact type, with a stronger correlation for the active contacts
(r [95%CI] = 0.68 [0.65, 0.69], p<0.001) than the passive contacts (r [95%CI] = 0.36 [0.33,
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0.39], p<0.001), as evidenced by the higher correlation coefficient and the lack of overlap
between the confidence intervals for the two participant contact types.
The overall mean [95% limits of agreement (LOA)] difference in the number of RDT-detected
malaria infections per week per CHW between the reference paper-based register and SMS
reporting platform, as estimated by the Bland-Altman method, was -2.3 ([-21.9, 17.2])
infections per CHW per week (Figure 21). Bland-Altman estimates for the mean [95% LOA]
difference in the number of register-recorded versus SMS-reported malaria infections in
active participant contacts was -1.4 ([-16.5, 13.7]) infections per CHW per week and less for
passive participant contacts at -0.9 ([-12.0 to 10.1]) infections per CHW per week (Figure
21).
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Figure 21.Bland-Altman plots of the difference between weekly numbers of rapid
diagnostic test detected malaria infections recorded in the reference paper register and
reported by SMS against their mean, overall (A), or disaggregated into active (B) and
passive (C) participant contacts.
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Thus, observations on the overall, active and passive malaria infections per CHW per week
suggest that the reference paper-based register records and SMS reports are approximately
similar but should be interpreted with caution due to the considerable data imprecision.
While the DP of participants tested has proven a robust indicator of malaria risk as recorded
in the reference patient registers (Hamainza, Moonga et al. 2014), the binomial distribution
that presumably stabilizes this proportional outcome to variations in participant contact
rates also precludes the use of Bland-Altman analysis. However, it was possible to compare
trends in the weekly aggregate values for RDT-detected malaria infections and DP outcomes
descriptively and using LOESS regression.
Trends over time for the overall number of malaria infections (Figure 22A) and, even more
so, overall DP (Figure 22B) aggregated by week across all CHWs suggests a close positive
association between the paper-based reference register and SMS reporting system. On
average, the two datasets closely matched each other in absolute terms and exhibited very
similar temporal variations that captured comparable seasonal trends, with both maxima
and minima consistently occurring at approximately the same times.
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Figure 22. Time series analysis plot of weekly means, aggregated across all community
health workers, for numbers rapid diagnostic test detected malaria infections (A) and
associated diagnostic positivity (B) as recorded by the reference paper-based registers and
reported by SMS
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This observation was confirmed when these two malaria infection burden indicators were
compared in terms of their mean relative difference overall (Figure 23A and B), and when
disaggregated into active (Figure 23C and D) and passive (Figure 23E and F) participant
contacts. Overall, mean relative differences in the SMS reports and reference register data
were more consistent with each other for DP than for absolute numbers of RDT-detected
infections, presumably because this indicator is robust to variations in patient reporting
rates by location, weather, season and calendar event because these are included in both
the nominator and denominator.
Figure 23.Difference plots for numbers of detected malaria infections (A, C, E) and
diagnostic positivity (B, D, F) as recorded by the reference paper register and reported by
SMS overall (A and B), or disaggregated by active (C and D) and passive (E and F)
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Cluster-disaggregated time series for both the reference paper registers and SMS reports
also exhibited similar time trends and seasonal variation in the number of RDT-detected
malaria infections (Figure 24) and especially DP (Figure 25). Visual inspection of the results
of LOESS regression, using identical bandwidths within each cluster, indicate that the SMS
reporting system captures similar temporal and geographic variation to that recorded in the
reference data detailed in the participant register.
Figure 24.Locally weighted scatter-plot smoother (LOESS) plots of weekly cluster-
disaggregated mean numbers of detected malaria infections recorded by the reference
paper-based registers and reported in the SMS system against time in weeks of reporting
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Figure 25.Locally weighted scatter-plot smoother (LOESS) plots of weekly cluster-
disaggregated diagnostic positivity recorded by the reference paper-based registers and
reported in the SMS system against time in weeks of reporting
A comprehensive cost-effectiveness analysis of the full running costs of CBSS, exclusive of
SMS reporting system and costs, is described in detail elsewhere (Hamainza, Moonga et al.
2014). However at a total annual provider fee running cost of only US$39.84 and a single
expenditure of US$9.47 for the mobile phone per CHW at start up, this SMS reporting
system may be considered an affordable, inexpensive operational supplement to this CBSS
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that may dramatically enhance the de facto value of its data recording and reporting
mechanisms.
3.5 Discussion
The CBSS routinely captured large volumes data on population characteristics (age, sex and
residence), symptomology, morbidity, diagnostic testing and treatment for malaria, as well
as LLINs and IRS which is not routinely captured by the national HMIS (MOH 2008;
Hamainza, Moonga et al. 2014). The study also further demonstrated that CHWs are able to
reliably record, summarise and transmit this data through an electronic reporting platform,
in this case a mobile phone. The study was conducted in a framework of evaluating the
adequacy and effectiveness of the CBSS SMS reporting system rather than its efficacy in
programmatic conditions (Habicht, Victora et al. 1999; Glasgow, Lichtenstein et al. 2003;
Flay, Biglan et al. 2005). This allowed for an opportunity to learn lessons about its potential
for scale up, generalizability and indeed relevance to real world program implementation
(Habicht, Victora et al. 1999; Flay, Biglan et al. 2005).
The comparison of the reference paper-based, quality-controlled register records with the
SMS weekly summaries indicates some modest incompleteness of the latter, with the paper
based system recording a higher overall number of malaria infections. This may have been
due to under-reporting in the SMS reporting system resulting from challenges in accurately
summarising the reference registers data and non-submission of the SMS reports by some
of the CHWs when they were required to. Additionally, the manual entry of the SMS-
transmitted data into an excel spreadsheet by the study team may have resulted in some
reports being lost in the process and not entered into the database because, unlike the
paper-based register records, there was no double entry verification of this data.
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Timeliness, a key performance measure of any public health reporting system (Jajosky and
Groseclose 2004; Mawudeku, Ruben et al. 2007) was achieved by the SMS based platform in
most instances, as these reports were received as expected within a week in the vast
majority of cases, and within a reasonably adequate timeline of one month the rest of the
time. Monthly quality control visits to CHWs were primarily provided to support correct
recording of data in the reference data on paper, in the form of a detailed review of the
data collected when the registers were handed over to the supervision team. During these
visits the SMS reporting records were also reviewed but in most cases the CHWs had already
submitted at least some of their SMS reports prior to the visit.
In the reference paper-based register, the high level of detail that included individual-level
data over the entire implementation period provided an invaluable resource in the form of a
rigorous epidemiological database for critical analysis of malaria transmission dynamics and
risk factors (Hamainza, Moonga et al. 2014). While such comprehensive, detailed data entry
and analysis is not realistically feasible beyond the unusually well-resourced context of such
a research study, summaries of these indicators could nevertheless be included in scalable
electronic reporting systems similar to the one described here.  These data could support
planning processes at district, provincial and national levels, and also assess independent
reports from these levels on needs, forecasts, access and use of various malaria
interventions. Additionally, these data may be used for targeting interventions as malaria
transmission drops as these SMS based reports demonstrate adequacy in reflecting
epidemiological trends in a population on a timely basis. Although, not explicitly explored in
this study the findings suggest a role for SMS based reporting as a potential management
tool to monitor performance of frontline health workers and in this case, the CHWs. This
was exemplified in this study through the monitoring of CHWs performance as to whether
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they achieved the targeted number of active household visits per week and tracking the
availability and use of AL and RDTs.
An obvious limitation of the study was that the SMS platform would have benefited from an
automated central server system of data capture when SMS reports were submitted, which
would have reduced human error in the form of missing or duplicated data and
transcription errors.
3.6 Conclusion
This SMS reporting system captured malaria transmission trends, as recorded in the
reference paper based registers, with adequate accuracy, suggesting potential use in
population-wide, continuous and longitudinal monitoring of temporal and geographic
trends in disease incidence.  Additionally, the summary reports through the SMS platform
enabled reasonable timely collation, access and dissemination of the paper-based
surveillance data which was shared among the study team and district health management
teams in the study districts and could be used for programmatic decision making. Given the
recent dramatic growth in mobile phone networks globally, and in Africa particularly, such
CBSS may be highly effective if mobile technology platforms are harnessed for reporting
directly from CHWs to central servers to allow for rapid data access, use and quality
assurance by stakeholders at the district, provincial and national levels.
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4.0 Abstract
Background
LLINs and IRS are the most widely accepted and applied malaria vector control methods.
However, evidence that incremental impact is achieved when they are combined remains
limited and inconsistent.
Methodology
Fourteen population clusters of approximately 1000 residents in Zambia’s Luangwa and
Nyimba districts, which had high pre-existing usage rates (81.7%) of pyrethroid-impregnated
long-lasting insecticidal nets (LLINs) were quasi-randomly assigned to receive IRS with either
of two pyrethroids, namely Deltamethrin (Wettable granules (WG)) and Lambdacyhalothrin
(Capsule suspension (CS)), with an emulsifiable concentrate (EC) or CS formulation of the
organophosphate pirimiphosmethyl, or with no supplementary vector control measure.
Diagnostic positivity of patients tested for malaria by community health workers in these
clusters was surveyed longitudinally over pre and post-treatment periods spanning 29
months over which the treatments were allocated and re-allocated in advance of 3
sequential rainy seasons.
Results
Supplementation of LLINs with pirimiphosmethyl CS offered the greatest initial level of
protection against malaria in the first 3 months of application (incremental protective
efficacy (IPE) [95% confidence interval (CI)] = 0.63 [CI 0.57,0.69], P<0.001), followed by
lambdacyhalothrin (IPE [95%CI] = 0.31 [0.10,0.47], P=0.006) and pirimiphosmethyl EC (IPE,
0.23 [CI 0.15,0.31], P<0.001) and then by deltamethrin (IPE [95%CI] =  0.19 [-0.01,0.35],
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P=0.064). Neither pyrethroid formulation provided protection beyond 3 months after
spraying, but the protection provided by both pirimiphosmethyl formulations persisted
undiminished for longer periods: 6 months for CS and 12 months for EC. The CS formulation
of PM provided greater protection than the combined pyrethroid IRS formulations
throughout its effective life IPE [95%CI] = 0.79 [0.75, 0.83] over 6 months. The EC
formulation of PM provided incremental protection for the first three months (IPE [95%CI] =
0.23 [0.15, 0.31]) that was approximately equivalent to the two pyrethroid formulations
(lambdacyhalothrin, IPE [95%CI] = 0.31 [0.10, 0.47] and deltamethrin, IPE [95%CI] = 0.19 [-
0.01, 0.35]) but the additional protection provided by the former, apparently lasted an
entire year.
Conclusion
Where universal coverage targets for LLINs utilization has been achieved, supplementing
LLINs with IRS using pyrethroids may reduce malaria transmission below levels achieved by
LLIN use alone, even in settings where pyrethroid resistance occurs in the vector population.
However, far greater reduction of transmission can be achieved under such conditions by
supplementing LLINs with IRS using non-pyrethroid insecticide classes such as
organophosphates, so this is a viable approach to mitigating and managing pyrethroid
resistance.
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4.1 Background
Long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) are the two first-
choice malaria vector control methods available globally (WHO 2013) because they can
achieve massive community-wide impact upon malaria transmission, even at partial
coverage (Killeen, Smith et al. 2007). This is possible because many of the world’s most
potent vector species prefer people as a source of blood and must feed several times upon
humans inside houses before they are old enough for infectious sporozoite-stage malaria
parasites to have fully developed within them (Koella, Sorensen et al. 1998).While IRS and
LLINs decrease exposure of directly protected humans to infected vectors and vice versa,
through contact irritancy or spatial repellency, most of the impact of LLINs and IRS upon
human transmission exposure and parasitaemia, results from community-level suppression
of vector population density and infection prevalence, achieved by reducing their longevity
through lethal exposure to their toxic active ingredients.(Smith and Webley 1968; Lines,
Myamba et al. 1987). The success of these modes of action are influenced by the choice,
dosage and formulation of insecticide utilized, as well as its coverage and mode of
application, combined with the behavioural and physiological susceptibility of the targeted
vector species (Dezulueta, Cullen et al. 1963; Grieco, Achee et al. 2007; White, Conteh et al.
2011).
Compared to IRS, LLINs coverage is much higher in most endemic countries (Lengeler 2004;
Pluess, Tanser et al. 2010) due to their flexibility of delivery mechanism and cheaper costs of
implementation (Bhatia, Fox-Rushby et al. 2004). Also, while most African vector
populations predominantly feed indoors, at night (Huho, Killeen et al. 2012), they may not
rest on the walls after a blood meal  or rest for a period insufficient to pick up a lethal dose
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of the active insecticide (Pates and Curtis 2005). However, for LLINs to be fully effective they
require deliberate active participation of individuals to use them consistently and
appropriately, in addition to them being regularly replaced and kept in good repair
(Rehman, Kleinschmidt et al. 2011; Mejía, Teklehaimanot et al. 2013). In contrast, IRS
requires only initial consent by the community to have their houses sprayed and compliance
with not painting or plastering over the sprayed walls for the expected duration of efficacy
of the insecticide used. Additionally,  a major advantage of IRS over LLINs is simply that the
treated surfaces are rarely in direct contact with occupants of protected houses so the
safety requirements for active ingredients that may be used are far less stringent and a
much wider variety of active ingredients can therefore be used (Rehman, Kleinschmidt et al.
2011).  The evidence on the effects of combining IRS and LLINs varies, with some studies
suggesting an incremental benefit of using both interventions (Kleinschmidt, Schwabe et al.
2009; Fullman, Burstein et al. 2013), while others suggest that IRS adds no incremental
impact relative to LLINs alone and/or vice versa (Curtis, Maxwell et al. 1998; Corbel,
Akogbeto et al. 2012), that LLINs alone have greater impact than IRS (Curtis 1999; Mnzava,
Dlamini et al. 1999) and others again indicate that the contrary is true (Misra, Webber et al.
1999; Mabaso, Sharp et al. 2004).  These diverse comparisons between IRS and LLINs are
based on a variety of outcome measures which include impacts on vector densities or
entomological inoculation rates,  as well as prevalence, incidence or diagnostic positivity of
parasitaemia among humans, as well as the relevant costs of providing such protection
(Curtis, Maxwell et al. 1998 ; Curtis 1999; Misra, Webber et al. 1999; Conteh, Sharp et al.
2004; Mabaso, Sharp et al. 2004).
Currently there are four classes of insecticides approved for use in IRS formats:
organochlorines, organophosphates, carbamates and pyrethroids (Najera and Zaim 2001),
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but only the latter are considered safe enough for use in LLINs. The wide-scale deployment
of pyrethroids in both LLIN and IRS formats has undoubtedly exerted considerable selection
pressure upon vector populations, resulting in the rapid and widespread emergence of
physiological resistance to these active ingredients which may negatively influence the
efficacy of LLINs in particular (WHO 1976; WHO 1992; Hargreaves, Koekemoer et al. 2000;
Curtis, Jana-Kara et al. 2003). As a consequence, the WHO recommends a reduction in use
of pyrethroids for IRS, particularly in areas where LLIN deployment has been scaled up to
reach high coverage (WHO 1976; WHO 1992). Furthermore, IRS application of multiple
insecticides from different classes, ideally with complementary modes of action and non-
overlapping resistance mechanisms, in rotations or mosaics is recommended as the optimal
means of insecticide resistance management in the short-to-medium term (WHO 2012).
Unfortunately, the utilization of organochlorines for IRS, particularly DDT, has been
discouraged and scaled down due to concerns about potentially negative environmental
effects associated with their use (Eskenazi, Chevrier et al. 2009). The remaining
recommended formulations of organophosphates and carbamates have not been
extensively used in IRS programs due to their comparatively high cost and relatively short
residual periods of approximately 2 to 6 months (Najera and Zaim 2001), which necessitates
spraying more than once in areas with protracted transmission seasons or perennial
transmission. Fortunately, new formulations of the organophosphate pirimiphosmethyl
(PM) have recently reformulated been brought to market for public health use that appear
to offer increased and prolonged efficacy, notably against pyrethroid-resistant vectors
(Rowland, Boko et al. 2013; Tangena, Adiamoh et al. 2013).
Given the substantial additional cost of supplementing LLINs with IRS, especially with such
expensive new insecticides, and the persisting controversy about whether incremental
172
protection against malaria is accrued, it is important to directly evaluate such combinations
at community-level with epidemiological primary outcomes and explanatory entomological
secondary outcomes in representative malaria-endemic settings. Thus, the overall aim of
the study was therefore to evaluate the incremental impact of supplementary vector
control with IRS upon malaria transmission by the widespread and highly efficient African
vector An. funestus in a study area with relatively high usage rates of pyrethroid-
impregnated LLINs, using either, one of two different formulations of pyrethroids, or one of
two different formulations of the new PM organophosphate.
4.2 Methods
4.2.1 Study area
The study was conducted in the predominantly rural districts of Luangwa and Nyimba,
located in Lusaka and Eastern provinces, respectively, of the Republic of Zambia (Figure 26).
These districts have perennial transmission of Plasmodium falciparum, with the
overwhelmingly predominant vector being Anopheles funestus Giles, which mediates a
mean entomological inoculation rate (EIR) for non-users of LLINs of approximately 70
infectious bites per unprotected person per year (Sikaala, Chinula et al. 2014).The district of
Luangwa (3,468 km2) is located 350-500 meters above sea level, 325 km south-east of
Lusaka the capital city of Zambia. It has a population of approximately 27,560 residents,
with an annual growth rate of 2.9% (CSO 2011). The main economic activities in the district
are fishing and agriculture. Nyimba is a larger district (10,943 km2), with an approximate
population of 108,637 inhabitants and an annual growth rate of 3.4 % (CSO 2011). The
district is located 400-1200 meters above sea level, 350 kilometres east of Lusaka.
Agriculture is the predominant economic activity in Nyimba district.
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Figure 26.Map indicating location of health facilities and associated catchment
populations enrolled in the study, with allocation of IRS treatments per cluster and year
LLINs  + IRS (Deltamethrine)
LLINs  + IRS (Lambdacyhalothrin  CS) LLINs  + IRS (CS Pirimiphosmethyl )
LLINs  + IRS (EC Pirimiphosmethyl)
OCTOBER  TO NOVEMBER 2010 OCTOBER  TO NOVEMBER 2011
OCTOBER  TO NOVEMBER 2012 FEBRUARY 2013
A B
C D
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4.2.2 Study design
In each district, 7 clusters of approximately 165 households were selected and enrolled in
the study to participate in longitudinal parasite surveys (Hamainza, Moonga et al. 2014). Of
these, 15 households in each cluster were selected and enrolled at the discretion of the
CHW, so that they were geographically distributed across the cluster, for participation in
monthly entomological observations, with the exception of Luangwa High School where 30
household were enrolled. Both parasitological and entomological assessments were
conducted continuously from January 2011 to March 2013 in Luangwa and from April 2011
to March 2013 in Nyimba district in all clusters.
The pyrethroid Deltamethrin (Wetable granule (WG) formulation) was sprayed in all
consenting households at the four southernmost clusters in Luangwa in October 2010,
immediately before that year’s rainy season and initiation of this study. During the study
period, 3 other selected IRS insecticide treatments (capsule suspension (CS) formulation of
the pyrethroid lambdacyhalothrin, as well as the emulsifiable concentrate (EC) and CS
formulations of the organophosphate pirimiphosmethyl) were randomly allocated to
clusters in advance of each rainy season.  In practice this randomized allocation was not
strictly adhered to by the implementation agencies in the two districts (District Medical
Office (DMO) in Luangwa and Abt Associates under the supervision of the DMO in Nyimba),
thus resulting in a quasi-randomised study design, described cartographically in Figure 26.
The parasitological and entomological surveys were conducted by paid community health
workers (CHWs) as previously described in detail (Hamainza, Moonga et al. 2014; Sikaala,
Chinula et al. 2014) and summarized below. In the south of Luangwa district, between
October and November 2010, clusters 4, 5, 6 and 7 received pyrethroid-based IRS with
deltamethrin (K-Othrine WG® 250, Bayer Environmental Science, South Africa) as described
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in Figure 26A. Subsequently, the organophosphate pirimiphosmethyl was introduced as an
alternative insecticide for IRS in a response to detection of resistance to pyrethroids in the
primary vector, An. funestus in Luangwa district (Chanda, Hemingway et al. 2011; Seyoum,
Sikaala et al. 2012; Sikaala, Killeen et al. 2013). The only formulation of pirimiphosmethyl
that was available at the time was the relatively short-lived (Rowland, Boko et al. 2013;
Oxborough, Kitau et al. 2014) emulsifiable concentrate (EC) formulation (Actellic® EC,
Syngenta Crop Protection AG, Switzerland). This formulation was sprayed during the months
of October and November 2011, in clusters 2, 4, 5 in Luangwa and 9, 11, 13 in Nyimba, while
IRS with pyrethroid lambdacyhalothrin (Icon® 10 Capsule Suspension (CS) formulation,
Syngenta Crop Protection AG, Switzerland) was applied in only two of the four clusters in
the south of Luangwa district which had been sprayed with deltamethrin the previous year,
specifically in clusters 6 and 7 (Figure 26B). The following year, in November 2012, the
longer-lasting microencapsulated formulation of pirimiphosmethyl (Actellic® 300CS,
Syngenta Crop Protection AG, South Africa) was applied in clusters 8, 9, 10, 12 and 14, all of
which were in Nyimba district (Figure 26C). In February 2013, IRS in Luangwa district was
implemented with PM-EC in clusters 2, 4 and 5 while clusters 6 and 7 received the CS
formulation of lambdacyhalothrin (Figure 26D).
4.2.3 Parasitological surveys of human infection
Active monthly parasitological surveys were coupled with questionnaires recording clinical
symptoms of illness, as well as access and utilization of preventive measures such as LLINs,
IRS and intermittent preventive therapy (IPT), between January 2011 and May 2013,
spanning a period of approximately 29 months, as described in detail previously (Hamainza,
Moonga et al. 2014). These surveys were conducted by paid CHWs who made active
monthly visits to households that consented to participate in the study. In between active
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visits, study participants who developed symptoms were encouraged to seek care through
passively offered diagnosis and treatment services, either from the CHWs at their place of
residence or at the nearest health facility. The rapid diagnostic test used in the study was
manufactured by ICT Diagnostics to detect circulating P. falciparum histidine-rich protein-2
antigen (ICT Malaria P.f. cassette test). All participants that were found positive for
antigenemia, which was presumed equivalent to infection, were treated with Artemether-
Lumefantrine as per National Malaria Diagnosis and Treatment Policy (NMCC 2010).  In both
the active and passive visits, all participants found to be negative for malaria infection but
febrile or had any other complaints were referred to the nearest HF.
4.2.4 Mosquito densities, species identification
The monthly mosquito collections were conducted by paid Community Health Workers
(CHWs) using Centres for Disease Control and Prevention light traps (LT) and Ifakara Tent
Traps (ITT) between January 2010 and April 2013, spanning a period of approximately 28
months, as described in detail previously (Sikaala, Chinula et al. 2014). In each consenting
household, the LTs were placed at the foot end of an occupied sleeping space covered with
an LLIN, hanging approximately 1.5m above the floor. An ITT was placed immediately
outside, approximately 5 meters away from the house where the LT was installed and was
occupied by an adult male volunteer from the same household. All the mosquito traps were
set up in the evenings and collection of the captured mosquitoes was done in the early
morning by aspiration. All the collected mosquitoes were initially sorted in the field to genus
level, by the CHWs, based on crude taxonomic features and then stored over silica until they
were collected on a monthly basis and transported to a central laboratory at the NMCC for
further detailed examination. Additional morphological identification of Anopheles to
species group or complex (Gillies and Coetzee 1987) was conducted at the central
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laboratory of the NMCC in Lusaka. Polymerase Chain Reaction (PCR) for the identification of
species within the An. funestus group (Koekemoer, Lochouarn et al. 1999) or An. gambiae
complex (Scott, Brogdon et al. 1993) were conducted on selected samples in the NMCC
laboratory.
4.2.5 Vector susceptibility to different classes of insecticides
A team of trained entomological technicians from the NMCC periodically collected samples
from the study sites to ascertain the susceptibility of the mosquitoes to different classes of
insecticides, as background descriptive data to support appropriate interpretation of
apparent impacts of various supplementary IRS treatments upon the vector population. In
Luangwa district, mosquitoes were collected from cluster 2 from 2010 to 2013. However, in
Nyimba district, collections were done over three years in different clusters (Cluster 14 in
2011, cluster 9 in 2012 and cluster 13 in 2013).  Adult mosquitoes were either collected
while attacking humans by human landing catch (HLC) or by using pack aspirators for the
indoors wall resting mosquitoes. These were collected in cups covered with a netting
material and placed in cooler box for transportation to the NMCC insectary where individual
female Anopheles funestus mosquitoes where allowed to feed on mouse blood so they
could lay eggs that were then reared into F1 generation mosquitoes. Standard World Health
Organization (WHO) susceptibility tests using insecticide-impregnated papers with
discriminatory dosages of two pyrethroids (Deltamethrin 0.05%, and Lambdacyhalothrin
0.05%), a carbamate (Bendiocarb 0.1%), an organophosphate (Malathion 0.4%) and an
organochlorine (DDT 4%) were carried out on 1 to 3 day old F1 An. funestus mosquitoes.
Control papers were impregnated with oil as directed by the WHO protocol (WHO 2013).
Knock down and mortality rates after 1 hour and 24 hour post exposure periods were
recorded.
178
4.2.6 Indoor-outdoor distribution of human exposure to An. funestus bites
To estimate proportions of human exposure to An. funestus bites and malaria transmission
that occurs indoors and outdoors, HLCs were conducted both indoors and outdoors by a
team of trained entomological technicians from the NMCC in Lusaka and these were
complemented by cross-sectional questionnaire surveys of when residents went indoors for
the night, went to sleep, awoke in the morning and left the house in the morning,  as
previous described in detail elsewhere (Seyoum, Sikaala et al. 2012), again as background
descriptive data to support appropriate interpretation of apparent impacts of various
supplementary IRS treatments upon the vector population and malaria transmission.
Trained CHWs conducted HLC from 6pm to 6am the next morning, with the exception of the
previously described 2010 studies where the starting time was 7pm and finishing at 7am.
The 2010 and 2011 HLC surveys were conducted in cluster 4 (Chisobe and Nyamumba
villages of Luangwa district) as part of a trap effectiveness study (Sikaala, Killeen et al. 2013),
while those conducted in 2012 and 2013 where part of the quality assurance surveys
conducted in 13 clusters  as part of a subsequent effectiveness assessment for a
community-based trapping scheme (Sikaala, Chinula et al. 2014). Mosquitoes were collected
for 45 minutes per hour to allow a 15 minutes break for rest and refreshment to the
collectors. Each hourly collection were labelled and kept for identifications to genus and
species as described above. The proportion of time residents spent whilst outdoors and
indoors, as well as asleep in bed, was estimated directly from answers to questionnaires
during a cross-sectional household survey in April 2010 in Luangwa district, in which people
indicated the time they usually went indoors and when they went to the bed as well as
when they arose in the morning and when they left their houses in (Seyoum, Sikaala et al.
2012)
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4.2.7 Data management and statistical analysis
The CHW malaria register data describing RDT results associated questionnaire responses
were double entered into Excel®, verified, reconciled and then cleaned following descriptive
frequency analysis of the distributions of values for each variable. All entomological data
were single entered, verified and cleaned prior to analysis. All statistical analyses were
accomplished using SPSS version 20 (IBM) and R version 2.14.1, augmented with the lattice,
Matrix and LME4 packages.
4.2.7.1 Incremental protection of humans against malaria infection risk by IRS treatments
Previous analyses of these data collected by CHWs have demonstrated that diagnostic
positivity (DP) for malaria infection, expressed as the proportion of RDT-tested individuals
who were found to be positive, was a extremely powerful indicator of malaria risk that
allowed numerous important epidemiological phenomena to be clearly illustrated
(Hamainza, Moonga et al. 2014). It also proved to be a more consistent and robust indicator
of geographic and temporal variation than absolute numbers of malaria infections detected,
presumably because variations in CHW service utilization rates, as well as RDT and ACT
availability, occur in both the nominator and denominator of DP (Hamainza, Killeen et al.
2014) and was therefore treated as the primary epidemiological outcome used for statistical
analysis of the effects of various IRS treatments, rather than incidence in terms of detected
events per number of participants per unit time.
Four sequential time period categories, based on the integer number of months since the
most recent spray round was completed were created for all the IRS treatments: 1 to 3
months, 4 to 6 months and 7 to 12 months since beginning of the last spray round started,
as well as a fifth category combining areas that had not yet received spraying during the
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study period and those for which the last spray round began more than 12 months ago,
which was treated as the reference value. Generalized linear mixed models (GLMMs) were
fitted to evaluate the association between observed malaria infection risk among human
residents and the various IRS treatments applied. Malaria infection status was treated as the
binary dependent, with use of an LLIN, having slept in a house that had been treated with
IRS in the previous 6 months and the categorised cluster-wide IRS treatments as the
independent variables of primary interest. Age category (<1, 1 to 4, 5 to 10, 11 to 14, 15 to
24, 25 to 44 and >45 years of age), sex, season (hot and wet from December to April, cool
and dry from May to August, and hot and dry from September to November), number of
previous RDT tests conducted per individual and geographical location (cluster) were also
included as independent variables of secondary interest (all categorical except for number
of RDT tests) while random effects to capture variance associated with nuisance variables of
no direct interest were also included in the model (the individual identity number nested
within the CHW catchment nested within the study cluster, as well as date of participant
contact). Further, in order to test for and quantify incremental impact of PM IRS as a
supplement to LLINs, relative to LLINs supplemented with pyrethroid-based IRS, both
pyrethroid formulations were represented by a single treatment variable, coding the same
periods of months since before spraying. Similarly, in order to test for and quantify the
incremental impact of the CS formulation of PM, relative to the EC formulation of the same
active ingredient, as well as the two pyrethroid formulations, an additional variable was
created which combined any previous treatment with any of the latter three formulations in
the reference group. In all cases, incremental protective efficacy (IPE) was calculated as the
complement of the odds ratio (OR) estimated directly by these GLMMs (IPE = 1-OR).
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4.2.7.2 Incremental protection of humans against human exposure to mosquito bites and
malaria parasite inoculation by IRS treatments
The effect of different IRS treatment regimens on densities of An. funestus species were
estimated by fitting GLMMs where An. funestus densities were treated as a dependent
variable with a Poisson distribution. In order to account for variance in mosquito densities
by location, identities for households where nested within those villages and then nested
within clusters as random effects. Similarly, nightly temporal variance in vector density was
accounted for by including date as an additional random effect. While the presence or
absence of open eaves is a simple binary independent variable with only two levels, it was
nevertheless treated as a random effect because it is not of direct interest to this analysis so
that the other independent variables represent values for the mean of all houses with and
without open eaves, rather than the mean for a reference condition, presumably absence of
eaves. The different IRS treatment regimens were coded in terms of time period since the
last round of IRS application began, exactly as described above for the epidemiological
primary outcomes, so that these treatments could be included as categorical independent
variables with which to detect and quantify impact upon these entomological secondary
outcomes.  In all the relative rate (RR) at which mosquitoes were captured, was calculated
as estimated directly by these GLMMs. Unfortunately, efforts to develop laboratory capacity
for determining sporozoite infection status by enzyme-linked immunosorbent assay at
NMCC were unsuccessful so neither sporozoite prevalence nor entomological inoculation
rate could be assessed as additional entomological secondary outcomes.
4.2.8 Physiological resistance to insecticides
Insecticide susceptibility assays were conducted on 2 – 5 day old F1 generation An. funestus
as described by the WHO standard protocol (WHO 1998) using papers impregnated with
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Deltamethrin (0.05%), Lambdacyhalothrin (0.05%), Bendiocarb (0.1%), Malathion (0.1%) or
DDT (4%).
In order to test for time trends in physiological resistance of An. funestus to pyrethroids and
carbamates over time, survival status of mosquitoes exposed to these insecticides in
standard WHO protocols (WHO 2013) was treated as the binary outcome variable in GLMMs
with, year as a continuous covariate, and a unique identification code for each experimental
replicate as a random effect. The data were stratified into subsets on the basis of the
insecticide class with separate models fitted for the carbamate (Bendiocarb), and the
combined pyrethroids (Deltamethrin and Lambdacyhalothrin). The model of resistance time
trends for the two pyrethroids, the identities of these two insecticides within this class were
included as a categorical independent variable. No such model was fitted for either the
organochlorine (DDT) or the organophosphate (Malathion) because no resistance to either
insecticide was apparent.
4.2.9 Proportions of human exposure to An. funestus bites occurring indoors and outdoors
The distribution of human exposure to An. funestus bites, and presumably malaria
transmission, across different times of the night and across indoor and outdoor
compartments of their living environment was calculated by weighting HLC measurements
of indoor and outdoor biting rates for each hour of the night by the estimated proportion of
humans indoors and outdoors during that time period, exactly as previously described
(Seyoum, Sikaala et al. 2012). These estimates of human exposure distribution across indoor
and outdoor environments were calculated and presented graphically for both users and
non-users of LLINs, so that the proportions of human exposure that occur indoors in the
presence (πi,n) and absence (πi) of a protective LLIN could be quantified and visualized.
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4.2.10 Protection of human participants and ethical approval
Prior to the study, community sensitization was conducted and permission obtained from
the local community leadership. Informed consent was obtained from all study participants
during all surveys and spraying activities. The study team ensured that all treatment and
diagnostic protocols were adhered to and that patients requiring malaria treatment
received it promptly or were referred to the nearest health facility. All standard safety
protocols were adhered to during the process of IRS as per national guidelines. Ethical
approval was obtained from the University of Zambia, Biomedical Research Ethics
Committee (Reference 004-05-09) and the Research Ethics Committee of the Liverpool
School of Tropical Medicine (Approval 09.60). Authority to conduct and publish the study
was also obtained from the Ministry of Health in Lusaka, Zambia.
4.3 Results
4.3.1 Characteristics of study participants and survey clusters
A total population of 25,354 people centred around HFs in the 14 clusters participated in the
study and were followed up for a period of 29 months in Luangwa and 26 months in
Nyimba, starting from January 2011 and April 2011, respectively. Out of these participants,
29% (7412) were children under the age of 5 but DP peaked in older children between the
age of 5 and 10. The overall cluster populations ranged from 1,158 to 3,429. A total of
31,974 malaria infections (21.7% DP) were identified, which translates into an incidence of 9
infections per 100 person years. The study population reported a relatively high average
rate of LLIN utilization of 81.7% of questionnaire responses over the course of the study
indicating that the respondent had slept under an LLIN the previous night, while 39.2% of
participant questionnaire responses indicated that the respondent’s house had been
184
treated by IRS in the last six months. During same overall study period mean DP by cluster
across all age groups and other potential stratification criteria ranged from 6.4% to 41.9%
(mean = 24.5%), with the lowest being in the southern urban cluster and the highest in the
northern rural cluster (Table 15). The potential confounding effect of LLIN ownership was
excluded from the model because it had no significant effect (P>0.05) on diagnostic
positivity (Table 15).
Table 15.Association of malaria infection status with age, sex, LLINs, IRS, number of tests
conducted per participant, geographical location, season and IRS insecticide used x xi
Category DP%a n/Nb(I) OR[95%CI]c Pd
Overall 21.7 31974 /147257(25354) 0.13 [0.08,0.21] <0.001
Age
<1 14.2 501 /3535 (1735) 1.26[1.09,1.45] 0.001
1-4 24.0 6127 /25505 (5677) 2.75[2.54,2.98] <0.001
5-10 27.4 10066 /36779 (7608) 3.62[3.35,3.91] <0.001
11-14 26.0 4892 /18840 (4746) 3.36[3.09,3.65] <0.001
15-24 20.3 4491 /22077 (5685) 2.04[1.88,2.22] <0.001
25-44 14.9 4028 /27044 (5807) 1.24[1.14,1.34] <0.001
≥45 13.8 1796 /13027 (2903) 1[NA] NA
Sex
Male 23.3 16068 /79208 (12008) 1[NA] NA
Female 20.3 15750 /67567 (13228) 0.86[0.83,0.90] <0.001
Interventions
LLINs 20.0 20613/103149 (20706) 0.89[0.85,0.93] <0.001
IRS 17.4 7568 /43560 (9926) 0.87[0.82,0.93] <0.001
Number of tests conducted per
participant
21.7e 31974 /147257(25354) 0.97[0.97,0.98] <0.001
Type of visit
Passive 43.4 6416 /14785 (8922) 1[NA] NA
Active 19.2 25281 /131359
(22055)
0.29[0.28,0.31] <0.001
Clusters
Luangwa district
Sinyawagora RHC 19.7 1314 /6655 (1959) 2.86[1.65,4.97] <0.001
Kasinsa RHC 16.7 2232 /13402 (3429) 4.67[2.78,7.84] <0.001
Chitope RHC 19.6 3419 /17463 (1215) 2.92[2.04,4.17] <0.001
Luangwa High School RHC 16.5 2854 /17320 (1158) 7.37[4.31,12.61] <0.001
Mphuka RHC 24.9 2981 /11957 (2147) 7.37[4.31,12.61] <0.001
Mandombe RHC 10.3 1386 /13508 (1805) 1.54[0.89,2.66] 0.119
Luangwa Boma RHC 6.4 839 /13161 (2033) 1[NA] NA
Nyimba district
Kacholola RHC 26.7 3108 /11654 (1166) 7.50[4.75,11.84] <0.001
Hofmeyer RHC 41.9 2601 /6214 (2120) 15.81[10.20,24.52] <0.001
Mtilizi RHC 37.6 2238 /5949 (2024) 12.35[7.72,19.76] <0.001
Mtilizi RHP 25.3 2478 /9788 (3379) 13.49[8.45,21.56] <0.001
Chinambi RHC 31.9 1740 /5463 (1741) 9.16[5.79,14.48] <0.001
Mkopeka RHC 32.8 2761 /8413 (1311) 14.22[8.55,23.63] <0.001
Chipembe RHC 32.1 2023 /6310 (1916) 13.54[8.03,22.84] <0.001
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Season
Hot & wet (Dec – April) 25.3 18283 /72217 (20243) 4.20[3.67,4.81] <0.001
Cool & dry (May - Aug) 23.9 11216 /46860 (16513) 3.25[2.80,3.76] <0.001
Hot & dry (Sept – Nov) 8.7 2444/ 27983 (12590) 1[NA] NA
Insecticide applied for IRS
Deltamethrine
1-3 months since last spray 13.3 322 /2419 (2166) 0.81[0.65,1.01] 0.064
4-6 months since last spray 23.8 2411 /10150 (4231) 1.07[0.94,1.23] 0.295
7-12 months since last spray 13.6 2128/15640 (4434) 1.16[1.03,1.30] 0.013
Never sprayed and >13  months
since last spray 22.8
27083/118899 (23233) 1[NA] NA
Lambdacyhalothrin
1-3 months since last spray 4.7 145/3102 (1526) 0.69[0.53,0.90] 0.006
4-6 months since last spray 9.4 207/2199 (1264) 1.26[1.01,1.57] 0.042
7-12 months since last spray 4.5 157/3508 (1469) 0.94[0.74,1.21] 0.653
Never sprayed and >13  months
since last spray 22.7
31435/138299 (24931) 1[NA] NA
Primiphosmethyl EC
1-3 months since last spray 18.9 1922/10194 (5527) 0.77[0.69,0.85] <0.001
4-6 months since last spray 28.8 2666/9259 (5926) 0.64[0.58,0.71] <0.001
7-12 months since last spray 16.0 1793/11184 (5760) 0.63[0.56,0.71] <0.001
Never sprayed and >13  months
since last spray 21.9
25563/116471 (22311) 1[NA] NA
Primiphosmethyl CS
1-3 months since last spray 13.0 468/3590 (2675) 0.37[0.31,0.43] <0.001
4-6 months since last spray 30.6 1386/4536 (3349) 0.24[0.21,0.27] <0.001
7-12 months since last spray 49.5 95/192 (191) 1.35[0.85,2.15] 0.204
Never sprayed and >13  months
since last spray 21.6
29995/138790 (24588) 1[NA] NA
x a – Diagnostic positivity, b – (n – Number RDT positive, N – Total number), I – number of
individuals that participated, c – odds ratio with 95% confidence intervals, d – p-value, e -
RDT determined diagnostic positivity at first, NA –Not applicable /reference group
xi The association of malaria infection with age, sex, use of LLINs, use of IRS, geographical
location (cluster), number of tests conducted per participant, season and insecticide used in
IRS was determined using GLMM; with observed malaria RDT determined status as a binary
dependent outcome with the independent categories of age, sex, access and use of LLINs or
IRS, insecticide used in IRS, number of tested conducted per participant and seasons. The
models included date and participant  nested within CHW catchment nested within
geographical location (cluster) as random effects except for one in which cluster was treated
as a categorical variable to determine the effects of each cluster. The final model consisted
of age, sex, access and use of LLINs or IRS, insecticide used in IRS, season, number of tests
conducted per participant and geographical location as the determinants of malaria
infection.
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Table 16: IRS coverage, LLIN utilization and Diagnostic Positivity Snapshot 1 to 6 months
post IRS implementation by cluster.
Period Cluster IRS Status IRS Coverage %
(n/N)
LLINs use % (n/N) Diagnostic positivity
% (n/N)
October 2010
to March  2011
1 None 0.0 (0/1577) 65.1 (1025/1575) 24.7 (372/1508)
2 None 0.0 (0/827) 98.0 (2485/2537) 20.9 (559/2676)
3 None 0.0 (0/2182) 49.0 (1492/3046) 26.9 (809/3006)
4 Deltamethrin WG 72.0 (1920/2667) 82.3 (2194/2667) 33.2 (825/2489)
5 Deltamethrin WG 92.4 (1362/1474) 95.8 (1412/1474) 27.5 (396/1439)
6 Deltamethrin WG 95.3 (2750/2886) 95.4 (2744/2876) 11.9 (338/2845)
7 Deltamethrin WG 98.5 (2358/2395) 99.7 (2467/2474) 6.0 (144/2415)
8 None 0.0 (0/424) 6.6 (28/426) 55.7 (202/363)
9 None 0.0 (0/7) 36.4 (4/11) 36.4 (4/11)
10 None 0.0 (0/343) 39.7 (136/343) 50.7 (172/339)
11 None 0.0 (0/134) 32.1 (43/134) 51.3 (60/117)
12 None 0.0 (0/49) 79.6 (39/49) 61.9 (26/42)
13 None 0.0 (0/221) 30.8 (68/221) 60.0 (120/200)
14 None 0.0 (0/77) 41.6 (32/77) 52.4 (33/63)
October 2011
to March 2012
1 None 0.0 (0/1105) 87.4 (1063/1217) 9.5 (95/998)
2 Pirimiphosmethyl EC 10.3 (245/2380) 75.8 (2235/2948) 8.5 (280/3292)
3 None 0.0 (0/2593) 33.1 (1253/3790) 10.8 (436/4033)
4 Pirimiphosmethyl EC 57.9 (2194/3788) 92.9 (3541/3811) 5.9 (217/3708)
5 Pirimiphosmethyl EC 57.6 (1952/3392) 97.7 (3388/3469) 18.2 (624/3436)
6 Lambdacyhalothrin CS 80.7 (1128/1398) 80.2 (1139/1421) 5.2 (76/1457)
7 Lambdacyhalothrin CS 81.8 (2317/2833) 99.9 (3107/3109) 4.2 (130/3111)
8 None 0.0 (0/3918) 75.4 (2952/2917) 29.9 (974/3261)
9 Pirimiphosmethyl EC 33.5 (541/1613) 51.95 (838/1613) 46.6 (684/1467)
10 None 0.0 (0/1466) 55.4 (812/1466) 35.4 (444/1254)
11 Pirimiphosmethyl EC 1.8 (74/4117) 60.1 (2474/4117) 30.2 (941/3112)
12 None 0.0 (0/1546) 59.7 (925/1549) 33.9 (514/1517)
13 Pirimiphosmethyl EC 16.8 (407/2422) 45.9 (1111/2422) 27 (5.033/1974)
14 None 0.0 (0/1964) 52.1 (1023/1964) 41.3 (786/1904)
October 2012
to March 2013
1 None 0.0 (0/464) 100.0 (464/464) 14.4 (150/1039)
2 None 0.0 (0/1076) 99.8 (1074/1076) 11.9 (126/1061)
3 None 0.0 (0/1915) 99.1 (1897/1915) 14.1 (282/2004)
4 Pirimiphosmethyl EC 100 (1170/1170) 100.0 (2632/2632) 10.8 (314/2908)
5 Pirimiphosmethyl EC 100 (1387/1387) 99.7 (1725/1730) 27.3 (456/1673)
6 Lambdacyhalothrin CS 100 (348/348) 100.0 (1386/1386) 3.8 (57/1505)
7 Lambdacyhalothrin CS 88.8 (645/726) 100.0 (1123/1123) 2.99 (33/1105)
8 Pirimiphosmethyl CS 0.7 (18/2439) 28.5(696/2439) 9.0 (209/2321)
9 Pirimiphosmethyl CS 73.7 (1386/1881) 48.5 (913/1881) 23.5 (366/1561)
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10 Pirimiphosmethyl CS 0.7 (10/1379) 85.1 (1174/1379) 27.1 (363/1341)
11 None 0.0 (0/3440) 16.5 (566/3440) 11.9 (300/2531)
12 Pirimiphosmethyl CS 30.3 (346/1143) 82.2 (940/1143) 21.7 (246/1132)
13 None 0.0 (0/2433) 46.4 (1128/2433) 30.6 (666/2180)
14 Pirimiphosmethyl CS 40.4 (574/1421) 38.1 (541/1421) 16.99 (221/1301)
The close associations of DP for P. falciparum malaria infection and An. funestus density,
clinical symptoms of illness, and a variety of other factors of this setting are described in
detail elsewhere based on the first year of data collection (Hamainza, Moonga et al. 2014;
Sikaala, Chinula et al. 2014). The detailed profile of the study participants, and their survey
contacts over the course of the entire study, are summarized in the context of the study
design in Figure 27.
A descriptive comparison of summarized data restricted to the period 1 to 6 months post
spraying demonstrates variability among study clusters in not only in IRS coverage (Range =
0% to 100%, mean= 29.4%) but also LLIN use (Range = 6.6% to 100%, mean= 68.2%) and
diagnostic positivity (Range = 2.99% to 61.9%, mean= 25.4%) (Table 16). Further analysis
using Pearson’s correlation, revealed a positive but weak association (R2=0.31) between IRS
coverage and LLIN use, suggesting that as IRS coverage increases, so does LLIN use.
However, this does not necessarily imply any causal relationship and factors which affect
delivery (e.g. accessibility) and acceptance (e.g. attitudes towards malaria or mosquitoes)
may well be similar for both of these vector control measures. However, there was no
obvious and clear-cut effect of any particular IRS treatment in this crude descriptive
comparison (Table 16) so detailed regression modelling analysis was required to detect and
estimate the separate impacts of these four different formulations (Figures 28 to 30).
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Figure 27. Study profile indicating treatments provided to each cluster with associated
timelines, population surveyed and persons nights of mosquito trapping
4.3.2 Magnitude and duration of incremental impact of IRS treatments as supplements to
LLINs upon human risk of infection with malaria
Reported coverage of deltamethrin WG, lambdacyhalothrin CS, pirimiphosmethyl EC, and
pirimiphosmethyl CS, by respondents within the first 3 months after their application in
clusters to which they were assigned were 82% (2132/2599),61% (2068/3384), 53%
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(5909/11078) and 69% (2716/3913), respectively. As illustrated in Figure 28,
Primiphosmethyl CS conferred the strongest initial incremental protection in the first 3
months after application (Incremental protective efficacy (IPE) [95% Confidence interval
(CI)= 0.63 [0.57, 0.69], P<0.001), relative to LLINs alone, followed by the CS formulation of
Lambdacyhalothrin (IPE [95%CI] = 0.31 [10, 47], P=0.006), the EC formulation of
primiphosmethyl (IPE [95%CI] = 0.23 [0.15, 0.31], P<0.001) and the WP formulation of
Deltamethrin (IPE [95%CI] = 0.19 [-0.01, 0.35], P=0.064). However, neither pyrethroid
formulation provided any incremental protection beyond 3 months post-application, while
the incremental protection provided by CS and EC formulations of Pirimiphosmethyl
persisted undiminished for 6 and 12 months respectively (Figure 28).
Figure 28. The incremental protective efficacy of each of the four IRS treatments on
diagnostic positivity for Plasmodium falciparum malaria infection over several time
periods since the last spray round began, relative to clusters that has either never been
sprayed or had last been sprayed >12 months ago (reference group).
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In the first three months after spraying,  IRS with the CS formulation of pirimiphosmethyl
offered greater protection against malaria infection than IRS with pyrethroids IPE [95%CI] =
0.51 [0.38, 0.62], P<0.001 for LLINs+IRS with PM-CS compared to LLINs+IRS in all clusters
treated with either DM-WG or LC-CS but not PM-EC (P<0.001). The incremental protection
against malaria infection by IRS with both PM formulations outlasted both pyrethroid
formulations so that they both offered greater protection from 4 to 6 months post-
application IPE [95%CI] = 0.79 [0.75, 0.83], P<0.001 for LLINs+IRS with PM-CS and IPE
[95%CI] = 0.42 [0.33, 0.48], P<0.001 for LLINs+IRS with PM-EC, compared to LLINs+IRS with
either DM-WG or LC-CS) (Figure 29).
Figure 29. The incremental protective efficacy of primiphosmethyl EC and CS IRS
treatments on diagnostic positivity for Plasmodium falciparum malaria infection over
several time periods since the last spray round began, relative to clusters that have been
sprayed with either deltamethrin and /or lambdacyhalothrin (reference group)
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Beyond 6 months post-application, LLINs plus IRS with PM-CS provided no apparent
incremental protection relative to LLINs alone (P=0.204), much less LLINs+IRS with
pyrethroids (P=0.432). However, LLINs+PM-EC continued to provide incremental protection
relative to not only LLINs alone (Figure 28), but also relative to all other LLIN+IRS treatments
(IPE [95%CI] = 0.41 [0.34, 0.48], P<0.001). When the duration of efficacy of PM-EC was
examined in further detail by breaking down the third post-spray time period into two
halves, it was clear that it lasted approximately a full year because similar levels of
incremental protection was confirmed for both the 7 to 9 month post-spray period (IPE
[95%CI] = 0.32 [0.22, 0.40], P<0.001) and the 10 to 12 month post-spray period (IPE [95%CI]
= 0.42 [0.31, 0.52], P<0.001).
Comparing these two IRS formulations of PM with each other as supplements to LLINs, the
CS formulation confers greater protection than the EC formulation, (IPE [95%CI] = 53.6
[0.43, 0.66] %, P<0.001 from 1 to 3 months post-application and 0.64 [0.57, 0.69], P<0.001
from 4 to 6 months post-application for the contrast between LLINs+PM-CS versus the
LLIN+PM-EC as the reference group) (Figure 30). However, once the incremental benefit of
supplementing LLINs with IRS using PM-CS waned after 6 months, IRS using PM-EC proved
statistically superior to all other IRS formulations as supplements to LLINs for a further 6
months, including the CS formulation of the same active ingredient (IPE [95%CI] =0.52 [0.21,
0.70], P<0.001 for the contrast between LLINs+PM-EC versus LLIN+PM-CS as a reference
group between 7 and 12 months post application).
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Figure 30. The incremental protective efficacy of pirimiphosmethyl EC IRS treatment on
diagnostic positivity for Plasmodium falciparum malaria infection over several time
periods since the last spray round began, relative to clusters that have been sprayed with
pirimiphosmethyl CS (reference group)
4.3.3 Magnitude and duration of incremental impact of IRS treatments as supplements to
LLINs upon human risk of exposure to bites of An. funestus.
Detailed description of the local mosquito fauna in the study area (Sikaala, Chinula et al.
2014) showed that 34.5% of all mosquitoes caught over the course of the study were
identified morphologically as members of the An. funestus group, of which  96.5% (575/596)
of those which were successfully  amplified by PCR were confirmed to be An. funestus Giles.
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consistent with previous studies in this area (Seyoum, Sikaala et al. 2012; Sikaala, Killeen et
al. 2013) indicating it as the overwhelmingly dominant vector of malaria in these two
districts of Zambia. Therefore, subsequently in this report we refer to all mosquitoes caught
from the An. funestus group as the nominate species in the strict sense.
The relative rates and the mean catches of Anopheles funestus per IRS treatment are
presented in Table 17. Relative to the times and places that had never been sprayed, or
sprayed or had been sprayed >12 months ago, there were no obvious differences in the
densities of An. funestus during the first three months post-spraying for both pyrethroid
formulations (DM-WG (IPE[95%CI]=0.01[-0.56,0.37],P=0.103) and LC-CS (IPE[95%CI]=-0.03[-
0.88,0.44],P=0.195) and PM-EC (IPE[95%CI]=-0.04[-0.30,0.17],P=0.103) (Figure 31, Table 17).
However, where PM-CS was applied, mosquito densities were dramatically reduced during
the same period of three months immediately after spraying (IPE [95%CI] =0.93[0.87, 0.97],
P<0.001). Between the fourth and the sixth month after spraying with DM-WG, there was an
apparent, but presumably spurious, three-fold increase in An. funestus densities while LC-
CS, PM-EC and PM-CS achieved 5, 3 and 71-fold  reductions, respectively (Table 17).
However, from the seventh to twelfth months after spraying, DM-WG and PM-EC had no
obvious effect on the An. funestus densities while insufficient data was available to examine
the incremental impact of LC-CS or PM-CS.
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Figure 31.The incremental protective efficacy of each of the four IRS treatments against
An. funestus bites over several time periods since the last spray round began, relative to
clusters that has either never been sprayed or had last been sprayed >12 months ago
(reference group)
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Table 17.Association of Anopheles funestus densities with different IRS insecticides
supplementing LLINs upon months before, during and when not spraying
Indoor residual spraying  Insecticide
treatment regimen applied
Absolute
numbers
caught
Mean catchesa
Relative rates of An. funestus
densities
[95% Confidence Interval (CI)] (RR)b [95% CI] P-value
Deltamethrin WG)
1-3 months since last spray 73 0.112[0.641, 0.371] 0.99 [0.63, 1.56 ] 0.897
4-6 months since last spray 1229 0.641[0.371, 1.109] 3.98 [3.15, 5.04] <0.001
7-12 months since last spray 134 0.111[0.062, 0.199] 0.86 [0.64, 1.17] 0.067
>12  months since last spray or never 1186 0.189[0.113, 0.317] 1[NA]c NA
Lambdacyhalothrin CS
1-3 months since last spray 20 0.191[0.090, 0.405] 1.03[0.56, 1.88] 0.805
4-6 months since last spray 6 0.055[0.022, 0.141] 0.17[0.08, 0.39] <0.001
7-12 months since last spray 0 NEe NE 0.972
>12  months since last spray or never 182 0.198[0.121] 1[NA]c NA
Pirimiphosmethyl EC
1-3 months since last spray 478 0.234[0.131, 0.417] 1.04[0.83, 1.30] 0.786
4-6 months since last spray 346 0.055[0.030, 0.098] 0.25[0.20, 0.33] <0.001
7-12 months since last spray 160 0.159[0.086, 0.293] 0.69[0.50, 0.95] 0.151
>12  months since last spray or never 2823 0.234[0.131, 0.417] 1[NA]c NA
Pirimiphosmethyl CS
1-3 months since last spray 14 0.021[0.009, 0.047] 0.07[0.04, 0.13] <0.001
4-6 months since last spray 70 0.004[0.002, 0.008] 0.02[0.01, 0.02] <0.001
7-12 months since last spray NAd NAd NAd NAd
>12  months since last spray or never 2087 0.253[0.152, 0.422] 1[NA]c NA
a & b The effect of different IRS treatment regimens on the mean catches of An. funestus
species where estimated by fitting  generalized linear mixed models (GLMMs) with An.
funestus catches treated as dependent variables. The households where nested within
villages which were also nested within the clusters, these together with date were treated
as random effects, while the different IRS treatment regimens were categorized as
independent variables. A Poisson distribution with no intercept was used to estimate the
mean catches while an intercept was included in estimating the RR.
C Treated as the reference group
d No spraying was conducted therefore and no data available for estimates
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4.3.4 Background observations of insecticide resistance and human exposure profiles for
local Anopheles funestus populations
From the outset of the study, An. funestus exhibited high levels of resistance to both
pyrethroids against which they were tested, and resistance level generally increased over
the course of the study (P<0.001). Alarming rates of resistance to the carbamate bendiocarb
were also observed but these did not increase over the course of the study (P=0.565).
During this same period, there was no evidence of Malathion or DDT resistance detected in
the mosquito populations (Figure 32).
Figure 32. Insecticide resistance profile of Anopheles funestus in the study site from 2010
to 2013
Throughout the study period, humans lacking LLINs were exposed to far more bites by An.
funestus indoors during the late hours of the night up to the early morning hours (Figure
33), consistent with the known behaviour of An. funestus across the continent (Gillies and
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Coetzee 1987; Huho, Briet et al. 2013). The vast majority potential exposure to bites by this
dominant vector occurred indoors at times when most individuals are asleep (Figure 33).
Even for those using an LLIN to prevent most indoor transmission, most residual human
exposure to An. funestus bites, and presumably malaria transmission, occurred indoors,
increased gradually from 57% in 2010 to 71% by 2013 (Figure 33).
Figure 33.Mean exposure of humans to Anopheles funestus bites when they are indoors
or outdoors, where πi is the average proportion of human exposure to bites of Anopheles
funestus’ population which occurs indoors in the absence of any protective measure, π s
is the average proportion of human exposure to bites of Anopheles funestus’ population
which occurs indoors when individuals are asleep in the absence of any protective
measure and π i,n is the average proportion of residual human exposure for users of net
which occurs indoors
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4.4 Discussion
In this setting of high LLIN unitization (>80%), even the modest (0-100%, mean=29.4%)
coverage achieved with supplementary IRS conferred an incremental protection against
malaria parasite infection through reduced vector population density, human exposure to
bites and, presumably, to sporozoite inoculations. Overall supplementing of LLINs with IRS
using  PM-CS gave the greatest apparent protection against malaria risk, which lasted for a
full 6 months, while IRS with PM-EC conferred less dramatic protection that was comparable
with pyrethroids but apparently lasted for one full year. Neither of the two pyrethroid
formulations exhibited any incremental protective effect for more than 3 months but it is
notable that LC-CS conferred an apparently greater protective effect than DM-WG. These
observations that quasi-randomly assigned IRS treatments conferred additional protection
when provided as a supplement to LLIN utilization are consistent with a variety of other
observational studies (Kleinschmidt, Schwabe et al. 2009; Kim, Fedak et al. 2012), as well as
more recent randomized controlled studies (West, Protopopoff et al. 2014). The high level
of incremental impacts observed, despite sometimes mediocre coverage with IRS, are
actually consistent with the predictions of process-explicit models used to support the policy
switch to universal coverage for both LLINs and IRS (WHO 2006), especially for a very
anthropophagic mosquito like Anopheles funestus (Killeen, Smith et al. 2007), which is even
more anthropophagic than the An. gambiae species (Killeen, McKenzie et al. 2001) used as
an example mosquito in that simulation paper.
The high protective effect of PM-CS is also evident in the low densities of An. funestus
caught in that group. The modest and short-lived protective effect of the two pyrethroid
formulations, DM-WG and LC-CS most probably a result of the emergence of resistance to
pyrethroids in the An. funestus population present in this study area, consistent with
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evidence from Benin in west Africa that the protective effect of these insecticide
formulations can be dramatically reduced to as little as a month by physiological resistance,
even where these specific formulations have a residual activity against susceptible insectary-
reared mosquitoes for up to 6 months (Rowland, Boko et al. 2013). While this rapid loss of
incremental protection towards malaria elimination with pyrethroid-based supplementary
IRS is of obvious and very direct concern (Wondji, Coleman et al. 2012; Haji, Khatib et al.
2013; Wang, Xia et al. 2013).The encouraging results obtained with IRS using PM, the CS
formulation in particular, provide further evidence that pyrethroid resistance may be
mitigated and managed in areas of high LLIN coverage using IRS (Corbel, Akogbeto et al.
2012; West, Protopopoff et al. 2014), or alternatively impregnating wall linings (Djènontin,
Chandre et al. 2010; Ngufor, Tchicaya et al. 2014), with non-pyrethroids selected on the
basis of standard WHO susceptibility assays. These observations are therefore consistent
with similar recent reports from several distinct settings across Africa (Hunt, Edwardes et al.
2010; N'Guessan, Boko et al. 2010; Akogbeto, Padonou et al. 2011; West, Protopopoff et al.
2014) and can be readily rationalized on the basis of the combined observations of strong
resistance to pyrethroids, complete susceptibility to organophosphates, and strong
tendency to feed, and presumably rest indoors among the local An. funestus population.
It was expected that PM-CS would be the most persistent because this microencapsulated
formulation is known to confer residual longevity for 6 months (Rowland, Boko et al. 2013;
Oxborough, Kitau et al. 2014) as confirmed here. However, it was surprising that PM-EC had
the longest longevity on these surfaces, apparently lasting 12 months after spraying,
contrary to other studies suggesting that PM-EC is ineffective on mud surfaces (Oxborough,
Kitau et al. 2014) and WHO estimates of a residual effect of only 3 months (WHO 2013) but
is consistent with one other recent study (Fuseini, Ebsworth et al. 2011). While it is possible
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to speculate that the persistence of PM-EC may have resulted from an initial absorption into
the porous mud walls in most of the houses in the study areas, followed by  slow
subsequent release, it is also possible that this is simply the result of a spurious model fit to
data from such a limited number of treated clusters with considerable inter-cluster variation
in malaria risk level and seasonality, as presumably occurred for DM-WG which is highly
unlikely to have really increased malaria transmission (Figure 28, Table 15) or vector density
(Figure 31, Table 17). The observation that impact of both PM formulations and LC-CS upon
vector density was greatest between 4 and 6 months after spraying suggests that maximum
impact upon the vector population required sustained impact upon several generations of
mosquitoes, well into the peak rainy season when they would be expected to grow
exponentially and improve in reproductive fitness as the availability of larval habitat rapidly
increases (Briet 2002; Russell, Lwetoijera et al. 2013).
Of course, there are several substantive limitations to this study. While the community-
based nature of both the parasitological and entomological surveys, with only modest
supervision and quality assurance, does leave some uncertainties about the data quality,
recent detailed analyses of these primary (Hamainza, Killeen et al. 2014; Hamainza, Moonga
et al. 2014) and secondary outcomes (Sikaala, Chinula et al. 2014) provide reassuring
confirmation of their epidemiological relevance and discriminative power. While this study
did not explicitly or comprehensively track the distinct costs of IRS and LLINs, these costs
may be assumed to incurred largely independently of each other because of their distinct
delivery methods, and have already been evaluated in detail across a variety of settings by
other authors (Goodman, Mnzava et al. 2001; Guyatt, Kinnear et al. 2002; Bhatia, Fox-
Rushby et al. 2004; Conteh, Sharp et al. 2004).
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However, the most obvious limitation of this study is that it was not conducted as a rigorous
randomized control trial and that deviations from the original randomization plan resulted
in only a quasi-randomised design in practice, with known selection biases. This was also
coupled with a lack of a statically estimated sample size. An additional considerable
limitation arising from dependency on delivery of supplementary IRS through routine
programmatic implementation mechanisms was the lack of consistent availability of a
single, optimal formulation of a single pyrethroid or a single formulation of PM, so the study
was unfortunately fragmented into more treatment arms with smaller numbers of assigned
clusters per spray round than originally planned. Also, delays and limitations in the
availability of PM formulations in the final year of the study resulted in a mismatch in the
timing of application of PM-CS in Nyimba (November 2012), PM-EC, and LC-CS (Both
February 2013).
So, in summary this study was not fully randomized because the implementation
contractors did not fully adhere to the study design stipulated to them by the NMCC. This
study may therefore be described as a quasi-randomized experimental evaluation to
generate plausible evidence that the IRS treatments provide effective incremental impact
beyond that already provided by high coverage with LLINs under near-programmatic
conditions. The biggest inherent limitation of observational studies is their vulnerability to
selection bias and confounding (Carlson and Morrison 2009; Boffetta 2011). The study
largely adhered to its original randomization plan, and some of the most confounding
variables were taken into consideration during planning and implementation (stratification
of clusters into those that had previously been sprayed with deltamethrin and those that
had not) and analysis (additional variables in regression models) phases. However, the
deviations from the randomization plan by the implementing agencies were specifically
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necessitated by product stock availability and motivated by efforts to target IRS to areas
where they felt it was needed most, so treatment allocation was clearly systematically
biased a priori in these cases. It is therefore prudent to interpret the level of evidence
generated conservatively, and to classify this study as being essentially observational in
nature. To generate probable evidence of efficacy under more precisely controlled (if
somewhat less programmatically relevant(Habicht, Victora et al. 1999; Glasgow,
Lichtenstein et al. 2003)) conditions would have entailed a rigorous, fully-randomised trial
with a registered protocol including sample size estimates, data quality assurance and
oversight committees (Habicht, Victora et al. 1999; Moher, Schulz et al. 2001; Glasgow,
Lichtenstein et al. 2003; Flay, Biglan et al. 2005).
While the shortcomings of this study must be accepted, there is no obvious specific reason
to suggest that they are inaccurate, and they do contribute to a relatively limited evidence
base regarding the incremental impact of IRS formulations as supplements to LLINs(Pinder,
Jawara et al. 2014). Despite these study design limitations, the evidence generated remains
useful for guiding programmatic selection of IRS treatments. Perhaps just as important, it
represents the first effort of the NMCC itself, rather than its specialist research and
academic partner institutions, to conduct a cluster-randomized experimental evaluation of
malaria transmission control measures. It therefore represents an invaluable experience
through which the capacity of the NMCC has grown and can hopefully build upon.
4.5 Conclusion
Despite these study limitations, the results presented here do provide substantial evidence
that (1) supplementing pyrethroid-based LLINs with pyrethroid-based IRS confers some,
albeit short-lived, incremental protection against malaria infection relative to LLINs alone,
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and (2) Replacing pyrethroids with an alternative insecticide class, in this case a long-lasting
CS formulation of the organophosphate PM, as the active ingredient for supplementary IRS
confers considerably enhanced protection, relative to IRS with pyrethroids. Supplementing
LLINs with IRS using non-pyrethroids therefore appears to be efficacious for mitigating the
immediate epidemiological consequences of vector population resistance to pyrethroids,
and the observed impact on An. funestus densities suggest it may also be a valuable option
for managing such resistance traits, ideally by using mosaics, rotations or combinations of
complementary active ingredients (WHO 2012). Of course the primary limitation to the
realization of such insecticide resistance management and mitigation plans in practice are
(1) the availability of more efficacious, affordable and diverse insecticide formulations
(Vontas, Moore et al. 2014), (2) increased financing for malaria vector control generally
(WHO 2014), and (3) more cost-effective methods for targeting insecticides to vector
populations so that both the biological resource coverage (Kiware, Chitnis et al. 2012;
Killeen, Seyoum et al. 2013) and mortality rates arising from exposure to their active
ingredients are maximized (Elliott 1972; Kitau, Oxborough et al. 2012; Okumu, Kiware et al.
2013; Okumu, Mbeyela et al. 2013; Killeen and Chitnis 2014).
204
CHAPTER FIVE
GENERAL DISCUSSION AND CONCLUSION
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Further to the work presented in the previous chapters, here is presented a summary of
how each objective was addressed, the immediate implications of the results, and
remaining knowledge gaps which should be prioritized for future research are as follows:
5.1 The role Community health workers as a resource for delivery of health care and
monitoring and evaluation
The roles of CHWs in provision of diverse health services has been well documented (Ajayi,
Falade et al. 2008; Yeboah-Antwi, Pilingana et al. 2010; Counihan, Harvey et al. 2012;
Ratsimbasoa, Ravony et al. 2012; Rutta, Francis et al. 2012) and have been promoted since
the 1970s, when the World Health Organization’s intensified the global drive for
strengthened primary health care services particularly in middle and low income countries
(WHO 1978; Cueto 2004) . The CHWs also provide a link between the community and
peripheral health facilities through their services which increase the reach of the healthcare
system within the communities they reside and serve (WHO 1989; Winch, Gilroy et al. 2005)
resulting in appreciable declines in morbidity and mortality particularly in maternal and child
health (Kumar, Mohanty et al. 2008; Thea and Qazi 2008; Lassi, Haider et al. 2010; Yeboah-
Antwi, Pilingana et al. 2010; Chanda, Hamainza et al. 2011).
The findings described in Chapters 2, 3 and 4 are all derived from the activities of CHWs,
whose primary goal was provision of malaria infection diagnostic testing, treatment of those
found with infection and referral of patients with a negative test result who are febrile or
have some other symptomatic compliant, thus further adding to the body of knowledge by
re-affirming the role of CHWs in primary health care with regard to diagnosis and treatment
of malaria. Chapter 2 further demonstrates that CHWs are able to follow provided
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guidelines and adhere to treatment protocols more than trained health workers as
demonstrated in other studies (Chanda, Hamainza et al. 2011; Chinbuah, Abbey et al. 2013).
In chapters 2, 3 and 4, in addition to the treatment functions, CHWs demonstrated their
ability to contribute to the overall monitoring and evaluation system through the
surveillance tools they were provided in the form of paper registers and mobile phones.
Globally, most CHW driven monitoring and evaluation activities are conducted as disease
specific vertical un-integrated programs resulting in information not being shared across
disease areas to benefit users at different levels with regard to efficient data use, program
implementation and resource allocation. However, there has been renewed interest in
integration of services provided by CHWs. Refinements made to algorithms under
integrated management of child illness (IMCI), has lead to the increased uptake of the
concept of integrated community case management (iCCM) primarily targeted at children in
most African countries (WHO 2004; WHO and UNICEF 2004). The iCCM concept increases
access to treatment of common ailments such as diarrhoea, pneumonia, and malaria by
training CHWs to assess / diagnose, treat and refer patients in their communities (WHO
2004; WHO and UNICEF 2004; Yeboah-Antwi, Pilingana et al. 2010; Hamer, Brooks et al.
2012). However, such concepts have not been effectively implemented in tandem with a
robust integrated monitoring and evaluation systems and thus for all intensive purposes
remain disease specific vertical programs. Integration has an advantage in that it fosters
coordination and communication between different disease groups. In this regard for CHW
operationalised monitoring and evaluation activities to achieve sustainability, they must be
integrated across disease areas that CHWs have the mandate to provide diagnosis and
treatment. Additionally these should be developed in a manner that can be integrated with
national health information systems through harmonization of indicators. An integrated
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system would facilitate pooling of resources from the different groups in order to
sufficiently support implementation and other investment requirements (Ruebush and
Godoy 1992; Ruebush, Zeissig et al. 1992; WHO 2012; WHO 2012).
5.2 Measuring malaria risk using Community Health Worker driven community based
surveillance
In general malaria surveillance is guided by analysis of aggregated morbidity and /or
mortality data which guides a programmatic population level response (WHO 2012; WHO
2012). Community Health Worker (CHW) implemented surveillance may be considered an
intervention (Mueller, Slutsker et al. 2011; The malEra Consultative Group on Monitoring
and Surveillance 2011; Chaki, Mlacha et al. 2012; WHO 2012), as it presumably increases the
number of individuals tested, treated, recorded and subsequently reported allowing for
more accurate risk mapping due to their larger geographical coverage (Alba, Hetzel et al.
2011; Liu, Sullivan et al. 2011; WHO 2012; WHO 2012; Tulenko, Mogedal et al. 2013).
Decentralised monitoring and evaluation activities that are focussed on identifying malaria
risk in communities are integral in evidence based planning and implementation of malaria
control interventions and resource allocation (WHO 2012; WHO 2012). As the burden of
malaria decreases there is need to strengthen monitoring and evaluation activities to the
smallest reporting unit possible to allow for focal responses (Chaki, Mlacha et al. 2012;
Smith, Cohen et al. 2013; Sikaala, Chinula et al. 2014). In most endemic countries CHWs
serve the smallest catchment population in the health system and thus can potentially serve
as such a reporting unit (Ruebush and Godoy 1992; Ruebush, Zeissig et al. 1992). Further,
this allows for simplified identification, selection and follow-up of these populations at a
reduced cost. These community based surveillance systems (CBSS) may additionally be
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utilised to not only estimate access and use of interventions but also evaluate their impact
longitudinally (Ruebush and Godoy 1992; Ruebush, Zeissig et al. 1992; Chaki, Govella et al.
2009; Alba, Hetzel et al. 2011; O'Sullivan, Kenilorea et al. 2011; WHO 2012; WHO 2012;
Sikaala, Chinula et al. 2014).
As demonstrated in chapter 2, CBSS can be added to the well documented various diagnosis
and treatment roles of CHWs (Ruebush and Godoy 1992; Ruebush, Zeissig et al. 1992;
Counihan, Harvey et al. 2012; Ratsimbasoa, Ravony et al. 2012) . This longitudinal study was
implemented through CHWs providing passive and monthly active malaria testing and
treatment of infected participants. This allowed for the establishment of symptomatic
criteria associated with malaria parasite infection to distinguish these from other causes of
symptomology such as fever in the entire population under study (Roucher, Rogier et al.
2012).The coupling of these activities with a questionnaire at participant contact further
allowed for in-depth assessment of various indicators with regard to symptoms, access and
use of malaria interventions and selected population demographics. Thus the use of both
passive and active testing and treatment in the CBSS allowed for an integrated and
comprehensive analysis of changes within the communities under study. This chapter
demonstrates that in areas of intense transmission, despite reasonably high LLIN and IRS
coverage monthly active testing and treatment activities did not eliminate the human
reservoir of malaria infection at the testing frequency experienced during the study (Okell,
Drakeley et al. 2008; Shah, Tyagi et al. 2013; Trape, Tall et al. 2014). However, there was a
notable decline in disease burden by participants that allowed to be tested and treated for
infection more regularly (Okell, Drakeley et al. 2008; Shah, Tyagi et al. 2013; Trape, Tall et al.
2014). Additionally, this chapter demonstrated the strong association of symptoms with
malaria infection, suggesting inexactness of the term “asymptomatic infection” with regard
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to chronic malaria infections (Bisoffi, Gobbi et al. 2012; Cucunuba, Guerra et al. 2013;
Lindblade, Steinhardt et al. 2013). A key programmatic emphasis of this chapter was to
capture and report all malaria infections in the study population as a practical indicator of
programmatic relevance. However this was not achieved due to being dependent on study
participants consent to participate thus affecting the overall sensitivity of the intervention.
This suggests that the community engagement approach used by the CHWs may have not
been sufficient to impact community participation in repeated testing and treatment
activities whether they had a positive or negative RDT result (Chen 1991; Espino, Koops et
al. 2004; Beier, Keating et al. 2008). This is of relevance to malaria control, particularly in an
elimination drive where such test and treatment activities play an integral part, particularly
in identification of mildly symptomatic cryptic/chronic infections which are able to drive
transmission and risk mapping for targeted intervention deployment (Bousema, Drakeley et
al. 2010; Bousema, Griffin et al. 2012; Okell, Bousema et al. 2012; WHO 2012; Sturrock,
Hsiang et al. 2013). Thus, a diminishing malaria burden scenario coupled with mild
symptom manifestation requires a well co-ordinated and comprehensive community
engagement approach for uptake of community based active test and treat programs
among others (Chen 1991; Espino, Koops et al. 2004; Chaki, Dongus et al. 2011) .
As further demonstrated in chapter 3, CHWs were not only able to collect epidemiological
data on the catchment populations they served (Baker and Ross 1996), but were able to
transmit this information onward using both paper and electronic media via mobile phones.
Information is critical to any effective malaria control program as it allows for data driven
decisions on intervention options and investments required (Barclay, Smith et al. 2012;
Chaki, Mlacha et al. 2012; Morse 2012; WHO 2012; WHO 2012; Free, Phillips et al. 2013;
Sikaala, Chinula et al. 2014). The evidence globally on the ability for CHWs to routinely
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transmit data through mobile phones or indeed any other electronic device remains limited.
However, chapter 3 demonstrated that weekly summaries of malaria infections and
estimates of diagnostic positivity transmitted via SMS were an adequate representation of
the paper registers which were the primary data capture mechanism for the CHWs.  The
SMS reports also adequately reflected the epidemiological transmission patterns of the
population under observation on a timely basis. Suggesting, a role for electronic devices for
routine surveillance at a community level operationalised by CHWs or other health workers
to allow for timely collation, access and dissemination for evidence based decision making
(Kamanga, Moono et al. 2010; Zurovac, Talisuna et al. 2012; Free, Phillips et al. 2013;
Githinji, Kigen et al. 2014). This technology thus, has the potential to improve service
delivery by bridging the communication gap between program managers and frontline
health workers including CHWs through provision of real time epidemiological spatial and
temporal data (Kamanga, Moono et al. 2010; Zurovac, Talisuna et al. 2012; Free, Phillips et
al. 2013; Githinji, Kigen et al. 2014).
Although, not explicitly explored the findings in chapter 3 further suggest a role for SMS
reporting as a potential management tool to monitor performance of frontline health
workers (Free, Phillips et al. 2013; Githinji, Kigen et al. 2014; Yukich, Butts et al. 2014) and in
this case, the CHWs, as exemplified particularly with regard to whether they achieved the
targeted number of active household visits per week and tracking the availability and use of
AL and RDTs. The SMS reporting system however would have benefited from server based
automation to reduce human error resulting from manual single entry of the received
reports and also if there was consideration to bring such a platform to scale (Barrington,
Wereko-Brobby et al. 2010; Meankaew, Kaewkungwal et al. 2010; NMCC 2011; Free, Phillips
et al. 2013; Githinji, Kigen et al. 2013; Githinji, Kigen et al. 2014).
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It is obvious that for the SMS platform to function there is need for mobile phone coverage,
which though currently increasing in Africa (ITU 2010) has not yet been adequately made
available in the remotest parts which are also in most cases the areas of highest burden.
Thus a limitation to scale of such a platform may be the availability of mobile phone
coverage which essentially is not in the hands of the health sector but a business decision by
the mobile phone companies.
Chapter 4 evaluated the impact of four insecticides used in IRS on malaria risk under the
backdrop of high LLIN utilization. This quasi-randomised study utilised data collected by the
CHWs from their parasitological (passive and active) and entomological surveys. Even
though active surveillance detects more malaria infections, it has been argued that it may
not be the best approach for intervention evaluation because early detection and cure of
infections by repeated testing and treatment may reduce prevalence by itself, and therefore
limit the level of impact achieved by the intervention, as well as by preventing re-infection if
drugs are used that have some prophylactic effects. Also, the most symptomatic acute
phases occur relatively early in the course of infection (Jeffery and Eyles 1954; Collins and
Jeffery 1999) so passive surveillance is considered a better measure of impact upon recently
acquired infections (Tiono, Kangoye et al. 2014). However this approach limits the findings
to only the population that seeks care and may not be representative of the entire
population, which requires larger population numbers (Tiono, Kangoye et al. 2014).
However, few studies have been conducted to directly compare active and passive
surveillance for intervention evaluation and thus the evidence still remains limited and
ambiguous (Tiono, Kangoye et al. 2014). This chapter demonstrated enhanced incremental
protection against malaria infection through reduced vector population density, human
exposure to bites and, presumably, to sporozoite inoculations using long lasting
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organophosphate formulations in IRS than the pyrethroids in an area of high LLIN utilization
and demonstrated pyrethroid resistance (Kleinschmidt, Schwabe et al. 2009; Kim, Fedak et
al. 2012).
As expected all the insecticides evaluated decay with regard to incremental protective effect
overtime at different rates, suggesting that even when IRS is applied, LLINs should continue
to be used in order to maintain some level of protection whenever the IRS insecticidal
effects diminish (Okumu, Chipwaza et al. 2012). These findings have programmatic
implications as preventive interventions such as LLINs and IRS constitute a substantial cost
of approximately 70% of the overall cost of malaria control (WHO 2009) and the debate of
their optimal use singularly or in combination at programmatic level is yet to be exhausted
(Curtis, Maxwell et al. 1998; Mnzava, Dlamini et al. 1999; Mabaso, Sharp et al. 2004;
Kleinschmidt, Schwabe et al. 2009; Corbel, Akogbeto et al. 2012; Fullman, Burstein et al.
2013). Through the CBSS, it was possible to routinely monitor these vector control
intervention utilization/coverage and their effect on both vector abundance and community
malaria prevalence as indicators of program progress (Breman and Holloway 2007; Fillinger,
Kannady et al. 2008; Chaki, Mlacha et al. 2012; Sikaala, Chinula et al. 2014). The
demonstration that CHWs are able to not only provide curative services but also with
minimum training provide complementary entomological data may provide an opportunity
for integrated longitudinal epidemiological and entomological monitoring of intervention
programs as part of a scalable national surveillance system (Breman and Holloway 2007;
Fillinger, Kannady et al. 2008; Chaki, Dongus et al. 2011; Chaki, Mlacha et al. 2012; Sikaala,
Chinula et al. 2014).
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The uptake of complementary community based surveillance systems may mitigate a
fundamental limitation of health facility based only surveillance which may be biased in its
reporting based on only those patients that have access to the facilities, further biasing any
analysis of epidemiological trends which may in fact not be a true reflection of the general
community trends in the catchment population of the health facility. This may lead to
incorrect application of interventions and resources. Additionally, health facility surveillance
does not routinely incorporate access and use of preventive interventions such as LLINs and
IRS (MOH 2008; WHO 2012; WHO 2012). Nationally representative surveys may also be
used to estimate from a community perspective these short comings from routine health
facility based surveillance. However these surveys are point estimates conducted at a very
high cost and provide a general picture of community trends which may be not adequate to
address specific focal community needs as can be done by a routine surveillance system that
reflects both health facility and community trends. Furthermore, as malaria prevalence
drops these surveys are not sensitive enough to capture changes in transmission without
increasing the sample size which has rather huge cost implications which may be a challenge
to met for most malaria programs (Hay, Smith et al. 2008).This further strengthens the
suggestion of a complementary role of CBSS which if implemented across disease areas may
be cost effective and sustainable by most endemic countries.
5.3 Limitations and future considerations for community based service provision and
surveillance systems
The successes of CHW driven community based health interventions have been well
documented and they range from health education, diagnosis and treatment, distribution of
preventive measures such as LLINs, implementation of IRS and community mobilization/
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sensitization among others (WHO 1989; Ruebush and Godoy 1992; Ruebush, Zeissig et al.
1992; Sikaala, Chinula et al. 2014) . For CHW driven activities to be successful they require
constant logistical, management, supervisory and monitoring support (Ruebush and Godoy
1992; Ruebush, Zeissig et al. 1992; Chaki, Govella et al. 2009; Sikaala, Chinula et al. 2014) .
An ever current, updated report on epidemiological indicators is vital to ensuring that CHWs
meet the desired objectives whether preventive, curative or otherwise. However, there are
some challenges that require urgent redress if CHW service provision is be successful.
A key challenge is the vertical approach to CHW program implementation (Ruebush and
Godoy 1992; Ruebush, Zeissig et al. 1992; Chanda, Hamainza et al. 2011; Counihan, Harvey
et al. 2012; Kalyango, Rutebemberwa et al. 2012; Keating, Hutchinson et al. 2012; Kisia,
Nelima et al. 2012; Sikaala, Chinula et al. 2014). In most endemic countries the CHW
approach is essentially threefold, where the service delivery needs of a community are
divided among available CHWs with each managing one service delivery aspect alone or
where CHWs manage several service delivery needs in a given community or a scenario
where these two approaches are implemented in a single community (WHO 2012; WHO
2012; WHO 2012). This is driven by among other things availability of potential CHWs within
a given community and the retention of these CHWs once selected. In all scenarios what still
remains common is the linkage with the health facility which is not only the supervisory
entity but also acts as commodity supply point and receives reports from the CHWs on their
activities. The reports received particularly on any commodity consumption such as RDTs
and treatments are incorporated as part of the health facility report, thus suppressing any
knowledge with regard to CHW contributions to service provision particularly higher up in
the reporting chain (Odhiambo-Otieno 2005; Mutemwa 2006; MOH 2008; Maokola, Willey
et al. 2011). This is mainly due to the fact that, a vast majority of CHWs globally do not have
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access to a surveillance reporting system that encompasses all their reporting requirements.
Such a platform would not only provide community based surveillance data for decision
making, but would also inadvertently be an advocacy tool for pushing for appropriate
compensation for CHW efforts. Such a platform would be expected to be a result of an
integrated training curriculum for CHWs across disease areas which would encompass an
integrated package of deliverables at the community level which would in turn foster
sustainability of the CHW activities though pooled infrastructure and resources both human
and financial (Chaki, Govella et al. 2009; WHO 2012; WHO 2012).
As most CHWs provide services on a voluntary basis and thus are unpaid, they seek other
activities that provide an income for them and their household. This may lead to attrition if
their CHWs duties demand more of their time than they can allocate away from their
income generating activities (Olang’o, Nyamongo et al. ; Bhattacharyya, Winch et al. 2001;
Alam, Tasneem et al. 2011; Greenspan, McMahon et al. 2013). Though not a key study
objective, of the 42 paid CHWs retained for the duration of the study, only 2 CHWs
relinquished their roles, 1 due to illness and the other due to relocation. In addition the
CHWs were incentivised by provision of a mobile phone and a weekly top for them to
submit their reports and for any other communication official or not. Additionally, frequent
supervisory visits and ensuring availability of commodities and any other requirements for
the CHWs to function optimally may also serve as an incentive. A clear recommendation
from chapters 2, 3 and 4 for malaria control is to formalise the establishment of CHWs into
the health system. Although efforts towards this have been made in some countries
(Medhanyie, Spigt et al. 2012; Kok and Muula 2013; Zulu, Kinsman et al. 2013), most
endemic countries are yet to formalise the roles of CHWs and develop sustainable
mechanisms to compensate them for their efforts which may even include formal
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employment and associated job security and monetary benefits (Kok and Muula 2013; Zulu,
Kinsman et al. 2013).
In addition to surveillance data providing raw numbers of disease trends, there is need to
have process indicators for monitoring and evaluation to measure progress of interventions
deployed, including the CHW activities themselves. As demonstrated in chapters 2,3 and 4 a
robust and stable indicator such as diagnostic or test positivity may be considered to
provide trends in spatial and temporal malaria transmission as estimates of this parameter
are robust to variations in reporting rates, diagnostic practices and health utilization
because these determinants equally affect the nominator and denominator (WHO 2012).
Such an indicator can be automatically calculated, graphed and if required mapped in real
time (Barrington, Wereko-Brobby et al. 2010; NMCC 2011; Free, Phillips et al. 2013; Githinji,
Kigen et al. 2014) to allow for improved local planning, response and managerial follow-up
to program implementation.
A general challenge for malaria control is the possibility of reduced acceptance of malaria
control interventions as malaria transmission drops and is perceived to be less important in
communities. Towards elimination, the CHW role on the curative side will greatly
encompass programs that will actively seek out infection in communities. As described in
chapter 2, communities may not be easily compliant to testing particularly when they
perceive a low risk of infection. Although, compliance to treatment regimes is acceptably
high in the communities, these assessments have only been done in populations that have
been diagnosed and found with infection. As part of the “end game” for malaria elimination
mass drug administration will become increasingly important and will most probably be in-
part driven by CHWs. Currently there is no effective single dose anti-malarial available on
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the market which could be used a “directly observed treatment” approach to MDA. Thus,
there is need for locally tailored community engagement strategies to improve uptake of
such interventions which could include in addition to MDA, mass or focal active test and
treatment activities.
Community based surveillance for monitoring and evaluation to track progress towards set
targets is an integral part of the overall malaria control and eventual elimination program
and can be operationalised by non expert cadres such as CHWs.
5.4 Conclusions and recommendations
The global strategy for malaria control and elimination is based on 4 key elements: (1)
Provision of prompt and effective treatment; (2) Implementation of sustainable preventive
measures, including vector control; (3) Early detection, prevention and containment of
epidemics, and; (4) Strengthening local capacities to generate evidence through research to
guide program implementation (WHO 1999). Successful implementation of all these
elements requires effective surveillance. One of the most important purposes of
surveillance is to guide decentralized, fine-scale, local program implementation at the level
were the data is collected. Local use of surveillance data, by the health system staff
responsible for collecting it also has the advantage of engaging those staff as motivated
stakeholders in maximizing the quality, quantity and relevance of the data(Wetterhall,
Pappaioanou et al. 1992; WHO 2013; Yukich, Butts et al. 2014). All three chapters of this
study provide evidence for the effectiveness, limitations and potential of a novel CB system
for not only providing universal, regular malaria testing and treatment services, but also
functions as a fine-scale system for surveillance of infection burden among the population.
The findings of this study suggest that repeated testing and treatment of malaria parasite
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infected populations may reduce the burden of disease and associated symptoms but only if
much higher rates of frequent participation are achieved. Also, data generated as an added-
value surveillance function, these activities can clearly be useful for tracking impact of
program interventions. Additionally, the adequacy of electronic platforms for near-real-time
reporting was also demonstrated. Important lessons learned and questions raised by this
study, as well as derived recommendations for future investigation are summarized as
follows:
1. The key to successful suppression of the infectious parasite reservoir in humans lies in
improved community participation in frequent testing and treatment, especially when they
are not acutely ill but may be carrying chronic, mildly symptomatic infections.
2. Decentralized, community-based health care and surveillance can be managed
programmatically and sustainably through existing, facility-based supervision and support
systems
3. Although many systems for engaging CHWs rely on volunteerism, it is important to
examine and optimize systems for recruiting, remunerating, incentiving and retaining of
such CB personnel.
4. Implementation of an effective CBSS beyond this pilot scale will require substantive
capacity development at district, provincial and national levels to support collation,
archiving, analysis and interpretation of the data generated to guide program decision
making.
5. Mobile phone technology can improve routine reporting by CHWs to enable for fine-scale
risk-mapping in near-real-time and enhance program targeting and implementation.
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6. Further studies to establish and evaluate feedback mechanisms through which data from
such a CBSS influence routine programmatic decisions and actions at district, HF and CHW
levels, so that the effectiveness of these systems are optimized through a sense of local
ownership and stewardship.
7. CBSS reports of commodity use and availability should be integrated with logistics
management systems, to mutually strengthen both platforms and ensure timely availability
of all CHW supply requirements.
8. In order to ensure maximum cost-effectiveness and affordability, CBSSs should integrate
all major disease entities which CHWs can diagnose and treat.
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Appendix 1. Community health worker paper register
Patient Register (National Malaria Control Centre / Malaria Transmission Consortium Impact Study)
(+ve = positive, -ve = negative, ND = Not Done, IRS = Indoor Residual Spraying, IPT = Intermittent Presumptive Treatment)
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Appendix 2. SMS reporting summary form (Completed prior to sending report via SMS)
SMS Reporting Summary Form
Health Facility / CHW: ………………………………Date Compiled:…………………Date sent: ………………
Patient
register
(Passive)
Total
OPD
Total
suspected
RDT
+ve
RDT
–ve
Microscopy
+ve
Microscopy -
ve
Under
5 +ve
Over
5 +ve
Patient
register
(active)
Total
screened
RDT
+ve
RDT
-ve
Under
5 +ve
RDT
–ve
REG SCR
Example sms: REG xxxx-xxx-xx-xx-xx-xx-xx-xx-SCR-xx-xx-xx-xx-xx (REG 2000-500-50-450-0-0-10-40-
SCR-50-0-0-0-0)
6s prescribed In stock
Y/N
12s prescribed In stock
Y/N
18s prescribed In stock
Y/N
24s prescribed In stock
Y/N
Available Used
ACT RDT
Example sms: ACT xx-y-xx-n-xx-y-xx-n-RDT-xx-xx (ACT 20-y-20-n-30-y-0-y-RDT-500-500)
SMS Reporting Summary Form
Health Facility / CHW: ………………………………Date Compiled:…………………Date sent: ………………
Patient
register
(Passive)
Total
OPD
Total
suspected
RDT
+ve
RDT
–ve
Microscopy
+ve
Microscopy -
ve
Under
5 +ve
Over
5 +ve
Patient
register
(active)
Total
screened
RDT
+ve
RDT
-ve
Under
5 +ve
RDT
–ve
REG SCR
Example sms: REG xxxx-xxx-xx-xx-xx-xx-xx-xx-SCR-xx-xx-xx-xx-xx (REG 2000-500-50-450-0-0-10-40-
SCR-50-0-0-0-0)
6s prescribed In stock
Y/N
12s prescribed In stock
Y/N
18s prescribed In stock
Y/N
24s prescribed In stock
Y/N
Available Used
ACT RDT
Example sms: ACT xx-y-xx-n-xx-y-xx-n-RDT-xx-xx (ACT 20-y-20-n-30-y-0-y-RDT-500-500)
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Appendix 3. Community health worker monthly summary report
NMCC/ MTC MONTHLY SUMMARY REPORT
DATE: _______ MONTH: ______________ SUBMITTED BY _______________________ SIGN______________
HEALTH CENTER / COMMUNITY HEALTH WORKER: ________________ CATCHMENT AREAS: _______________
ACTIVE PASSIVE TOTAL
TOTAL
TOTAL SUSPECTED
UNDER 5 RDT +VE
UNDER 5 RDT –VE
OVER 5 RDT –VE
OVER 5 RDT +VE
UNDER 5 MICROSCOPY  +VE
UNDER 5 MICROSCOPY -VE
OVER 5 MICROSCOPY +VE
OVER 5 MICROSCOPY –VE
FEVER UNDER 5
FEVER OVER 5
UNDER 5 WITH HISTORY OF FEVER IN LAST
MONTH
OVER  5 WITH HISTORY OF FEVER IN LAST
MONTH
# WITH ITNS
# SLEPT UNDER ITN PREVIOUS NIGHT
# WITH IRS SPRAYED IN LAST 6 MONTHS
# ON IPT
NUMBER NOT TESTED - NOT AVAILABLE
NUMBER NOT TESTED - REFUSED
# OF RDTS IN STOCK
# OF SLIDES IN STOCK
